Web Catalog CRS

List of European Pharmacopoeia Reference Standards
Order
Reference Standard
Code
Y0001561 Abacavir sulfate
Effective from 2015/7/1

Batch n Quantity Sale
per vial Unit
1
20 mg
1
Information
Monograph Leaflet
Storage
2589
Yes
+5C 3C
Extra
Price
charges
79
a
Y0001552 Abacavir for peak identification
10 mg
2589
Yes
+5C 3C
79
Y0001551 Abacavir for system suitability
10 mg
2589
Yes
+5C 3C
79
Y0000055 Acamprosate calcium - reference spectrum
n/a
79
Y0000116 Acamprosate impurity A
50 mg
3-aminopropane-1-sulphonic acid
1585
Yes
+5C 3C
79
Y0000500 Acarbose
100 mg
See leaflet ; Batch 2 is valid until 31 August 2015
2089
Yes
+5C 3C
79
Y0000354 Acarbose for identification
10 mg
2089
Yes
+5C 3C
79
Y0000427 Acarbose for peak identification
20 mg
2089
Yes
+5C 3C
79
A0040000 Acebutolol hydrochloride
50 mg
0871
Yes
+5C 3C
79
Y0000359 Acebutolol impurity B
10 mg
-[3-acetyl-4-[(2RS)-2-hydroxy-3-[(1-methylethyl)amino]
acetamide (diacetolol)
0871
Yes
+5C 3C
79
Y0000127 Acebutolol impurity C
20 mg
N-(3-acetyl-4-hydroxyphenyl)butanamide
0871
Yes
+5C 3C
79
Y0000128 Acebutolol impurity I
0.004 mg
N-[3-acetyl-4-[(2RS)-3-(ethylamino)-2-hydroxypropoxy]phenyl]
butanamide
0871
Yes
+5C 3C
79
Y0000056 Aceclofenac - reference spectrum
n/a
79
Y0000085 Aceclofenac impurity F
15 mg
benzyl[[[2-[(2,6-dichlorophenyl)amino]phenyl]acetyl]oxy]acetate
1281
Yes
+5C 3C
79
Y0000086 Aceclofenac impurity H
10 mg
[[[[[[[2-[(2,6-dichlorophenyl)amino]phenyl]acetyl]oxy]acetyl] oxy]acetyl]oxy]
acetic acid
1281
Yes
+5C 3C
79
Y0001094 Aceclofenac for peak identification
10 mg
1281
Yes
+5C 3C
79
Y0000810 Acemetacin
100 mg
1686
Yes
+5C 3C
79
Y0000811 Acemetacin impurity A
10 mg
1686
Yes
+5C 3C
79
Y0000842 Acemetacin impurity mixture
0.06 mg
1686
Yes
+5C 3C
79
A0070000 Acesulfame potassium
50 mg
1282
Yes
+5C 3C
79
A0070020 Acesulfame potassium impurity B
15 mg
1282
Yes
+5C 3C
79
A0100000 Acetazolamide
100 mg
0454
Yes
+5C 3C
79
Y0001084 Acetazolamide for system suitability
0.0068 mg
Y0000002 Acetylcholine chloride
50 mg
A0150000 Acetylcysteine
50 mg
A0152000 Acetylcysteine impurity C
10 mg
See leaflet; N,N'-diacetyl-L-cystine ; Batch 8 is valid until 31 October 2014
A0153000 Acetylcysteine impurity D
10 mg
Y0000565 -Acetyldigoxin
50 mg
Y0000642 -Acetyldigoxin for peak identification
10 mg
A0200000 Acetylsalicylic acid
15 mg
Y0001460 Acetylsalicylic acid for peak identification
10.3 mg
Y0001462 Acetylsulfadiazine
0.002 mg
A0208000 N-Acetyltryptophan
125 mg
A0202000 N-Acetyltyrosine
200 mg
Council of Europe, all rights reserved 2015
1585
Batch 2 is valid until 31 January 2015

propoxy]phenyl]
1281
4-chlorobenzoic acid
see leaflet; 5-chloro-6-methyl-1,2,3-oxathiazin-4(3)-one 2,2-dioxide
0454
Yes
+5C 3C
79
1485,1971
Yes
-20C 5C
79
0967
Yes
+5C 3C
79
0967
Yes
+5C 3C
79
N,-diacetyl-L-cysteine ; Batch 5 is valid until 28 May 2015
0967
Yes
+5C 3C
79
See leaflet CHO
2168
Yes
+5C 3C
79
2168
Yes
+5C 3C
79
0309
Yes
+5C 3C
79
0309
Yes
+5C 3C
79
0294
Yes
+5C 3C
79
1383
Yes
+5C 3C
79
1384
Yes
+5C 3C
79
Batch 1 is valid until 31 May 2015
Batch 1 is valid until 30 November 2014
For extra charges, please see supply terms and conditions.

Order
Reference Standard
Code
Y0000693 Acholeplasma laidlawii BRP

per vial Unit
1
1 ml
1
Information
Monograph Leaflet
20607
Yes
Storage
Extra
Price
charges
120
-80C 10C
d
A0220000 Aciclovir
75 mg
0968
Yes
+5C 3C
79
Y0001271 Aciclovir for peak identification 1
0.303 mg
0968
Yes
+5C 3C
79
Y0001269 Aciclovir for peak identification 2
0.004 mg
Batch 2 is valid until 31 December 2014
0968
Yes
+5C 3C
79
Y0001264 Aciclovir for system suitability
10 mg
0968
Yes
+5C 3C
79
A0225000 Acitretin
100 mg
1385
Yes
+5C 3C
79
Y0001463 Actaea racemosa HRS
1200 mg
2069
Yes
+5C 3C
79
Y0001543 Actaea racemosa for assay CRS
300 mg
2069
Yes
+5C 3C
79
Y0001464 Actaea racemosa dry extract for system suitability HRS
1200 mg
2069
Yes
-20C 5C
79
Y0001121 Adapalene
100 mg
See leaflet CHO
2445
Yes
+5C 3C
79
Y0001120 Adapalene impurity C
6 mg
1-[2-(methyloxy)phenyl]tricyclo[3.3.1.1]decane ; Batch 2 is valid until 30

September 2014
2445
Yes
+5C 3C
79
Y0001119 Adapalene for peak identification
2.022 mg
2445
Yes
+5C 3C
79
A0230000 Adenine
50 mg
0800
Yes
+5C 3C
79
A0230200 Adenosine
50 mg
1486
Yes
+5C 3C
79
Y0000110 Adipic acid
50 mg
1586
Yes
+5C 3C
79
Y0000882 Adrenaline
5 mg
2303
Yes
+5C 3C
79
Y0000740 Adrenaline impurity mixture
0.0045 mg
0254,2303
Yes
+5C 3C
79
Y0000883 Adrenaline with impurity F
10 mg
2303
Yes
+5C 3C
79
A0300000 Adrenaline tartrate
100 mg
0254
Yes
+5C 3C
79
Y0000707 Adrenaline tartrate with impurity A
15 mg
0254
Yes
+5C 3C
79
Y0001724 Agnus castus fruit dry extract
350 mg
see leaflet
2309, 2147
Yes
-20C 5C
79
A0325000 Alanine
60 mg
This reference standard will be deleted from mono 0614 on july 2015 1st
0614, 0752
Yes
+5C 3C
79
New A0325100 Albendazole
50 mg
1386
Yes
+5C 3C
79
50 mg
1285
Yes
-20C 5C
79
1286
Yes
-20C 5C
e(d)
300
1286
Yes
-20C 5C
e(d)
79
79
Yes
+5C 3C
79
A0325200 Alcuronium chloride

New A0325450 Alfacalcidol
See leaflet CHO

See leaflet CHNO; Monoammonium glycyrrhizate
5 mg
Y0001601 Alfacalcidol for system suitability
2.5 mg
A0325451 Alfacalcidol - reference spectrum
n/a
A1225000 Alfadex
150 mg
A0325500 Alfentanil hydrochloride - reference spectrum
n/a
1062
79
A0325800 Alfuzosin hydrochloride
10 mg
1287
Yes
+5C 3C
79
Y0000832 Alfuzosin for system suitability
10 mg
1287
Yes
+5C 3C
79
Y0001583 Alimemazine hemitartrate
15 mg
2650
Yes
+5C 3C
79
Y0001581 Alimemazine for system suitability
5 mg
2650
Yes
+5C 3C
79
A0349000 Allantoin
60 mg
1288
Yes
+5C 3C
79
100 mg
0576
Yes
+5C 3C
79
New A0350000 Allopurinol

See leaflet ; Batch 8 is valid until 31 October 2015
1286
See leaflet [CH0]

2
1070,1487

Order
Reference Standard
Code
A0350010 Allopurinol impurity A
A0350020 Allopurinol impurity B

Information
per vial Unit
2
10 mg
1 5-amino-1H-pyrazole-4-carboxamide
3
10 mg
1 5-formylamino-1H-pyrazole-4-carboxamide
Monograph Leaflet
Storage
0576
Yes
+5C 3C
Extra
Price
charges
79
a
0576
Yes
+5C 3C
79
A0350030 Allopurinol impurity C
10 mg
5-(4H-1,2,4-triazol-4-yl)-1H-pyrazole-4-carboxamide
0576
Yes
+5C 3C
79
New A0350040 Allopurinol impurity D
15 mg
ethyl 5-amino-1H-pyrazole-4-carboxylate ; Batch 3 is valid until 30 September

2015
0576
Yes
+5C 3C
79
A0350050 Allopurinol impurity E
20 mg
ethyl 5-(formylamino)-1H-pyrazole-4-carboxylate
0576
Yes
+5C 3C
79
A0351000 Allylstrychnine bromide
10 mg
1285
Yes
-20C 5C
79
Y0000235 Almagate
25 mg
2010
Yes
+5C 3C
79
Y0000255 Almagate - reference spectrum
n/a
79
A0357000 Alprazolam - * psy
100 mg
1065
Yes
+5C 3C
79
A0360000 Alprenolol hydrochloride
100 mg
0628,0876
Yes
+5C 3C
79
Y0000054 Alprostadil
50 mg
see leaflet
Y0000606 Altizide
150 mg
See leaflet CHClNOS
Y0000843 Altizide impurity B
15 mg
3-[(2,2-dimethoxyethyl)sulphanyl]prop-1-ene
Y0000687 Alverine citrate
5 mg
Y0000607 Alverine impurity D
10 mg
Y0000595 Alverine for peak identification
0.125 mg
A0363000 Amantadine hydrochloride
100 mg
A0363700 Ambroxol hydrochloride
125 mg
A0900000 Amfetamine sulfate - reference spectrum
A0365000 Amidotrizoic acid dihydrate
Y0001461 Amidotrizoic acid for system suitability
0.08 mg
A0368000 Amikacin
200 mg
See leaflet
Y0001467 Amikacin impurity I
20 mg
(2S)-4-amino-2-hydroxybutanoic acid
Y0001117 Amikacin for system suitability
10 mg
A0365900 Amikacin sulfate
200 mg
A0370000 Amiloride hydrochloride
100 mg
Y0000020 Amiloride impurity A
20 mg
Y0000173 4-Aminobenzoic acid
60 mg
A0420000 Aminocaproic acid
50 mg
A0460000 7-Aminodesacetoxycephalosporanic acid
20 mg
A0496000 Aminoglutethimide
125 mg
A0496005 Aminoglutethimide impurity A
20 mg
A0496020 Aminoglutethimide impurity D
10 mg
A0575000 Amiodarone hydrochloride
100 mg
See leaflet
2010
1488
Yes
-20C 5C
79
0370,2185
Yes
+5C 3C
79
2185
Yes
+5C 3C
79
2156
Yes
+5C 3C
79
2156
Yes
+5C 3C
79
2156
Yes
-20C 5C
79
0463
Yes
+5C 3C
79
1489
Yes
+5C 3C
79
n/a
0368
79
100 mg
0873
Yes
+5C 3C
79
0873
Yes
+5C 3C
79
1289,1290
Yes
+5C 3C
79
1289, 1290
Yes
+5C 3C
79
1289,1290
Yes
+5C 3C
79
1290
Yes
+5C 3C
79
0651
Yes
+5C 3C
79
0651
Yes
+5C 3C
79
1687
Yes
+5C 3C
79
0874
Yes
+5C 3C
79
0708,0813
Yes
+5C 3C
79
1291
Yes
+5C 3C
79
(3)-3-(3-aminophenyl)-3-ethylpiperidine-2,6-dione; (3-aminoglutethimide)
1291
Yes
+5C 3C
79
3,3'-[diazenediyldi(4,1-phenylene)]bis(3-ethylpiperidine-2,6-dione);
(azoglutethimide)
1291
Yes
+5C 3C
79
0803
Yes
+5C 3C
79
N-(3-cyclohexylpropyl)-N-ethyl-3-phenylpropan-1-amine
The batch 3 is not suitable for use in the assay in monograph 1290:07/2012.
Amikacin CRS A0368000 is also needed. See leaflet.
methyl-3,5-diamino-6-chloropyrazine-2-carboxylate
Cefadroxyl impurity B

Order
Reference Standard
Code
Y0000129 Amiodarone impurity D
Y0000130 Amiodarone impurity E

Information
per vial Unit
3
20 mg
1 (2-butyl-benzofuran-3-yl)-(4-hydroxy-3,5-diiodophenyl)methanone
3
20 mg
1 (2-butylbenzofuran-3-yl)(4-hydroxyphenyl)methanone
Monograph Leaflet
Storage
0803
Yes
+5C 3C
Extra
Price
charges
79
a
0803
Yes
+5C 3C
79
A0590000 Amisulpride
10 mg
1490
Yes
+5C 3C
79
Y0001534 Amisulpride for system suitability
1.0015 mg
1490
Yes
+5C 3C
79
Y0000563 Amitriptyline hydrochloride
10 mg
0464
Yes
+5C 3C
79
Y0000049 Amlodipine besilate
150 mg
See leaflet
1491
Yes
+5C 3C
79
Y0001068 Amlodipine impurity A
15 mg
3-ethyl 5-methyl (4RS)-4-(2-chlorophenyl)-2-[[2-(1,3-dioxo-1,3-dihydro-2Hisoindol-2-yl)ethoxy]methyl]-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate
1491
Yes
+5C 3C
79
Y0001069 Amlodipine impurity B
15 mg
3-ethyl 5-methyl (4RS)-4-(2-chlorophenyl)-6-methyl-2-[[2-[[2(methylcarbamoyl)benzoyl]amino]ethoxy]methyl]-1,4-dihydropyridine-3,5dicarboxylate
1491
Yes
+5C 3C
79
Y0001070 Amlodipine impurity G
15 mg
dimethyl 4-(2-chlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5dicarboxylate
1491
Yes
+5C 3C
79
Y0001067 Amlodipine for peak identification
15 mg
1491
Yes
+5C 3C
79
Y0000302 Ammonio methacrylate copolymer(type A) - reference

spectrum
n/a
2081
79
Y0000303 Ammonio methacrylate copolymer(type B) - reference

spectrum
n/a
2082
79
A0650000 Amobarbital - * psy
500 mg
0594
Yes
79
A0700000 Amobarbital sodium - * psy
500 mg
0166
Yes
+5C 3C
79
A0800000 Amoxicillin trihydrate
200 mg
See leaflet CHNOS
0167,0168,0
260,
0577,0578,0
813,
1140,1653
Yes
+5C 3C
79
Y0001521 Amoxicillin trihydrate for performance verification
5000 mg
See leaflet
20232, 20512
Yes
+5C 3C
79
Y0000005 Amphotericin B
100 mg
See leaflet ; Batch 4 is valid until 30 September 2015
1292
Yes
-20C 5C
79
Y0001361 Amphotericin B for microbiological assay
100 mg
See leaflet
20702
Yes
-20C 5C
79
Y0001014 Amphotericin B for peak identification
10 mg
1292
Yes
-20C 5C
79
A1000000 Ampicillin (anhydrous)
220 mg
0167,0168,0
578,
1168,1169
Yes
+5C 3C
79
A1100000 Ampicillin trihydrate
150 mg
0168,0260,0
577,
0578,0808,2
211, 2212
Yes
+5C 3C
79
Y0001244 Amylmetacresol
285 mg
2405
Yes
+5C 3C
79
Y0001245 Amylmetacresol for peak identification
10 mg
2405
Yes
+5C 3C
79
Y0001522 Anastrozole
100 mg
See leaflet CHN
2406
Yes
+5C 3C
79
Y0001531 Anastrozole impurity E
10 mg
2,2'-[5-(hydroxymethyl)benzene-1,3-diyl]bis(2-methylpropanenitrile)
2406
Yes
+5C 3C
79
See leaflet CHNOS
See leaflet CHO
+5C 3C

Order
Reference Standard
Code
Y0001386 Angelica dahurica root HRS

per vial Unit
1
160 mg
1
Y0001385 Angelica pubescens root
500 mg
A1200000 Anhydrotetracycline hydrochloride
15 mg
Y0001466 Anhydrous Docetaxel
15 mg
A1210000 Antazoline hydrochloride
Y0001465 Apomorphine hydrochloride hemihydrate
Y0001471 Apomorphine impurity B (morphine sulfate) * - narc

A1220000 Alpha-apo-oxytetracycline
A1230000 Beta-apo-oxytetracycline
Y0001154 Aprotinin for system suitability
A1250000 Aprotinin solution BRP
A1269000 L-Arabinitol
Information
Monograph Leaflet
2556
Yes
Storage
+5C 3C
Extra
Price
charges
79
a
2557
Yes
+5C 3C
79
0210,0211,1
654
Yes
+5C 3C
79
2593
Yes
+5C 3C
79
50 mg
0972
Yes
+5C 3C
79
15 mg
0136
Yes
+5C 3C
79
40 mg
0136
Yes
+5C 3C
90
20 mg
0198
Yes
+5C 3C
79
20 mg
2.7 mg
0.5 ml
10 mg
Y0000806 Arbutin
100 mg
See leaflet CHO
A1270000 Arginine
50 mg
see leaflet
Y0000304 Arginine aspartate
20 mg
A1271000 Arginine hydrochloride
Y0001649 Aripiprazole
Y0001650 Aripiprazole impurity F
See leaflet
See leaflet; morphine sulfate

See leaflet CHNO
See leaflet
0198
Yes
+5C 3C
79
0580, 0579
Yes
+5C 3C
79
0579,0580
Yes
+5C 3C
79
1381
Yes
+5C 3C
79
1054
Yes
+5C 3C
79
0806, 1654,
2114, 2566
Yes
+5C 3C
79
2096
Yes
+5C 3C
79
60 mg
0805,0885,0
998
Yes
+5C 3C
79
170 mg
See leaflet
2617
Yes
+5C 3C
79
10 mg
7-[4-[4-(2,3-dichlorophenyl)-1-oxidopiperazin-1-yl]-3,4-dihydroquinolein-2
(1H)-one
2617
Yes
+5C 3C
79
n/a
140 mg
See leaflet
20821
Yes
+5C 3C
79
Y0001185 Aristolochic acid I
11 mg
See leaflet
20821
Yes
+5C 3C
79
Y0001175 Aristolochic acid for system suitability
1 mg
20821
Yes
+5C 3C
79
Y0000079 Articaine hydrochloride
200 mg
Batch 2 is valid until 30 June 2015
1688
Yes
+5C 3C
79
Y0000080 Articaine impurity A
25 mg
methyl3-[[2-(propylamino)acetyl]amino]-4-methylthiophene-2- carboxylate ;
1688
Yes
+5C 3C
79
Y0000081 Articaine impurity E
10 mg
methyl 4-methyl-3-[[(2RS)-2-[(1-methylethyl)amino]propanoyl]amino]
thiophene-2-carboxylate ; Batch 1 is valid until 31 August 2014
1688
Yes
+5C 3C
79
Y0001091 Artichoke leaf dry extract HRS
60 mg
2389
Yes
-20C 5C
79
A1300000 Ascorbic acid
100 mg
Vitamin C
0253,0958,1
791
Yes
+5C 3C
79
Y0001024 Ascorbic acid impurity C
20 mg
see leaflet CHO; D-xylo-hex-2-ulosonic acid (D-sorbosonic acid) ; Batch 2

is valid until 31 May 2015
0253,1791
Yes
+5C 3C
79
Y0001170 Ascorbic acid impurity D
10 mg
methyl D-xylo-hex-2-ulosonate (methyl D-sorbosonate)
0253,1791
Yes
+5C 3C
79
Y0000800 Ascorbyl palmitate
10 mg
0807
Yes
+5C 3C
79
Y0000305 Asparagine monohydrate
60 mg
2086
Yes
+5C 3C
79
Y0001323 Aristolochia

Order
Code
A1320000 Aspartame
Reference Standard

per vial Unit
2
40 mg
1
Information
A1321000 Aspartame impurity A
10 mg
A1330000 Aspartic acid
50 mg
Y0001171 Astragaloside IV
40 mg
A1340000 Atenolol
100 mg
Y0001089 Atenolol for system suitability
5 mg
Y0001586 Atomoxetine hydrochloride
110 mg
See leaflet CHClNO
Y0001588 Atomoxetine impurity B
10 mg
Y0001589 Atomoxetine impurity D
5 mg
Y0001587 Atomoxetine for impurity A identification
Y0001327 Atorvastatin calcium trihydrate
Y0001328 Atorvastatin impurity A
Y0001329 Atorvastatin impurity B
Y0001330 Atorvastatin impurity C

Y0001331 Atorvastatin impurity D
Monograph Leaflet
Storage
0973
Yes
+5C 3C
Extra
Price
charges
79
a
0973
Yes
+5C 3C
79
0750,0797
Yes
+5C 3C
79
2435
Yes
-20C 5C
79
0703
Yes
+5C 3C
79
0703
Yes
+5C 3C
79
2640
Yes
+5C 3C
79
(3S)-N-methyl-3-(2-methylphenoxy)-3-phenylpropan-1amine
2640
Yes
+5C 3C
79
(3R)-N-methyl-3-(3-methylphenoxy)-3-phenylpropan-1amine
2640
Yes
+5C 3C
79
10 mg
N-methyl-3-phenoxy-3-phenylpropan-1-amine
2640
Yes
+5C 3C
79
150 mg
See leaflet CHCaFNO
2191
Yes
+5C 3C
79
10 mg
desfluoroatorvastatin
2191
Yes
+5C 3C
79
10 mg
3-epi-atorvastatin
2191
Yes
+5C 3C
79
10 mg
fluoroatorvastatin ; Batch 1 is valid until 30 August 2014
2191
Yes
+5C 3C
79
10 mg
3-[(4-fluorophenyl)carbonyl]-2-(2-methylpropanoyl)-N,3-diphenyloxirane-2carboxamide
2191
Yes
+5C 3C
79
Y0001332 Atorvastatin impurity E
10 mg
ent-atorvastatin
2191
Yes
+5C 3C
79
Y0001572 Atovaquone
270 mg
See leaflet CHClO
2192
Yes
+5C 3C
79
Y0001573 Atovaquone for system suitability
10 mg
2192
Yes
+5C 3C
79
Y0000424 Atracurium besilate
120 mg
1970
Yes
+5C 3C
79
Y0000503 Atracurium for impurity F identification
5 mg
1970
Yes
+5C 3C
79
Y0000504 Atracurium for peak identification
5 mg
1970
Yes
+5C 3C
79
Y0000878 Atropine
30 mg
2056
Yes
+5C 3C
79
Y0000816 Atropine impurity B
10 mg
0068,2056
Yes
+5C 3C
79
Y0000845 Atropine for peak identification
0.25 mg
0068,2056
Yes
+5C 3C
79
A1400000 Atropine sulfate
20 mg
0068
Yes
+5C 3C
79
Y0000029 Azaperone
50 mg
1708
Yes
+5C 3C
79
A1500000 Azathioprine
100 mg
0369
Yes
+5C 3C
79
Y0001240 Azathioprine impurity A
10 mg
1-methyl-4-nitro-1H-imidazol-5-amine
0369
Yes
+5C 3C
79
Y0001246 Azathioprine impurity G
5 mg
6-[(1-methyl-4-nitro-1H-imidazol-5-yl)sulfanyl]-7H-purin-2-amine
(thiamiprine)
0369
Yes
+5C 3C
79
Y0000326 Azelastine hydrochloride
25 mg
1633
Yes
+5C 3C
79
Y0000327 Azelastine impurity B
5 mg
1-benzoyl-2-[(4RS)-1-methylhexahydro-1H-azepin-4-yl]diazane
1633
Yes
+5C 3C
79
Y0000328 Azelastine impurity D
5 mg
4-(4-chlorobenzyl)phthalazin-1(2H)-one
1633
Yes
+5C 3C
79
5 mg
3-(4-chlorobenzilidene)isobenzofuran-1(3H)-one
6
Y0000329 Azelastine impurity E

2-(5-benzyl-3,6-dioxopiperazin-2-yl) acetic acid (diketopiperazine)

See leaflet CHO
see leaflet CHNOS
(1R,3r,5S)-8-azabicyclo[3.2.1]oct-3-yl (2RS)-3-hydroxy-2-phenylpropanoate
(noratropine)
79
1633
Yes
+5C 3C
a

Order
Code
Y0000306 Azithromycin
Reference Standard
Y0000307 Azithromycin impurity A

per vial Unit
4
200 mg
1 See leaflet CHNO
2
10 mg
1 6-demethylazithromycin
Information
Monograph Leaflet
Storage
Extra
Price
charges
79
a
1649
Yes
+5C 3C
1649
Yes
+5C 3C
79
1649
Yes
+5C 3C
79
Y0000637 Azithromycin for peak identification
15 mg
Batch 2 is valid until 31 August 2014
Y0000641 Azithromycin for system suitability
0.05 mg
1649
Yes
+5C 3C
79
Y0000285 B19 virus DNA for NAT testing BRP
150 mg
See leaflet
0557,
1527,1646
Yes
-20C 5C
e(d)
242
B0070000 Bacampicillin hydrochloride
120 mg
See leaflet CHClNOS
0808,0852
Yes
+5C 3C
79
B0100000 Bacitracin zinc
150 mg
See leaflet ; Batch 2 is valid until 28 February 2015
0465,0466,2
0702
Yes
-20C 5C
79
B0200000 Baclofen
50 mg
0653
Yes
+5C 3C
79
B0200050 Baclofen impurity A
60 mg
(4RS)-4-(4-chlorophenyl)pyrrolidin-2-one ; Batch 3 is valid until 30 April 2015
0653
Yes
+5C 3C
79
Y0001273 Baicalin
10 mg
See leaflet CHO
2438
Yes
+5C 3C
79
B0250000 Bambuterol hydrochloride
100 mg
1293
Yes
+5C 3C
79
B0300000 Barbital - * psy
500 mg
0170
Yes
+5C 3C
79
Y0001525 Basic butylated methacrylate copolymer
20 mg
1975
Yes
+5C 3C
79
B0305000 Beclometasone dipropionate anhydrous
150 mg
0654,1449,
1709
Yes
+5C 3C
79
Y0000469 Beclometasone dipropionate for peak identification
10 mg
0654,1709
Yes
+5C 3C
79
Y0000352 Beclometasone dipropionate for system suitability
15 mg
0654,1709
Yes
+5C 3C
79
Y0001073 Beclometasone dipropionate impurities F and N
0.052 mg
0654,1709
Yes
+5C 3C
79
Y0000351 Beclometasone dipropionate monohydrate
10 mg
1709
Yes
+5C 3C
79
Y0001607 Belamcanda chinensis rhizome HRS
110 mg
2561
Yes
+5C 3C
79
Y0001025 Benazepril hydrochloride
160 mg
See leaflet CHClNO
2388
Yes
+5C 3C
79
10 mg
[(3R)-3-[[(1R)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]-2-oxo-2,3,4,5tetrahydro-1H-1-benzazepin-1-yl]acetic acid ; Batch 1 is valid until 30

November 2015
2388
Yes
+5C 3C
79
Y0001038 Benazepril for system suitability
0.016 mg
2388
Yes
+5C 3C
79
B0400000 Bendroflumethiazide
100 mg
0370
Yes
+5C 3C
79
Y0000564 Bendroflumethiazide impurity A
5 mg
0370
Yes
+5C 3C
79
B0470000 Benperidol
100 mg
1010,1172,1
254, 1708
Yes
+5C 3C
79
B0477000 Benserazide hydrochloride
50 mg
1173
Yes
+5C 3C
79
B0477010 Benserazide impurity A
20 mg
(2RS)-2-amino-3-hydroxy-2-[(1EZ)-(2,3,4-trihydroxybenzylidene)]
propanohydrazide
1173
Yes
+5C 3C
79
Y0001071 Benserazide impurity C
10 mg
(2RS)-2-amino-3-hydroxy-2'-[(1EZ)-(2,3,4-trihydroxybenzylidene)]
propanohydrazide
1173
Yes
+5C 3C
79
Y0001079 Benserazide for peak identification
10 mg
1173
Yes
+5C 3C
79
New Y0001026 Benazepril impurity A
See leaflet CHClO
4-amino-6-(trifluoromethyl)benzene-1,3-disulphonamide

Order
Code
Y0001064 Benzaldehyde
Reference Standard

per vial Unit
1
150 mg
1
Y0001060 Benzalkonium chloride for system suitability
B0490000 Benzarone
B0500000 Benzathine benzylpenicillin
Y0000775 Benzbromarone
B0550000 Benzethonium chloride
Information
Monograph Leaflet
Storage
Extra
Price
charges
79
a
0372,0371,1
740
Yes
+5C 3C
0371,0372
Yes
+5C 3C
79
20 mg
10 mg
(2-ethylbenzofuran-3-yl)(4-hydroxyphenyl)methanone
1393
Yes
+5C 3C
79
200 mg
See leaflet
0373
Yes
+5C 3C
79
10 mg
1393
Yes
+5C 3C
79
100 mg
0974
Yes
+5C 3C
79
B0600000 Benzocaine
50 mg
0011,1088
Yes
+5C 3C
79
Y0001470 Benzoic acid
30 mg
0934
Yes
+5C 3C
79
Y0000647 Benzophenone
40 mg
1784
Yes
+5C 3C
79
Y0000167 Benzyl alcohol
70 mg
0256,0371,0
372,1827
Yes
+5C 3C
79
B0670000 Benzyl benzoate - reference spectrum
n/a
79
B0680000 S-Benzylmercaptoacetyltriglycin
10 mg
1372
Yes
+5C 3C
79
B0700000 Benzylpenicillin potassium
100 mg
0113,0148,0
149
Yes
+5C 3C
79
B0900000 Benzylpenicillin sodium
200 mg
See leaflet CHNNaOS
0113,0114,0
148, 0149
Yes
+5C 3C
79
Y0001149 Berberine chloride
20 mg
See leaflet CHClNO
1831,2500
Yes
+5C 3C
79
B0950000 Betadex
200 mg
See leaflet [CHO]
1070,1487,1
804
Yes
+5C 3C
79
Y0000391 Betahistine dihydrochloride
50 mg
1665
Yes
+5C 3C
79
B0990000 Betahistine mesilate
50 mg
Batch 1 is valid until 30 April 2015
1071
Yes
+5C 3C
79
B1000000 Betamethasone
60 mg
0312,0354,0
388, 0811
Yes
+5C 3C
79
B1030000 Betamethasone acetate
100 mg
0548,0975
Yes
+5C 3C
79
B1040000 Betamethasone dipropionate
150 mg
0809
Yes
+5C 3C
79
Y0001416 Betamethasone dipropionate for peak identification
10 mg
0809
Yes
+5C 3C
79
Y0001418 Betamethasone dipropionate for system suitability
10 mg
0809
Yes
+5C 3C
79
B1045000 Betamethasone sodium phosphate
100 mg
0549,0810
Yes
+5C 3C
79
B1054000 Betamethasone 17-valerate
100 mg
0322,0811
Yes
+5C 3C
79
B1055000 Betamethasone 21-valerate
15 mg
0811
Yes
+5C 3C
79
Y0001027 Betamethasone valerate for system suitability
25 mg
0811
Yes
+5C 3C
79
Y0001065 Betamethasone valerate impurity mixture
0.018 mg
0811
Yes
+5C 3C
79
B1103000 Betaxolol hydrochloride
60 mg
1072
Yes
+5C 3C
79
B1103100 Betaxolol impurity A
10 mg
(2RS)-1-(4-ethylphenoxy)-3-[(1-methylethyl)amino]propan-2-ol
1072
Yes
+5C 3C
79
Y0001354 Betaxolol impurity C
5 mg
2-[[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]methyl]oxirane
1072
Yes
-20C 5C
79
Y0001360 Betaxolol for peak identification
15 mg
1072
Yes
+5C 3C
79
See leaflet
0705
See leaflet CHFO

Order
Code
B1115000 Bezafibrate
Reference Standard

per vial Unit
1
100 mg
1
Information
Monograph Leaflet
Storage
Extra
Price
charges
79
a
1394
Yes
+5C 3C
2196
Yes
+5C 3C
79
2196
Yes
+5C 3C
79
2123
Yes
+5C 3C
79
1395
Yes
+5C 3C
79
Y0001444 Bicalutamide
100 mg
Y0001448 Bicalutamide for system suitability
15 mg
Y0001078 Bicisate labelling kit
24 mg
B1110000 Bifonazole
50 mg
Y0001421 Bifonazole for system suitability
10 mg
1395
Yes
+5C 3C
79
Y0001059 Bilberry dry extract
250 mg
See leaflet
2394
Yes
-20C 5C
79
New Y0001788 Bilberry dry extract HRS
See leaflet CHFNOS
Batch 1 is valid until 30 September 2015
250 mg
see leaflet
2394
Yes
-20C 5C
B1116000 Biotin
20 mg
Vitamin H
1073
Yes
+5C 3C
79
B1120000 Biperiden hydrochloride
60 mg
1074
Yes
+5C 3C
79
B1121000 Biperiden impurity A
20 mg
1074
Yes
+5C 3C
79
B1140000 Bisacodyl
50 mg
0595
Yes
+5C 3C
79
Y0000608 Bisacodyl for peak identification
10 mg
0595
Yes
+5C 3C
79
Y0000694 Bisacodyl for system suitability
5 mg
0595
Yes
+5C 3C
79
Y0000812 Bisoprolol fumarate
50 mg
1710
Yes
+5C 3C
79
Y0000877 Bisoprolol for peak identification
1.007 mg
Bisoprolol for system suitability method A CRS has been renamed as

Bisoprolol for peak identification CRS.
1710
Yes
+5C 3C
79
Y0000813 Bisoprolol for system suitability
1.003 mg
Bisoprolol for system suitability method B CRS has been renamed as

Bisoprolol for system suitability CRS
1710
Yes
+5C 3C
79
B1141000 Bleomycin sulfate
7 mg
See leaflet
0976,20702
Yes
-20C 5C
79
New Y0000434 Boldine
(1RS)-1-[(1SR,2SR,4SR)-bicyclo[2.2.1]hept-5-en-2-yl]-1-phenyl- 3(piperidin-1-yl)propan-1-ol (endo form)
79
30 mg
See leaflet
1396, 1816
Yes
+5C 3C
79
B1142000 Bordetella pertussis mouse antiserum BRP
0.5 mg
See leaflet
See leaflet,
20716
Yes
-20C 5C
90
Y0001634 Brimonidine for system suitability
1.3 mg
2760
Yes
+5C 3C
79
Y0001658 Brimonidine tartrate
5 mg
B1143000 Bromazepam - * psy
60 mg
Y0000645 Bromazepam for system suitability - * psy
10 mg
B1145000 Bromhexine hydrochloride
100 mg
New Y0001757 Bromhexine for system suitability
2760
Yes
+5C 3C
79
0778,0879
Yes
+5C 3C
79
0879
Yes
+5C 3C
79
0706
Yes
+5C 3C
79
0706
Yes
+5C 3C
79
0706
Yes
+5C 3C
79
n/a
15 mg
Y0000200 Bromhexine impurity C
15 mg
B1150000 Bromocriptine mesilate
30 mg
0596
Yes
-20C 5C
79
Y0000677 Bromocriptine mesilate for system suitability
5 mg
0596
Yes
-20C 5C
79
B1152000 Bromperidol
100 mg
0616,1178
Yes
+5C 3C
79
B1152050 Bromperidol decanoate
60 mg
1397,1431
Yes
+5C 3C
79
B1153000 Brompheniramine maleate
100 mg
0977,1196
Yes
+5C 3C
79
Y0000468 Brotizolam - * psy
10 mg
2197
Yes
+5C 3C
79
N-(2-aminobenzyl)-N-methylcyclohexanamine

Order
Reference Standard
Code
Y0000470 Brotizolam impurity B

Information
per vial Unit
1
10 mg
1 2-bromo-4-(2-chlorophenyl)-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]
diazepine (demethylbrotizolam)
Y0001196 Brucine
40 mg
see leaflet
B1157300 Budesonide
110 mg
See leaflet CHO
Y0001148 Budesonide for system suitability
10 mg
B1156000 Bufexamac
100 mg
Y0001729 Bufexamac impurity A
10 mg
4-butoxyphenylacetic acid
Y0001730 Bufexamac impurity B
15 mg
methyl 2-(4-butoxyphenyl)acetate
B1157400 Buflomedil hydrochloride
100 mg
Y0001731 Bufexamac impurity C
15 mg
Y0001732 Bufexamac impurity D
10 mg
2-(4-butoxyphenyl)acetamide
B1157410 Buflomedil impurity B
20 mg
4-(pyrrolidin-1-yl)-1-(4-hydroxy-2,6-dimethoxyphenyl)butan-1-one
Y0001529 Buflomedil for peak identification
0.45 mg
B1158000 Bumetanide
150 mg
Y0000309 Bumetanide impurity A
5 mg
3-nitro-4-phenoxy-5-sulphamoylbenzoic acid
Y0000310 Bumetanide impurity B
5 mg
3-amino-4-phenoxy-5-sulphamoylbenzoic acid
B1160000 Bupivacaine hydrochloride
100 mg
New Y0000088 Bupivacaine impurity B
20 mg
Y0000089 Bupivacaine impurity E
20 mg
Y0001575 Bupivacaine impurity F
Y0001108 Buprenorphine - * psy
Y0001122 Buprenorphine for system suitability - * psy

Y0001109 Buprenorphine hydrochloride - * psy
B1168000 Buserelin
Storage
Extra
Price
charges
79
a
2197
Yes
+5C 3C
2513,2514
Yes
+5C 3C
79
1075
Yes
+5C 3C
79
1075
Yes
+5C 3C
79
1179
Yes
+5C 3C
79
1179
Yes
+5C 3C
79
1179
Yes
+5C 3C
79
1398
Yes
+5C 3C
79
1179
Yes
+5C 3C
79
1179
Yes
+5C 3C
79
1398
Yes
+5C 3C
79
1398
Yes
+5C 3C
79
1076
Yes
+5C 3C
79
1076
Yes
+5C 3C
79
1076
Yes
+5C 3C
79
0541, 2335
Yes
+5C 3C
79
(2RS)-N-(2,6-dimethylphenyl)piperidine-2-carboxamide ; Batch 2 is valid until

30 October 2015
0541
Yes
+5C 3C
79
6-(butylamino)-N-(2,6-dimethylphenyl)hexanamide ; Batch 2 is valid until 30

November 2014
0541
Yes
+5C 3C
79
70 mg
2,6-dimethylaniline
0541
Yes
+5C 3C
79
10 mg
1180
Yes
+5C 3C
79
10 mg
1180,1181
Yes
+5C 3C
79
10 mg
1181
Yes
+5C 3C
79
1077
Yes
-20C 5C
79
-20C 5C
79
2 mg
New Y0001740 Buserelin for peak identification
1 mg
New B1168020 D-His-Buserelin
See leaflet CHNO
1077
0.5 mg
Y0000131 Buspirone hydrochloride
5 mg
Y0000471 Buspirone for system suitability
2.018 mg
B1170000 Busulfan
50 mg
Y0001487 Butyl methacrylate
100 mg
Y0001304 Butyl methanesulfonate
30 L
B1217000 Butyl parahydroxybenzoate
100 mg
See leaflet
Y0001357 Butyl parahydroxybenzoate impurity E
15 mg
2-methylpropyl 4-hydroxybenzoate (iso-butyl parahydroxybenzoate)
B1212000 Butylhydroxyanisole
60 mg
Monograph Leaflet
1077
Yes
-20C 5C
79
1711
Yes
+5C 3C
79
1711
Yes
+5C 3C
79
0542
Yes
+5C 3C
79
1975
Yes
+5C 3C
79
20537,2053
8, 20539,
20540
0881,1216
Yes
+5C 3C
79
Yes
+5C 3C
79
0881
Yes
+5C 3C
79
0880
Yes
+5C 3C
79
10

Order
Reference Standard
Code
B1215000 Butylhydroxytoluene

per vial Unit
1
50 mg
1 Plastic additive 07
Information
Y0000472 Cabergoline
160 mg
See leaflet ; Batch 1 is valid until 28 February 2015
C0100000 Caffeine
70 mg
See leaflet; 04/2008:0267
Y0000787 Caffeine for system suitability
10 mg
New C0166000 Calcifediol
5 mg
C0166001 Calcifediol - reference spectrum
n/a
Y0000499 Calcipotriol (anhydrous) - reference spectrum
n/a
Y0000473 Calcipotriol monohydrate
10 mg
See leaflet ; Batch 4 is valid until 31 December 2015
Monograph Leaflet
Storage
0581,30103,
30105,3010
6, 30107
Yes
+5C 3C
1773
Yes
-20C 5C
79
0267,0268,1
504,2412
Yes
+5C 3C
79
0267, 0268
Yes
+5C 3C
79
1295
Yes
-20C 5C
e(d)
150
79
1295
2011
See leaflet CHO
Extra
Price
charges
79
a
2011,2284
79
Yes
+5C 3C
79
Y0000474 Calcipotriol monohydrate - reference spectrum
n/a
79
C0200000 Calcitonin (salmon)
11
1 mg
See leaflet
0471
Yes
-20C 5C
79
Y0000632 Calcitonin-Gly
1 ml
About 0.9 mg per ml
0471
Yes
-20C 5C
79
C0200010 N-acetyl-cys1-calcitonin
0.1 mg
See leaflet ; Batch 4 is valid until 31 March 2015
0471
Yes
-20C 5C
79
0883
Yes
-20C 5C
e(d)
New C0225000 Calcitriol
2284
10 mg
C0226000 Calcitriol - reference spectrum
n/a
C0249000 Calcium ascorbate - reference spectrum
n/a
C0250000 Calcium folinate
130 mg
C0299000 Calcium glucoheptonate
60 mg
C0300000 Calcium gluconate
100 mg
C0340000 Calcium levulinate dihydrate
250 mg
C0350000 Calcium oxalate monohydrate
500 mg
C0400000 Calcium pantothenate
50 mg
C0405000 Camphor (racemic)
50 mg
Y0001388 Candesartan cilexetil
60 mg
Y0001387 Candesartan cilexetil for peak identification
10 mg
Y0001389 Candesartan cilexetil for system suitability
10 mg
New C0410000 Canrenone
0883
1182
See leaflet
0978,1606
Yes
1000
79
79
+5C 3C
79
1399
Yes
+5C 3C
79
0172,0658,0
979,1399,21
61,2162,216
4,2364
Yes
+5C 3C
79
1296
Yes
+5C 3C
79
See leaflet
20234
Yes
+5C 3C
79
0470
Yes
+5C 3C
79
0655,1400
Yes
+5C 3C
79
2573
Yes
+5C 3C
79
2573
Yes
+5C 3C
79
2573
Yes
+5C 3C
79
Calcium digluconate
15 mg
0688
Yes
+5C 3C
79
Y0001642 Capecitabine
150 mg
See leaflet CHFNO
2762
Yes
+5C 3C
79
Y0001643 Capecitabine impurity A
5 mg
2762
Yes
+5C 3C
79
Y0001644 Capecitabine impurity B
5 mg
2762
Yes
+5C 3C
79
Y0001645 Capecitabine impurity D
10 mg
2762
Yes
+5C 3C
79
C0426000 Caprylic acid
100 mg
1401,1471
Yes
+5C 3C
79

11

Order
Code
Y0000671 Capsaicin
Reference Standard

Information
per vial Unit
2
50 mg
1 See leaflet CHNO ; (E)-N-[(4-Hydroxy-3-methoxyphenyl)methyl]-8methylnon-6-enamide
Monograph Leaflet
Storage
Extra
Price
charges
79
a
1859,2336,2
337, 2529
Yes
+5C 3C
1079
Yes
+5C 3C
79
C0430000 Captopril
10 mg
Y0001219 Captopril impurity B
10 mg
See leaflet CHBrNO; (2S)1-[(2S)-3-bromo-2-methylpropanoyl]

pyrrolidine-2-carboxylic acid
1079
Yes
+5C 3C
79
Y0001220 Captopril impurity C
10 mg
See leaflet CHOS; (2RS)-2-methyl-3-sulphanylpropanoic acid
1079
Yes
+5C 3C
79
Y0001221 Captopril impurity D
10 mg
See leaflet CHBrO; (2RS)-3-bromo-2-methylpropanoic acid
1079
Yes
+5C 3C
79
Y0000435 Captopril impurity E
10 mg
(2S)-1-isobutyryl-pyrrolidine-2-carboxylic acid
1079
Yes
+5C 3C
79
Y0001450 Captopril impurity J
10 mg
See leaflet CHNOS; (2S)-1-[(2S)-3-(acetylsulfanyl)-2-methylpropanoyl]

pyrrolidine-2-carboxylic acid (acetylcaptopril)
1079
Yes
+5C 3C
79
Y0001182 Captopril for system suitability
20 mg
1079
Yes
+5C 3C
79
Y0000113 Carbachol
50 mg
1971
Yes
+5C 3C
79
C0450000 Carbamazepine
200 mg
See leaflet CHNO
0543
Yes
+5C 3C
79
Y0000033 Carbamazepine impurity A
10 mg
10,11-dihydro-5H-dibenz[b,f]azepine-5-carboxamide (10,11dihydrocarbamazepine)
0543
Yes
+5C 3C
79
C0451000 Carbasalate calcium - reference spectrum
n/a
1185
79
Y0001161 Carbasalate impurity B
5 mg
1185
Yes
+5C 3C
79
C0455000 Carbenicillin sodium
50 mg
0956
Yes
-20C 5C
79
C0460000 Carbidopa
50 mg
0755
Yes
+5C 3C
79
Y0001713 Carbidopa for system suitability
10 mg
0755
Yes
+5C 3C
79
Y0001716 Carbidopa impurity mixture
0.008 mg
0755
Yes
+5C 3C
79
C0465000 Carbimazole
120 mg
0884
Yes
+5C 3C
79
C0470000 Carbocisteine
60 mg
0885
Yes
+5C 3C
79
C0499900 Carbon dioxide - reference spectrum
n/a
0375
79
C0550000 Carboplatin - reference spectrum
n/a
1081
79
Y0000475 Carboprost trometamol
40 mg
79
Y0000536 Carboprost trometamol - reference spectrum
n/a
79
Y0000035 Carisoprodol
50 mg
Y0000036 Carisoprodol impurity A
10 mg
Y0001214 Carmellose
10 mg
C0580004 Carmustine - reference spectrum
n/a
C0580010 Carmustine impurity A
20 mg
Y0000846 Carprofen
30 mg
Y0000884 Carprofen for system suitability
5 mg
Y0000192 Carteolol hydrochloride - reference spectrum
Y0000193 Carteolol for system suitability
Y0001427 Carvedilol
50 mg
See leaflet CHNOS
See leaflet CHNO
1712
Yes
-20C 5C
1712
1689
Yes
+5C 3C
79
1689
Yes
+5C 3C
79
2360
Yes
+5C 3C
79
79
1187
Yes
-20C 5C
79
2201
Yes
+5C 3C
79
2201
Yes
+5C 3C
79
n/a
1972
79
30 mg
1972
Yes
+5C 3C
79
(2RS)-2-(hydroxymethyl)-2-methylpentyl(1-methylethyl)carbamate ; Batch 1 is valid until 28 February 2015
1187
1,3-bis(2-chloroethyl)urea
12
79
1745
Yes
+5C 3C
a

Order
Reference Standard
Code
Y0000075 Carvedilol - reference spectrum

per vial Unit
1
n/a
1
Y0000103 Carvedilol impurity C
Y0001426 Carvedilol for system suitability

C0600000 Casein BRP
Information
Monograph Leaflet
Storage
1745
Extra
Price
charges
79
l
15 mg
(2RS)-1-[benzyl[2-(2-methoxyphenoxy)ethyl]amino]-3-(9H- carbazol-4-yloxy)
propan-2-ol
1745
Yes
+5C 3C
10 mg
1745
Yes
+5C 3C
79
100000 mg
0350
Yes
+5C 3C
131
C0630000 Cefaclor
450 mg
0986
Yes
+5C 3C
79
C0640000 Delta-3-Cefaclor
20 mg
0986
Yes
-20C 5C
79
C0650000 Cefadroxil
250 mg
see leaflet
0260,0577,0
813,2342
Yes
+5C 3C
79
C0675000 Cefalexin monohydrate
150 mg
0708,0814
Yes
+5C 3C
79
C0682000 Cefalotin sodium
170 mg
See leaflet ; Batch 2 is valid until 31 July 2014
0987
Yes
+5C 3C
79
Y0000505 Cefalotin for impurity B identification
10 mg
0987
Yes
+5C 3C
79
C0682300 Cefamandole nafate
125 mg
See leaflet CHNNaOS
1402
Yes
+5C 3C
79
Y0000240 Cefapirin sodium
100 mg
See leaflet CHNNaOS
1650
Yes
+5C 3C
79
C0682400 Cefatrizine propylene glycol
150 mg
see leaflet CHNOS ; Batch 1 is valid until 31 March 2015
1403
Yes
+5C 3C
79
C0682410 Cefatrizine impurity A
60 mg
7-amino-(6R,7R)-3-[(2H-1,2,3-triazol-4-yl)sulfanyl]-methyl-8- oxo-5-thia-1azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid (7-ACA triazole)
1403
Yes
+5C 3C
79
C0682800 Cefazolin
150 mg
See leaflet CHNOS
0988
Yes
+5C 3C
79
Y0000633 Cefepime dihydrochloride monohydrate
150 mg
2126
Yes
+5C 3C
79
Y0001336 Cefepime impurity E
10 mg
(6R,7R)-7-amino-3-[(1-methylpyrrolidinio)methyl]-8-oxo-5thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
2126
Yes
-20C 5C
79
Y0000634 Cefepime dihydrochloride monohydrate for system

suitability
15 mg
2126
Yes
+5C 3C
79
C0684000 Cefixime
200 mg
See leaflet CHNOS
1188
Yes
-20C 5C
79
C0684750 Cefoperazone dihydrate
100 mg
See leaflet CHNOS
1404
Yes
+5C 3C
79
C0684800 Cefoperazone sodium - reference spectrum
n/a
79
C0685000 Cefotaxime sodium
20 mg
Batch 4 is valid until 31 July 2014
0708,0989
Yes
+5C 3C
79
Y0000420 Cefotaxime acid
80 mg
See leaflet CHNOS
0989
Yes
+5C 3C
79
Y0000506 Cefotaxime for peak identification
10 mg
0989
Yes
+5C 3C
79
C0688000 Cefoxitin sodium
100 mg
0990
Yes
+5C 3C
79
Y0001496 Cefoxitin for peak identification
15 mg
0990
Yes
+5C 3C
79
Y0001305 Cefpodoxime proxetil
70 mg
2341
Yes
-20C 5C
79
Y0001318 Cefpodoxime proxetil for impurity H identification
10 mg
2341
Yes
-20C 5C
79
Y0001306 Cefpodoxime proxetil for peak identification
10 mg
2341
Yes
-20C 5C
79
Y0001371 Cefprozil
120 mg
See leaflet
2342
Yes
+5C 3C
79
Y0001372 Cefprozil impurity A
20 mg
(2R)-2-amino-2-(4-hydroxyphenyl)acetic acid
(p-hydroxyphenylglycine)
2342
Yes
+5C 3C
79
Y0001367 Cefprozil for peak identification
10 mg
2342
Yes
+5C 3C
79
See leaflet CHClNOS
1404
See leaflet CHNNaOS

See leaflet CHNOS
13
79

Order
Reference Standard
Code
Y0001368 Cefprozil impurity mixture

per vial Unit
1
10 mg
1
Information
C0690000 Cefradine
300 mg
Y0000568 Cefradine for peak identification
15 mg
Y0001174 Cefradine impurity mixture
0.04 mg
C0690500 Ceftazidime
200 mg
Y0001111 Ceftazidime for peak identification
10 mg
C0691000 Ceftriaxone sodium
100 mg
See leaflet CHNNaOS
C0692000 Ceftriaxone impurity A
10 mg
C0694990 Cefuroxime axetil
60 mg
C0695000 Cefuroxime sodium
150 mg
Y0001445 Celecoxib
200 mg
Y0001446 Celecoxib impurity A
Y0001447 Celecoxib impurity B
Y0000311 Celiprolol hydrochloride

Y0000312 Celiprolol impurity I
See leaflet
Monograph Leaflet
Storage
Extra
Price
charges
79
a
2342
Yes
+5C 3C
0167,0168,0
578,
0708,0814
Yes
+5C 3C
79
0814
Yes
+5C 3C
79
0814
Yes
+5C 3C
79
1405, 2344
Yes
+5C 3C
79
1405, 2344
Yes
+5C 3C
79
0991
Yes
+5C 3C
79
E-isomer
0991
Yes
+5C 3C
79
See leaflet CHNOS
1300
Yes
+5C 3C
79
See leaflet CHNNaOS
0988,0992
Yes
+5C 3C
79
2591
Yes
+5C 3C
79
10 mg
4-[5-(3-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]
benzenesulfonamide
2591
Yes
+5C 3C
79
10 mg
4-[3-(4-methylphenyl)-5-(trifluoromethyl)-1H-pyrazol-1-yl]
benzenesulfonamide ; Batch 1 is valid until 30 June 2015
2591
Yes
+5C 3C
79
10 mg
1632
Yes
+5C 3C
79
0.02 mg
1632
Yes
+5C 3C
79
Y0000239 Celiprolol for peak identification
20 mg
1632
Yes
+5C 3C
79
Y0000784 Cellulose acetate
40 mg
0887
Yes
+5C 3C
79
Y0001585 Cellulose acetate butyrate
60 mg
1406
Yes
+5C 3C
79
Y0001054 Cellulose acetate phthalate
10 mg
0314
Yes
+5C 3C
79
C0700000 Cephaeline hydrochloride
15 mg
0081,0093,
0094,1530,1
875
Yes
+5C 3C
79
C0980650 Cetirizine dihydrochloride
100 mg
1084
Yes
+5C 3C
79
C0980651 Cetirizine impurity A
10 mg
(RS)-1-[(4-chlorophenyl)phenylmethyl]piperazine
1084
Yes
+5C 3C
79
Y0001197 Cetirizine for peak identification
1.01 mg
1084
Yes
+5C 3C
79
C0984100 Cetostearyl isononanoate - reference spectrum
n/a
79
C0990000 Cetyl alcohol
300 mg
0540,0702,0
801,
0802,0847,0
969, 1411
Yes
+5C 3C
79
Y0000073 Cetyl palmitate 15
60 mg
1906
Yes
+5C 3C
79
Y0000074 Cetyl palmitate 95
50 mg
1906
Yes
+5C 3C
79
C1000000 Cetylpyridinium chloride
20 mg
0379
Yes
+5C 3C
79
C1050000 Chenodeoxycholic acid
125 mg
1189,1275
Yes
+5C 3C
79
Y0000104 Chitosan hydrochloride
30 mg
1774
Yes
+5C 3C
79
See leaflet CHNOS
1-acetyl-1-(4-ethoxyphenyl)-3,3-diethylurea
1085
See leaflet CHO
14

Order
Code
C1100000 Chlorambucil
Reference Standard

per vial Unit
1
100 mg
1
Information
Monograph Leaflet
Storage
0137
Yes
+5C 3C
Extra
Price
charges
79
a
Y0001298 Chlorambucil for system suitability
10 mg
0137
Yes
+5C 3C
79
Y0001299 Chlorambucil with impurity G
10 mg
0137
Yes
+5C 3C
79
C1200000 Chloramphenicol
500 mg
0071,0473,0
709
Yes
+5C 3C
79
C1300000 Chloramphenicol dipalmitate
100 mg
0473
Yes
+5C 3C
79
C1350000 Chloramphenicol disodium disuccinate
25 mg
0709
Yes
+5C 3C
79
C1400000 Chloramphenicol palmitate isomer
100 mg
0473
Yes
+5C 3C
79
C1425000 Chloramphenicol sodium succinate
30 mg
0709
Yes
+5C 3C
79
C1435000 Chlorcyclizine hydrochloride
100 mg
1086
Yes
+5C 3C
79
C1450000 Chlordiazepoxide - * psy
50 mg
0656,1974
Yes
+5C 3C
79
C1500000 Chlordiazepoxide hydrochloride - * psy
100 mg
Y0000476 Chlordiazepoxide impurity A
10 mg
C1510000 Chlorhexidine
50 mg
C1520000 Chlorhexidine diacetate
10 mg
C1540000 Chlorhexidine dihydrochloride
50 mg
Y0001545 Chlorhexidine for system suitability
15 mg
Y0001653 Chlormadinone acetate
120 mg
Y0001656 Chlormadinone acetate impurity G
20 mg
Y0001638 Chlormadinone acetate for system suitability
10 mg
Y0000569 Chlorogenic acid
25 mg
C1650000 Chloroquine sulfate
200 mg
C1700000 Chlorothiazide
10 mg
C1800000 Chlorphenamine maleate
20 mg
Batch 1 is valid until 31 October 2014
Y0000436 Chlorphenamine impurity A
0.01 mg
Y0000437 Chlorphenamine impurity C
10 mg
C1900000 Chlorpromazine hydrochloride
200 mg
Y0000507 Chlorpromazine impurity A
15 mg
Y0000479 Chlorpromazine impurity D
10 mg
Y0000508 Chlorpromazine impurity E
Y0001449 Chlorpromazine impurity F
See leaflet CHClNNaO

0474
Yes
+5C 3C
79
0474,0656
Yes
+5C 3C
79
0658
Yes
+5C 3C
79
01/2015:0657
Yes
+5C 3C
79
0659
Yes
+5C 3C
79
0658, 0657,
0659
Yes
+5C 3C
79
2702
Yes
+5C 3C
79
2702
Yes
+5C 3C
79
2702
Yes
+5C 3C
79
Yes
+5C 3C
79
0544,0545
Yes
+5C 3C
79
0394
Yes
+5C 3C
79
0386,0977,1
084, 1196
Yes
+5C 3C
79
2-(4-chlorophenyl)-4-(dimethylamino)-2-[2-(dimethylamino)
ethyl]butanenitrile
0386
Yes
+5C 3C
79
(3RS)-3-(4-chlorophenyl)-N-methyl-3-(pyridin-2-yl)propan-1-amine
0386
Yes
+5C 3C
79
0475
Yes
+5C 3C
79
3-(2-chloro-10H-phenothiazin-10-yl)-N,N-dimethylpropan-1amine S-oxide (chlorpromazine sulphoxide)
0475
Yes
+5C 3C
79
3-(2-chloro-10H-phenothiazin-10-yl)-N-methypropan-1-amine
(demethylchlorpromazine)
0475
Yes
+5C 3C
79
10 mg
2-chloro-10H-phenothiazine
0475
Yes
+5C 3C
79
2 mg
3-(4-chloro-10H-phenothiazin-10-yl)-N,N-dimethylpropan-1-amine
0475
Yes
+5C 3C
79
7-chloro-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one 4-oxide
See leaflet
See leaflet CHO ; (1S,3R,4R,5R)-3-[(3,4-Dihydroxycinnamoyl)oxy]-1,4,5- 1821,1822,1

trihydroxycyclohexanecarboxylic acid
823,
1824,1866,1
897, 2389
15

Order
Reference Standard
Code
C1905000 Chlorpropamide

per vial Unit
1
100 mg
1
Information
C1905020 Chlorpropamide impurity B
50 mg
1,3-Dipropylurea
C1915000 Chlorprothixene hydrochloride
50 mg
See leaflet ; Batch 4 is valid until 31 January 2015
C1950000 Chlortalidone
150 mg
See leaflet CHClNOS
Y0000779 Chlortalidone for peak identification
1.017 mg
C2000000 Chlortetracycline hydrochloride
100 mg
New Y0001451 Chlortetracycline for system suitability
10 mg
C2100000 Cholecalciferol
480 mg
See leaflet CHO ; Vitamin D3
C2150000 Cholecalciferol for system suitability
1 mL
New C2155000 Cholesterol
100 mg
C2158000 Cholic acid
60 mg
Y0000280 Chondroitin sulfate sodium
250 mg
Y0000593 Chondroitin sulfate sodium (marine)
100 mg
C2160000 Chymotrypsin BRP
100 mg
See leaflet
Y0001553 Ciclesonide
150 mg
See leaflet CHO
Y0001554 Ciclesonide containing impurity A
15 mg
Y0001555 Ciclesonide impurity B
10 mg
Y0001556 Ciclesonide impurity C
Y0000040 Ciclopirox
C2162701 Ciclopirox impurity A
C2162702 Ciclopirox impurity B
C2162700 Ciclopirox olamine
Monograph Leaflet
Storage
1087
Yes
+5C 3C
Extra
Price
charges
79
a
1087
Yes
+5C 3C
79
0815,1365
Yes
+5C 3C
79
0546
Yes
+5C 3C
79
0546
Yes
+5C 3C
79
See leaflet
0173
Yes
+5C 3C
79
0173
Yes
+5C 3C
79
0072, 0574,
0575, 0598,
1192, 1193,
2398
Yes
-20C 5C
79
0072,0082,0
574,
0575,0598
Yes
-20C 5C
79
0593, 0993,
2397
Yes
+5C 3C
79
1189
Yes
+5C 3C
79
2064,2090
Yes
+5C 3C
79
2064
Yes
+5C 3C
79
0476,0694
Yes
+5C 3C
79
2703
Yes
+5C 3C
79
(2S)-2-cyclohexyl-11b-hydroxy-3,20-dioxo-16bH-[1,3]dioxolo[4,5:16,17]
pregna-1,4-diene-21-yl 2-methylpropanoate (S-epimer of ciclesonide)
2703
Yes
+5C 3C
79
(2R)-2-cyclohexyl-11b,21-dihydroxy-16bH-[1,3]dioxolo[4,5:16,17]
pregna-1,4-diene-3,20-dione
2703
Yes
+5C 3C
79
10 mg
(2R)-2-[(1RS)-cyclohex-3-enyl]-11b-hydroxy-3,20-dioxo-16bH-[1,3]dioxolo
[4,5:16,17]pregna-1,4-diene-21-yl 2-methylpropanoate
2703
Yes
+5C 3C
79
100 mg
1407
Yes
+5C 3C
79
40 mg
()-2-(3-cyclohexyl-5-methyl-4,5-dihydroisoxazol-5-yl)acetic acid
1302,1407
Yes
+5C 3C
79
20 mg
6-cyclohexyl-4-methyl-2H-pyran-2-one
1302,1407
Yes
-20C 5C
79
150 mg
1302
Yes
+5C 3C
79
C2163000 Ciclosporin
120 mg
0994
Yes
+5C 3C
79
Y0000361 Ciclosporin for system suitability
5 mg
0994
Yes
+5C 3C
79
C2170000 Cilastatin sodium
10 mg
1408
Yes
+5C 3C
79
Y0001651 Cilastatin for system suitability 1
5 mg
1408
Yes
+5C 3C
79
Y0001652 Cilastatin for system suitability 2
5 mg
1408
Yes
+5C 3C
79
C2174000 Cilazapril
50 mg
1499
Yes
+5C 3C
79
See leaflet HO(CHNNaOS)
See leaflet
16

Order
Reference Standard
Code
C2174002 Cilazapril impurity A

Information
per vial Unit
1
25 mg
1 1,1-dimethylethyl(1S,9S)-9-[[(S)-1-ethoxycarbonyl-3-phenylpropyl]
amino]-10-oxo-octahydro-6H-pyridazino[1,2a][1,2]diazepine-1-caboxylate
Monograph Leaflet
Storage
Extra
Price
charges
79
a
1499
Yes
+5C 3C
1499
Yes
+5C 3C
79
0756
Yes
+5C 3C
79
C2174005 Cilazapril impurity D
10 mg
C2175000 Cimetidine
50 mg
C2175500 Cimetidine hydrochloride
100 mg
1500
Yes
+5C 3C
79
Y0001130 Cimetidine for peak identification
10 mg
0756, 1500
Yes
+5C 3C
79
Y0001146 Cimetidine for system suitability
0.5085 mg
0756, 1500
Yes
+5C 3C
79
C2177000 Cinchocaine hydrochloride
60 mg
1088
Yes
+5C 3C
79
Y0000176 Cineole
180 mg
1973
Yes
+5C 3C
79
C2180000 Cinnarizine
100 mg
0816
Yes
+5C 3C
79
Y0000362 Ciprofibrate
5 mg
2013
Yes
+5C 3C
79
Y0000363 Ciprofibrate for system suitability
5 mg
2013
Yes
+5C 3C
79
Y0000198 Ciprofloxacin
20 mg
C2190000 Ciprofloxacin hydrochloride
100 mg
Y0000199 Ciprofloxacin hydrochloride for peak identification
15 mg
C2190050 Ciprofloxacin impurity A
25 mg
7-chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic
acid (fluoroquinolonic acid)
C2210000 Cisplatin
100 mg
Y0001018 Cisplatin impurity A
15 mg
Y0001019 Cisplatin impurity B
15 mg
Y0001008 Citalopram hydrobromide
5 mg
Y0001007 Citalopram hydrochloride
5 mg
Y0000855 Citalopram for system suitability
A1202000 Citric acid (anhydrous)
C2219000 Citric acid monohydrate

Y0000639 Cladribine
Y0000610 Cladribine impurity C
Y0000609 Cladribine for peak identification
(1S,9S)-9-[[(R)-1-ethoxycarbonyl-3-phenylpropyl]amino]-10- oxooctahydro-6H-pyridazino[1,2a][1,2]diazepine-1-carboxylic acid
See leaflet
1089
Yes
+5C 3C
79
0888,1353
Yes
+5C 3C
79
0888,1089
Yes
+5C 3C
79
0888,1089,2
229
Yes
+5C 3C
79
See leaflet [PtCl(NH)] ; Batch 5 is valid until 30 June 2015
0599
Yes
+5C 3C
79
trans-diamminedichloroplatinum (II)
0599
Yes
+5C 3C
79
See leaflet [PtCl(NH)]-; amminetrichloroplatinate(-)
0599
Yes
+5C 3C
79
2288
Yes
+5C 3C
79
2203
Yes
+5C 3C
79
0.065 mg
2203,2288
Yes
+5C 3C
79
50 mg
0455
Yes
+5C 3C
79
50 mg
0456
Yes
+5C 3C
79
50 mg
See leaflet CHClNO
2174
Yes
+5C 3C
79
5 mg
2-chloro-7H-purin-6-amine
2174
Yes
+5C 3C
79
10 mg
2174
Yes
+5C 3C
79
Y0000320 Clarithromycin
160 mg
1651
Yes
+5C 3C
79
Y0000321 Clarithromycin for peak identification
40 mg
1651
Yes
+5C 3C
79
Y0001193 Clazuril
10 mg
1714
Yes
+5C 3C
79
Y0000269 Clazuril for system suitability
10 mg
1714
Yes
+5C 3C
79
C2221000 Clebopride malate
100 mg
1303
Yes
+5C 3C
79
C2223000 Clemastine fumarate
100 mg
1190
Yes
+5C 3C
79
Y0001613 Clemastine for system suitability
0.165 mg
1190
Yes
+5C 3C
79
C2248000 Clenbuterol hydrochloride
30 mg
1409
Yes
+5C 3C
79
See leaflet CHNO
17

Order
Reference Standard
Code
C2248010 Clenbuterol impurity B
C2250000 Clindamycin hydrochloride

Information
per vial Unit
2
10 mg
1 1-(4-amino-3,5-dichlorophenyl)-2-[(1,1-dimethylethyl)amino] ethanone
4
200 mg
1 See leaflet
Monograph Leaflet
Storage
Extra
Price
charges
79
a
1409
Yes
+5C 3C
0582
Yes
+5C 3C
79
0996
Yes
+5C 3C
79
C2269000 Clindamycin phosphate
250 mg
Y0001680 Clindamycin phosphate for system suitability
10 mg
0996
Yes
+5C 3C
79
Y0000364 Clioquinol
5 mg
2111
Yes
+5C 3C
79
Y0000205 Clobazam - reference spectrum
n/a
79
Y0000241 Clobazam impurity A
10 mg
7-chloro-5-phenyl-1,5-dihydro-1,5-dihydro-3H-1,5-benzodiazepine-2,4-dione
1974
Yes
+5C 3C
79
Y0000559 Clobetasol propionate
40 mg
See leaflet CHClFO
2127
Yes
+5C 3C
79
Y0000571 Clobetasol impurity J
0.4 mg
(17R)-4'-chloro-5'-ethyl-9-fluoro-11-hydroxy-16-methylspiro
[androsta-1,4-diene-17,2'(3'H)-furan]-3,3'-dione (17 alpha-spiro compound)
2127
Yes
+5C 3C
79
Y0000570 Clobetasol for peak identification
2 mg
2127
Yes
+5C 3C
79
C2285000 Clobetasone butyrate
50 mg
1090
Yes
+5C 3C
79
Y0001137 Clobetasone butyrate for system suitability
30 mg
1090
Yes
+5C 3C
79
Y0000888 Clodronate disodium tetrahydrate
5 mg
1777
Yes
+5C 3C
79
Y0000885 Clodronate impurity D
5 mg
1777
Yes
+5C 3C
79
Y0000313 Clofazimine
150 mg
2054
Yes
+5C 3C
79
Y0000358 Clofazimine for system suitability
10 mg
2054
Yes
+5C 3C
79
C2300000 Clofibrate
0.5 ml
C2320000 Clomifene citrate
50 mg
C2332000 Clomifene citrate for performance test
50 mg
C2360000 Clomipramine hydrochloride
100 mg
Y0000132 Clomipramine impurity C
10 mg
Y0000133 Clomipramine impurity D
10 mg
Y0000134 Clomipramine impurity F
C2385000 Clonazepam - * psy
Y0000286 Clonazepam - reference spectrum
n/a
C2385015 Clonazepam impurity B
5 mg
C2400000 Clonidine hydrochloride
100 mg
Y0000801 Clonidine impurity B
20 mg
Y0000833 Clopamide
40 mg
Y0000848 Clopamide for system suitability
10 mg
Y0001333 Clopidogrel hydrogen sulfate
60 mg
Y0001335 Clopidogrel impurity A
10 mg
(2S)-(2-chlorophenyl)[6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl]acetic acid ;
Y0001334 Clopidogrel for system suitability
100 mg
see leaflet
1974
(chloromethylene)bis(phosphonic acid)
0318
Yes
+5C 3C
79
0997,1046
Yes
+5C 3C
79
0997
Yes
+5C 3C
79
0889
Yes
+5C 3C
79
See leaflet CHClN; 3-(3-chloro-5H-dibenzo[b,f]azepin-5-yl)-N,Ndimethylpropan-1-amine
0889
Yes
+5C 3C
79
See leaflet CHClN; 3-(3,7-dichloro-10,11-dihydro-5H-dibenzo[b,f]

azepin-5-yl)-N,N-dimethylpropan-1-amine
0889
Yes
+5C 3C
79
5 mg
3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepine
0889
Yes
+5C 3C
79
50 mg
1974,0415
Yes
+5C 3C
79
79
0890
Yes
+5C 3C
79
0477
Yes
+5C 3C
79
0477
Yes
+5C 3C
79
1747
Yes
+5C 3C
79
1747
Yes
+5C 3C
79
2531
Yes
+5C 3C
79
2531
Yes
+5C 3C
79
2531
Yes
+5C 3C
79
See leaflet CHClNO
0890
3-Amino-4-(2-chlorophenyl)-6-nitro-1-quinolin-2-one
1-acetyl-2-[(2,6-dichlorophenyl)amino]-4,5-dihydro-1H-imidazole
18

Order
Reference Standard
Code
Y0000392 Closantel sodium dihydrate

per vial Unit
1
20 mg
1
Information
Monograph Leaflet
1716
Yes
Storage
+5C 3C
Extra
Price
charges
79
a
Y0000393 Closantel for system suitability
20 mg
1716
Yes
+5C 3C
79
C2424400 Clostridia (multi-component) rabbit antiserum(for

vaccines-vet.use)BRP
1 mg
See leaflet
0362,0363,0
364, 0697
Yes
-20C 5C
90
C2424550 Clostridium tetani guinea pig antiserum (for vaccines human use) BRP
1 mg
See leaflet
20708
Yes
-20C 5C
90
C2424500 Clostridium tetani guinea pig antiserum (for vaccines vet. use) BRP
1 mg
See leaflet
See leaflet,
0697
Yes
-20C 5C
90
C2425600 Clostridium tetani rabbit antiserum (for vaccines - vet.

use) BRP
1 mg
See leaflet
See leaflet,
0697
Yes
-20C 5C
90
C2430000 Clotrimazole
100 mg
0757
Yes
+5C 3C
79
Y0000818 Clotrimazole impurity E
15 mg
0757
Yes
+5C 3C
79
Y0000849 Clotrimazole for peak identification
1.005 mg
0757
Yes
+5C 3C
79
C2450000 Cloxacillin sodium
200 mg
0661, 0663,
0668, 2260,
2346
Yes
+5C 3C
79
C2460000 Clozapine
60 mg
1191
Yes
+5C 3C
79
Y0000758 Clozapine for peak identification
0.41 mg
1191
Yes
+5C 3C
79
Y0001472 Coagulation Factors V, VIII, XI and XIII plasma
1 mg
See leaflet
0903,1646,2
0740,20722
Yes
-20C 5C
90
Y0000162 Cocaine hydrochloride - reference spectrum
n/a
79
C2480000 Cocoyl caprylocaprate
40 mg
Y0000722 Codeine - * narc
20 mg
C2500000 Codeine - reference spectrum
n/a
Y0000334 Codeine impurity A
15 mg
C2500100 Codeine hydrochloride dihydrate - reference spectrum
n/a
1412
C2510000 Codergocrine mesilate
60 mg
Y0001500 Coix seed HRS
1300 mg
C2580000 Colchicine
15 mg
Y0000209 Colchicine for system suitability
Y0000374 Colestyramine
C2600000 Colistimethate sodium

Y0000277 Colistin sulfate
see leaflet
0073
1411
Yes
+5C 3C
79
0076,0777,1
839,1840,18
41
0074,0075
Yes
+5C 3C
79
79
0074,0075,0
076, 1412
Yes
+5C 3C
79
79
1416,2060
Yes
+5C 3C
79
2454
Yes
+5C 3C
79
0758
Yes
+5C 3C
79
10 mg
0758
Yes
+5C 3C
79
10 mg
1775
Yes
+5C 3C
79
20 mg
See leaflet
0319,20702
Yes
+5C 3C
79
25 mg
See leaflet
0320
Yes
-20C 5C
79
C2700000 Colistin sulfate for microbiological assay
25 mg
See leaflet; For microbiological assay only
0320
Yes
-20C 5C
79
C2725000 Copovidone - reference spectrum
n/a
0891
79
New Y0001748 Copper tetramibi tetrafluoroborate
15 mg
2547
g(c)
79
See leaflet
7,8-didehydro-4,5 alpha-epoxy-3,6 alpha-dimethoxy-17-methylmorphinan ;

19
Yes
-20C 5C

Order
Reference Standard
Code
C2800000 Cortisone acetate

per vial Unit
6
250 mg
1
Information
Monograph Leaflet
Storage
Extra
Price
charges
79
a
0321,0736,0
767
Yes
+5C 3C
0036
Yes
+5C 3C
79
2120
Yes
+5C 3C
79
0892
Yes
+5C 3C
79
C2900000 Cotton wool standard for neps
1000 mg
Y0000438 Coumarin
110 mg
Y0001053 Crospovidone
5 mg
C2970000 Crotamiton
100 mg
see leaflet CHNO ; Batch 2 is valid until 30 June 2015
1194
Yes
-20C 5C
79
C2970005 Crotamiton impurity A
35 mg
See leaflet; N-ethyl-N-(2-methylphenyl)but-3-enamide ; Batch 3 is valid until

31 August 2014
1194
Yes
-20C 5C
79
Y0001061 Cyanidin chloride
25 mg
See leaflet CHClO
C3000000 Cyanocobalamin
20 mg
Vitamin B12 ; Batch 4 is valid until 28 February 2015
C3090000 Cyclizine hydrochloride
50 mg
Y0000886 Cyclizine impurity A
15 mg
1-methylpiperazine
Y0000887 Cyclizine impurity B
15 mg
diphenylmethanol (benzhydrol)
C3200000 Cyclobenzaprine hydrochloride
100 mg
C3230000 Cyclohexa-1,4-dienylglycine
15 mg
C3245000 Cyclopentolate hydrochloride
50 mg
Y0001088 Cyclopentolate for system suitability
20 mg
C3250000 Cyclophosphamide
50 mg
C3280000 Cyproheptadine hydrochloride
15 mg
Y0001095 Cyproheptadine impurity C
5 mg
C3283000 Cyproterone acetate
30 mg
Y0001390 Cyproterone acetate for peak identification
5 mg
Y0001223 Cyproterone impurity mixture
C3290000 Cysteine hydrochloride monohydrate
C3300000 Cystine
C3350000 Cytarabine
See leaflet CHO
2394
Yes
+5C 3C
79
0269,0270,0
547,
0710,1505
Yes
+5C 3C
79
1092
Yes
+5C 3C
79
1092
Yes
+5C 3C
79
1092
Yes
+5C 3C
79
0408,0464
Yes
+5C 3C
79
0814
Yes
-20C 5C
79
1093
Yes
+5C 3C
79
1093
Yes
+5C 3C
79
0711
Yes
+5C 3C
79
0817,0846
Yes
+5C 3C
79
0817
Yes
+5C 3C
79
1094
Yes
+5C 3C
79
1094
Yes
+5C 3C
79
0.01 mg
1094
Yes
+5C 3C
79
100 mg
0895
Yes
+5C 3C
79
100 mg
0998
Yes
+5C 3C
79
150 mg
0760
Yes
+5C 3C
79
Y0000733 Dacarbazine
20 mg
1691
Yes
+5C 3C
79
Y0000734 Dacarbazine impurity A
20 mg
See leaflet CHNO; 3,7-dihydro-4H-imidazo[4,5-d]-1,2,3-triazin-4-one (2azahypoxanthine)
1691
Yes
+5C 3C
79
Y0000735 Dacarbazine impurity B
10 mg
See leaflet; 5-amino-1H-imidazole-carboxamide
1691
Yes
+5C 3C
79
New D0070000 Dalteparin sodium
(2R)-amino(cyclohexa-1,4-dienyl)acetic acid (d-dihydrophenylglycine)

250 mg
1195
Yes
+5C 3C
79
Y0000600 Danaparoid sodium
10.5 mg
2090
Yes
+5C 3C
79
D0100000 Dapsone
100 mg
0077
Yes
+5C 3C
79
D0125000 Daunorubicin hydrochloride
120 mg
See leaflet CHClNO
0662
Yes
+5C 3C
79
D0120000 Daunorubicinone
10 mg
Daunorubicin aglycone
0662
Yes
+5C 3C
79
20

Order
Reference Standard
Code
D0160000 Deferoxamine mesilate

per vial Unit
2
30 mg
1
Information
Monograph Leaflet
Storage
Extra
Price
charges
79
a
0896
Yes
+5C 3C
1221
Yes
+5C 3C
79
D0201000 Dehydrohexetidine
50 mg
Y0000611 Dembrexine hydrochloride monohydrate
10 mg
2169
Yes
+5C 3C
79
Y0001707 Demeclocycline for system suitability
10 mg
0176
Yes
+5C 3C
79
D0300000 Demeclocycline hydrochloride
100 mg
see leaflet
0211,0210,0
176,
0173,1654
Yes
+5C 3C
79
15 mg
0179,0274,0
490,
0552,1098
Yes
+5C 3C
79
New D0350000 N-Demethylerythromycin A
2-ethyl-N-[[1-(2-ethylhexyl)-4-methyl-4,5-dihydro-1H-imidazol-4-yl]methyl]
hexan-1-amine
Y0000228 Demethylflumazenil - reference spectrum
n/a
1917
79
D0406200 Deptropine citrate
60 mg
1308
Yes
+5C 3C
79
D0430000 Dequalinium chloride
50 mg
1413
Yes
+5C 3C
79
D0431000 Dequalinium chloride for performance test
50 mg
1413
Yes
+5C 3C
79
Y0001321 Dermatan sulfate and oversulfated chondroitin sulfate
1 mL
0332,0333
Yes
-20C 5C
79
D0480000 Desacetylvinblastine
1 mg
1276
Yes
-80C 10C
79
Y0000879 Desflurane - reference spectrum
n/a
79
Y0000807 Desflurane impurity A
1 mL
1666
Yes
+5C 3C
79
D0500000 Desipramine hydrochloride
100 mg
0481
Yes
+5C 3C
79
D0600000 Deslanoside
150 mg
See leaflet CHO
0482
Yes
+5C 3C
79
Y0001584 Desloratadine
100 mg
2570
Yes
+5C 3C
79
D0630000 Desmethylmetrifonate
30 mg
1133
Yes
+5C 3C
79
Y0001582 Desloratadine for system suitability
5 mg
2570
Yes
+5C 3C
79
D0650000 Desmopressin
0.94 mg
See leaflet CHNOS
0712
Yes
-20C 5C
79
Y0000509 Desogestrel
50 mg
See leaflet CHO
1717
Yes
+5C 3C
79
Y0000510 Desogestrel for system suitability
10 mg
1717
Yes
+5C 3C
79
D0400000 Desoxycortone acetate
100 mg
0322, 1327
Yes
+5C 3C
79
Y0000001 Detomidine hydrochloride
100 mg
1414
Yes
+5C 3C
79
D0660020 Detomidine impurity B
20 mg
1414
Yes
+5C 3C
79
D0700000 Dexamethasone
50 mg
0312,0388,0
548,
0768,1376,2
237,0549
Yes
+5C 3C
79
Y0001593 Dexamethasone for peak identification
10 mg
0388
Yes
+5C 3C
79
Y0001177 Dexamethasone for system suitability
10 mg
0388
Yes
+5C 3C
79
D0710000 Dexamethasone acetate
100 mg
0548,0933,0
975, 2237
Yes
+5C 3C
79
See leaflet
1666
1,1'-oxybis(1,2,2,2-tetrafluoroethane) ; Batch 1 is valid until 30 September
2015
(RS)-(1-benzyl-1H-imidazol-5-yl)(2,3-dimethylphenyl)methanol
21

Order
Reference Standard
Code
Y0001169 Dexamethasone acetate impurity E

Information
per vial Unit
1
0.013 mg 1 9-fluoro-11beta,17-dihydroxy-16alpha-methyl-3,20-dioxopregn-4-en-21-yl
acetate
Monograph Leaflet
Storage
0548
Yes
+5C 3C
Extra
Price
charges
79
a
Y0000538 Dexamethasone isonicotinate
10 mg
2237
Yes
+5C 3C
79
Y0000511 Dexamethasone isonicotinate for impurity C identification
10 mg
2237
Yes
+5C 3C
79
D0718000 Dexamethasone pivalate
50 mg
1327
Yes
+5C 3C
79
D0720000 Dexamethasone sodium phosphate
130 mg
0549,0735,0
810
Yes
+5C 3C
79
Y0001477 Dexamethasone sodium phosphate for peak

identification
10 mg
0549
Yes
+5C 3C
79
D0720800 Dexchlorpheniramine maleate
60 mg
D0730000 Dexpanthenol
5 mg
D0731000 Dextran
25 mg
D0731005 Dextran 1
50 mg
D0733000 Dextran 4 for calibration
50 mg
D0738000 Dextran 40 for performance test

D0739000 Dextran 60/70 for performance test
See leaflet
1196
Yes
+5C 3C
79
0761
Yes
+5C 3C
79
0999,1000,1
001
Yes
+5C 3C
79
See leaflet; Average molecule mass : 930-1000

Fraction with less than 3 glucose units : 8.0 to 10.5%
Fraction with more than 9 glucose units : 10.0 to 12.5%
1506
Yes
+5C 3C
79
See leaflet
20239
Yes
+5C 3C
79
50 mg
See leaflet
20239
Yes
+5C 3C
79
50 mg
See leaflet
20239
Yes
+5C 3C
79
50 mg
20239
Yes
+5C 3C
79
50 mg
20239
Yes
+5C 3C
79
50 mg
See leaflet
20239
Yes
+5C 3C
79
50 mg
See leaflet
20239
Yes
+5C 3C
79
D0732000 Dextran Vo
10 mg
20239
Yes
+5C 3C
79
Y0000744 Dextranomer
50 mg
2238
Yes
+5C 3C
79
D0740000 Dextromethorphan hydrobromide
100 mg
0020
Yes
+5C 3C
79
Y0000261 Dextromethorphan impurity A
5 mg
0020
Yes
+5C 3C
79
Y0001058 Dextropropoxyphene hydrochloride - * narc
10 mg
0713
Yes
+5C 3C
79
Y0001150 Dextropropoxyphene for system suitability - * narc
5 mg
0713
Yes
+5C 3C
79
Y0001595 Diacerein
150 mg
See leaflet CHO
2409
Yes
+5C 3C
79
Y0001596 Diacerein impurity B
20 mg
see leaflet
2409
Yes
+5C 3C
79
Y0001597 Diacerein impurity mixture
0.014 mg
2409
Yes
-20C 5C
79
Y0000454 Diacetylfluorescein
100 mg
1213
Yes
+5C 3C
79
D0940000 Diazepam - * psy
30 mg
0022
Yes
+5C 3C
79
Y0000596 Diazepam for system suitability - * psy
0.5 mg
0022
Yes
+5C 3C
79
D0950000 Diazoxide
50 mg
0550
Yes
+5C 3C
79
D0970000 Dibenzocycloheptene
20 mg
0817
Yes
+5C 3C
79
ent-3-methoxymorphinan
See leaflet
22

Order
Reference Standard
Code
D1000000 Dibenzosuberone

per vial Unit
2
30 mg
1
Information
Monograph Leaflet
Storage
0464,0817,0
941
Yes
+5C 3C
Extra
Price
charges
79
a
Y0000480 Dibrompropamidine diisetionate
10 mg
2300
Yes
+5C 3C
79
Y0000481 Dibrompropamidine for system suitability
20 mg
2300
Yes
+5C 3C
79
D1010000 Dibutyl phthalate
1 ml
0762
Yes
+5C 3C
79
Y0001620 2,4-dichlorobenzyl alcohol
250 mg
2410
Yes
+5C 3C
79
Y0001621 2,4-Dichlorobenzyl alcohol impurity A
25 mg
2410
Yes
+5C 3C
79
Y0001622 2,4-Dichlorobenzyl alcohol impurity C
25 mg
2410
Yes
+5C 3C
79
Y0000275 Dichlorodiaminocyclohexaneplatinum
15 mg
2017
Yes
+5C 3C
79
Y0000264 Diclazuril for veterinary use - reference spectrum
n/a
1718
79
Y0000259 Diclazuril for system suitability
20 mg
1718
Yes
+5C 3C
79
D1039990 Diclofenac potassium
100 mg
1508
Yes
+5C 3C
79
S0765000 Diclofenac sodium
100 mg
1002,1281
Yes
+5C 3C
79
D1040000 Diclofenac impurity A
0.005 mg
1281
Yes
+5C 3C
79
Y0001635 Diclofenac for system suitability
1.002 mg
1002
Yes
+5C 3C
79
D1050000 Dicloxacillin sodium
250 mg
0661, 0663,
0668, 2346
Yes
-20C 5C
79
D1060000 Dicycloverine hydrochloride
100 mg
1197
Yes
+5C 3C
79
Y0000439 Didanosine
10 mg
2200
Yes
+5C 3C
79
Y0000441 Didanosine impurity A
10 mg
1,7-dihydro-6H-purin-6-one (hypoxanthine)
2200
Yes
+5C 3C
79
Y0000442 Didanosine impurity G
10 mg
9-(2,3-dideoxy--D-glycero-pentofuranosyl)-9H-purin-6-amine (2',3'dideoxyadenosine)
2200
Yes
+5C 3C
79
Y0000440 Didanosine for system suitability
10 mg
2200
Yes
+5C 3C
79
D1200000 Dienestrol
150 mg
0484
Yes
+5C 3C
79
D1410000 Diethyl phthalate
1 ml
0897
Yes
+5C 3C
79
D1300000 Diethylcarbamazine citrate
250 mg
0271
Yes
+5C 3C
79
Y0000217 Diethylene glycol (monoethyl ether) - reference spectrum
n/a
79
D1500000 Diethylstilbestrol
100 mg
0484
Yes
+5C 3C
79
D1600000 Diethylstilbestrol dimethyl ether
10 mg
0484
Yes
+5C 3C
79
D1700000 Diethylstilbestrol monomethyl ether
10 mg
0484
Yes
+5C 3C
79
Y0001423 Difloxacin hydrochloride
60 mg
2239
Yes
+5C 3C
79
Y0001429 Difloxacin impurity G
15 mg
2239
Yes
+5C 3C
79
D1750000 Diflunisal
30 mg
D1800000 Digitoxin
200 mg
See leaflet CHO
Y0000640 Digoxigenin
10 mg
D1900000 Digoxin
30 mg
See leaflet CHClO
1-(2,6-dichlorophenyl)-1,3-dihydro-2H-indol-2-one
See leaflet CHClNNaOS
See leaflet CHO

See leaflet CHNO
1198
See leaflet CHO
7-chloro-6-fluoro-1-(4-fluorophenyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic
acid
0864
Yes
+5C 3C
79
0078,0117
Yes
+5C 3C
79
See leaflet
0079
Yes
+5C 3C
79
See leaflet CHO
0079
Yes
+5C 3C
79
23

Order
Reference Standard
Code
Y0000554 Digoxin for peak identification

per vial Unit
1
10 mg
1
Information
Monograph Leaflet
0079
Storage
Extra
Price
charges
79
a
Yes
+5C 3C
79
Yes
+5C 3C
79
79
1512
Yes
-20C 5C
79
1416,2060
Yes
+5C 3C
79
0551
Yes
+5C 3C
79
D1940001 Dihydralazine sulfate (hydrated) - reference spectrum
n/a
1310
Y0000232 Dihydralazine for system suitability
10 mg
1310
Y0000216 Dihydrocodeine hydrogen tartrate - reference spectrum
n/a
Y0000053 17 alpha-dihydroequilin
10 mg
D1945000 Dihydroergocristine mesilate
250 mg
D1950000 Dihydroergotamine mesilate
50 mg
Y0000831 Dihydroergotamine for peak identification
10 mg
0551
Yes
+5C 3C
79
D1952000 Dihydroergotamine tartrate
150 mg
0600
Yes
+5C 3C
79
D1954000 Dihydrostreptomycin sulfate
25 mg
See leaflet CHNOS
0485
Yes
-20C 5C
79
Y0000544 Dihydrotachysterol
30 mg
See leaflet CHO
2014
Yes
-20C 5C
e(d)
79
Y0000482 Dihydrotachysterol for system suitability
5 mg
2014
Yes
-20C 5C
e(d)
79
D1980000 Diltiazem hydrochloride
300 mg
1004
Yes
+5C 3C
79
Y0001439 Diltiazem impurity F
10 mg
(2S,3S)-5-[2-(dimethylamino)ethyl]-3-hydroxy-2-(4-methoxyphenyl)-2,3dihydro-1,5-benzothiazepin-4(5H)-one
1004
Yes
+5C 3C
79
Y0001141 Diltiazem for system suitability
10 mg
Replaces Diltiazem impurity A CRS
1004
Yes
+5C 3C
79
D2000000 Dimenhydrinate
100 mg
0601
Yes
+5C 3C
79
Y0001103 Dimenhydrinate for peak identification
1 mg
0601
Yes
+5C 3C
79
Y0000234 N,N-Dimethylacetamide - reference spectrum
n/a
1667
79
New D2050000 Dimethyl sulfoxide
1776
See leaflet
Batch 3 is valid until 31 March 2015
1 mL
Y0001489 2-(Dimethylamino)ethyl methacrylate
50 mg
D2200000 Dimeticone
200 mg
D2205000 Dimetindene maleate
50 mg
D2255000 Dinoprost trometamol
60 mg
D2250000 Dinoprostone
100 mg
D2250015 Dinoprostone impurity C
10 mg
(E)-7-[(1R,2R,3R)-3-hydroxy-2-[(E)-(3S)-3-hydroxyoct-1-enyl]- 5oxocyclopentyl]-hept-5-enoic acid (5-trans-PGE2 ; (5E)-PGE2)
Y0000094 Diosmin
70 mg
Y0000095 Diosmin for system suitability
5 mg
D2600000 Diphenhydramine hydrochloride
100 mg
Y0000135 Diphenhydramine impurity A
10 mg
Y0001415 Diphenoxylate hydrochloride - * narc
15 mg
D2630000 Diphenoxylate hydrochloride - reference spectrum
Y0001430 Diphenoxylate for system suitability - * narc
Y0000258 Diphtheria toxin BRP
1 ml
0763
Yes
+5C 3C
79
1975
Yes
+5C 3C
79
0138,1470
Yes
+5C 3C
79
1417
Yes
+5C 3C
79
See leaflet CHNO
1312
Yes
-20C 5C
79
See leaflet CHO
1311
Yes
-20C 5C
79
1311,1488
Yes
-20C 5C
240
1611
Yes
+5C 3C
79
1611
Yes
+5C 3C
79
0023,0601
Yes
+5C 3C
79
0023,0601
Yes
+5C 3C
79
0819
Yes
+5C 3C
79
n/a
0819
79
10 mg
0819
Yes
+5C 3C
79
See leaflet,
0443
Yes
+5C 3C
90

See leaflet
2-(diphenylmethoxy)-N-methylethanamine ; Batch 3 is valid until 31

December 2014
See leaflet
24

Order
Reference Standard
Code
D2700000 Diphtheria vaccine (adsorbed) BRP

per vial Unit
4
32 mg
1 See leaflet
Information
Monograph Leaflet
Storage
Extra
Price
charges
90
c
See leaflet,
20706
Yes
-20C 5C
1719
Yes
+5C 3C
79
Yes
+5C 3C
79
79
Y0000376 Dipivefrine hydrochloride
100 mg
Y0000394 Dipivefrine for system suitability
10 mg
1719
D2750100 Dipotassium clorazepate - reference spectrum
n/a
0898
D2800000 Diprophylline
100 mg
0486
Yes
+5C 3C
79
D2850000 Dipyridamole
50 mg
1199
Yes
+5C 3C
79
Y0000802 Dipyridamole for peak identification
2.04 mg
D2880000 Dirithromycin
100 mg
D2900000 Disodium edetate
100 mg
D2920000 Disopyramide
100 mg
D2922000 Disopyramide phosphate
D2950000 Disulfiram
D2953000 Dithranol
D2953025 Dithranol impurity C
D2953050 Dithranol impurity D

D2954000 Dobutamine hydrochloride
Y0001239 Dobutamine impurity mixture
Y0001133 Docetaxel trihydrate
See leaflet CHClNO
1199
Yes
+5C 3C
79
1313
Yes
+5C 3C
79
0232
Yes
+5C 3C
79
1006
Yes
+5C 3C
79
100 mg
1005
Yes
+5C 3C
79
100 mg
0603
Yes
+5C 3C
79
55 mg
1007
Yes
+5C 3C
79
15 mg
See leaflet; Dithranol-dimer

4,4',5,5'-tetrahydroxy-9,9'-bianthracenyl-10,10'(9H,9'H)-dione ; Batch 3 is
valid until 30 September 2014
1007
Yes
+5C 3C
79
20 mg
1-hydroxyanthracen-9(10H)-one
1007
Yes
+5C 3C
79
100 mg
1200
Yes
+5C 3C
79
0.1 mg
160 mg
Y0001155 Docetaxel for system suitability
10 mg
Y0001452 Docetaxel impurity E
15 mg
5,20-epoxy-4-(acetyloxy)-1,7,10,13-tetrahydroxy-9-oxotax-11-en-2-yl
benzoate (10-desacetyl-baccatin III)
D2954600 Docosahexaenoic acid ethyl ester
150 mg
See leaflet
Y0001567 Docusate sodium
10 mg
Y0000365 Dodecyl gallate
30 mg
D2955000 Domperidone
D2957000 Domperidone maleate
D2960000 Dopamine hydrochloride

Y0000612 Dopexamine dihydrochloride
See leaflet CHNO
1200
Yes
-20C 5C
79
2449, 2593
Yes
+5C 3C
79
2449,2593
Yes
+5C 3C
79
2593
Yes
+5C 3C
79
20429
Yes
-20C 5C
79
1418
Yes
+5C 3C
79
2078
Yes
+5C 3C
79
150 mg
1009
Yes
+5C 3C
79
150 mg
1008
Yes
+5C 3C
79
20 mg
0664,1200
Yes
+5C 3C
79
10 mg
1748
Yes
+5C 3C
79
Y0000613 Dopexamine impurity B
10 mg
2-methoxy-4-[2-[[6-[(2-phenylethyl)amino]hexyl]amino]ethyl]phenol
1748
Yes
-20C 5C
79
Y0000614 Dopexamine impurity F
10 mg
4-chloro-5-[2-[[6-[(2-phenylethyl)amino]hexyl]amino]ethyl]benz -ene-1,2-diol
1748
Yes
-20C 5C
79
Y0000726 Dorzolamide hydrochloride
50 mg
2359
Yes
+5C 3C
79
Y0000727 Dorzolamide impurity A
5 mg
2359
Yes
+5C 3C
79
Y0000750 Dorzolamide for system suitability
5 mg
2359
Yes
+5C 3C
79
100 mg
D2962000 Dosulepin hydrochloride

See leaflet CHNO.3HO
(4R,6R)-4-(ethylamino)-6-methyl-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2sulphonamide 7,7-dioxide
25
79
1314
Yes
+5C 3C
a

Order
Reference Standard
Code
D2962005 Dosulepin impurity A

Information
per vial Unit
2
30 mg
1 (E)-3-(6,11-dihydrodibenzo[b,e]thiepin-11-ylidene)-N,N'dimethylpropan-1-amine -oxide
Monograph Leaflet
Storage
Extra
Price
charges
79
a
1314
Yes
+5C 3C
1201
Yes
+5C 3C
79
D2963000 Doxapram hydrochloride
50 mg
Y0000208 Doxapram impurity B
10 mg
(4RS)-1-ethyl-4-[2-[(2-hydroxyethyl)amino]ethyl]-3,3-diphenylpyrolidin-2-one
1201
Yes
+5C 3C
79
Y0000553 Doxazosin mesilate
60 mg
See leaflet
2125
Yes
+5C 3C
79
Y0000551 Doxazosin impurity D
10 mg
6,7-dimethoxyquinazoline-2,4(1H,3H)-dione
2125
Yes
+5C 3C
79
Y0000552 Doxazosin impurity F
15 mg
2-chloro-6,7-dimethoxyquinazolin-4-amine
2125
Yes
+5C 3C
79
Y0000838 Doxepin hydrochloride
5 mg
1096
Yes
+5C 3C
79
Y0000851 Doxepin for system suitability
1 mg
1096
Yes
+5C 3C
79
D2975000 Doxorubicin hydrochloride
150 mg
See leaflet CHClNO
0714,0662,1
590
Yes
-20C 5C
79
D3000000 Doxycycline hyclate
50 mg
see leaflet ; Batch 4 is valid until 30 September 2015
Yes
+5C 3C
79
Y0001714 Doxycycline for system suitability
10 mg
04/2015:027
2,
04/2015:082
0
0272,0820
Yes
+5C 3C
79
Y0001562 Doxylamine hydrogen succinate
60 mg
1589
Yes
+5C 3C
79
Y0000163 Doxylamine hydrogen succinate - reference spectrum
n/a
1589
79
Y0001492 Doxylamine for system suitability
110 mg
Batch 1 is valid until 28 February 2015
D3100000 Droperidol
150 mg
Y0001105 Drospirenone
60 mg
Y0001115 Drospirenone impurity E
0.06 mg
Y0001718 Drospirenone for peak identification
10 mg
Y0001453 Duloxetine hydrochloride
120 mg
See leaflet CHClNOS
Y0001455 Duloxetine impurity A
10 mg
(3R)-N-methyl-3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propan-1-amine ;
Y0001454 Duloxetine for system suitability
40 mg
Y0001598 Dutasteride
150 mg
Y0001603 Dutasteride for system suitability
10 mg
Y0001004 Dydrogesterone
50 mg
See leaflet CHO
Y0001005 Dydrogesterone impurity A
6 mg
Y0001006 Dydrogesterone impurity B
5 mg
Y0000249 Ebastine - reference spectrum
n/a
Y0000247 Ebastine impurity C
10 mg
4-(diphenylmethoxy)piperidine
Y0000248 Ebastine impurity D
10 mg
1-[4-(1,1-dimethylethyl)phenyl]-4-(4-hydroxypiperidin-1-yl)butan-1-one
Y0001236 Econazole
10 mg
Y0000254 Econazole for system suitability
20 mg
1589
Yes
+5C 3C
79
1008,1009,1
010, 1172
Yes
+5C 3C
79
See leaflet CHO
2404
Yes
+5C 3C
79
3-oxo-6alpha,7alpha,15alpha,16alpha-tetrahydro-3'H,3''H-dicyclopropa
[6,7:15,16]pregn-4-ene-21,17- carbolactone (17-epidrospirenone)
2404
Yes
+5C 3C
79
2404
Yes
+5C 3C
79
2594
Yes
+5C 3C
79
2594
Yes
+5C 3C
79
2594
Yes
+5C 3C
79
2641
Yes
+5C 3C
79
2641
Yes
+5C 3C
79
2357
Yes
+5C 3C
79
9,10-pregna-4,6,8(14)-triene-3,20-dione
2357
Yes
+5C 3C
79
pregna-4,6-diene-3,20-dione
2357
Yes
+5C 3C
79
79
2015
Yes
+5C 3C
79
2015
Yes
+5C 3C
79
2049
Yes
+5C 3C
79
0665,2049
Yes
+5C 3C
79
See leaflet
2015
26

Order
Reference Standard
Code
E0050000 Econazole nitrate

per vial Unit
3
100 mg
1
Y0001738 Edrophonium chloride
10 mg
E0085000 Eicosapentaenoic acid ethyl ester
200 mg
Y0000537 Emedastine difumarate
10 mg
Y0000512 Emedastine impurity E
10 mg
E0100000 Emetine hydrochloride
100 mg
E0109000 Enalapril maleate
E0110000 Enalapril for system suitability

Y0001211 Enalapril impurity mixture
Y0000615 Enalaprilat dihydrate
Y0000678 Enalaprilat impurity G
Information
Monograph Leaflet
0513,0665,0
921, 0935,
1017,1018
Yes
Storage
+5C 3C
Extra
Price
charges
79
a
2106
Yes
+5C 3C
79
20429
Yes
-20C 5C
79
2242
Yes
+5C 3C
79
2242
Yes
+5C 3C
79
0081,0093,
0094,1530,1
875
Yes
+5C 3C
79
50 mg
1420
Yes
+5C 3C
79
20 mg
1420
Yes
+5C 3C
79
0.06 mg
1420
Yes
+5C 3C
79
100 mg
1749
Yes
+5C 3C
79
0.005 mg
1749
Yes
+5C 3C
79
Y0000629 Enalaprilat for system suitability
10 mg
1749
Yes
+5C 3C
79
E0150000 Endotoxin standard BRP
10 mg
20614, 20630
Yes
-20C 5C
79
Y0000136 Enilconazole
60 mg
1720
Yes
+5C 3C
79
Y0000137 Enilconazole impurity E
20 mg
1720
Yes
+5C 3C
79
E0180000 Enoxaparin sodium
200 mg
1097
Yes
+5C 3C
79
E0180500 Enoxolone
100 mg
1511
Yes
+5C 3C
79
Y0001259 Enrofloxacin
5 mg
2229
Yes
+5C 3C
79
Y0001160 Enrofloxacin for system suitability
10 mg
2229
Yes
+5C 3C
79
Y0001249 Entacapone
160 mg
See leaflet CHNO
2574
Yes
+5C 3C
79
Y0001250 Entacapone impurity A
10 mg
Z isomer of entacapone
2574
Yes
+5C 3C
79
E0200000 Enterokinase BRP
200 mg
0350
Yes
+5C 3C
79
E0300000 Ephedrine hydrochloride - * Drug Precursor
150 mg
Yes
+5C 3C
79
E0305000 Ephedrine hydrochloride (racemic) - * Drug Precursor
50 mg
0487,0488,0
489,1367,24
51
0715
Yes
+5C 3C
79
E0400000 4-Epianhydrotetracycline hydrochloride
20 mg
See leaflet
0210,0211,1
654
Yes
+5C 3C
79
Y0001139 Epinastine hydrochloride
20 mg
2411
Yes
+5C 3C
79
Y0001128 Epinastine for system suitability
10 mg
E0530000 4-Epioxytetracycline
40 mg
See leaflet CHNO
E0550000 Epirubicin hydrochloride
100 mg
See leaflet CHClNO
E0600000 4-Epitetracycline hydrochloride
30 mg
See leaflet CHO

1-(2-ethoxyethyl)-2-(hexahydro-1H-1,4-diazepin-1yl)benzimidazole.
(2SR)-2-[(3SR,8aRS)-3-methyl-1,4-dioxohexahydropyrrolo[1,2-a] pyrazin-2
(1H)-yl]-4-phenylbutanoic acid
See leaflet
(1RS)-1-(2,4-dichlorophenyl)-2-(-1H-imidazol-1-yl)ethanol
27
2411
Yes
+5C 3C
79
0198,0199
Yes
+5C 3C
79
0662,0714,1
590
Yes
-20C 5C
79
0210,0211,1
654
Yes
+5C 3C
79

Order
Code
Y0001704 Eplerenone
Reference Standard

per vial Unit
1
75 mg
1 see leaflet CHO
Information
Monograph Leaflet
Storage
2765
Yes
+5C 3C
Extra
Price
charges
79
a
Y0001706 Eplerenone for peak identification
10 mg
2765
Yes
+5C 3C
79
Y0001705 Eplerenone for system suitability
10 mg
2765
Yes
+5C 3C
79
P1609010 trans-Epoxyphytomenadione
5 mg
1036
Yes
+5C 3C
79
E0850010 Eq Influenza Subtype 1 Strain A/eq/Newmarket/77

Horse Antiserum BRP
1 mg
See leaflet; Common standard OIE

Strain A/eq/Newmarket/77
See leaflet,
0249
Yes
-20C 5C
90
E0850021 Eq Influenza Subtype 2 American-like/Newmarket

Horse Antiserum BRP
1 mg

Strain A/eq/Newmarket/1/93
See leaflet,
0249
Yes
-20C 5C
90
Y0000712 Eq Influenza Subtype 2 American-like/South Africa

Horse Antiserum BRP
1 mg
See leaflet
See leaflet,
0249
Yes
-20C 5C
90
E0850022 Eq Influenza Subtype 2 European-like/Newmarket

Horse Antiserum BRP
1 mg

Strain A/eq/Newmarket/2/93
See leaflet,
0249
Yes
-20C 5C
90
Y0000052 Equilin
15 mg
See leaflet CHO
1512
Yes
-20C 5C
79
Y0001325 Equisetum palustre
200 mg
E0900000 Ergocalciferol
500 mg
E1000000 Ergometrine maleate - * Drug Precursor
50 mg
E1100000 Ergosterol
20 mg
E1200000 Ergotamine tartrate - * Drug Precursor
100 mg
Y0000051 Erysipelas ELISA coating antigen BRP
0.4 mg
See leaflet
Y0000177 Erythritol
1000 mg
See leaflet CHO
E1400000 Erythromycin estolate
100 mg
E1500000 Erythromycin ethylsuccinate
10 mg
E1500800 Erythromycin stearate
50 mg
E1305000 Erythromycin A
250 mg
New E1310000 Erythromycin B
50 mg
E1320000 Erythromycin C
E1300000 Erythromycin for microbiological assay

E1515000 Erythropoietin BRP
Y0001725 Erythropoietin for physicochemical tests
1825
Yes
+5C 3C
79
0082,0574,0
575,
0598,1192,1
193, 2398
Yes
-20C 5C
79
0223
Yes
+5C 3C
79
0082
Yes
-20C 5C
79
0224, 0551
Yes
+5C 3C
79
See leaflet,
0064
Yes
-20C 5C
90
1803
Yes
+5C 3C
79
0552
Yes
+5C 3C
79
0274
Yes
+5C 3C
79
0490
Yes
+5C 3C
79
See leaflet
0179,0274,0
293,
0490,0552,1
098
Yes
-20C 5C
79
0179,0274,0
490,
0552,1098
Yes
-20C 5C
79
50 mg
See leaflet
0179,0274,0
490,
0552,1098
Yes
-20C 5C
79
250 mg
See leaflet
20702
Yes
-20C 5C
79
15 mg
see leaflet ; Batch 3 is valid until 30 June 2015
1316
Yes
-20C 5C
150
0.1 mg
1316
Yes
-20C 5C
150
See leaflet; Vitamin D2
28

Order
Code
Y0001611 Esculetin
Reference Standard
Y0001612 Esculin

per vial Unit
1
25 mg
1 See leaflet CHO
1
25 mg
1 See leaflet CHO
Information
Monograph Leaflet
Storage
2452
Yes
+5C 3C
2452
Yes
+5C 3C
Extra
Price
charges
79
a
a
79
79
+5C 3C
79
+5C 3C
79
Yes
+5C 3C
79
Yes
+5C 3C
79
0139
Yes
+5C 3C
79
0139
Yes
+5C 3C
79
1614
Yes
+5C 3C
79
0821,1203
Yes
+5C 3C
79
10 mg
0821
Yes
+5C 3C
79
50 mg
1614
Yes
+5C 3C
79
50 mg
1203
Yes
+5C 3C
79
20 mg
See leaflet; 9,11-didehydroestriol
1203
Yes
+5C 3C
79
15 mg
See leaflet
1512,0140
Yes
+5C 3C
79
100 mg
0457
Yes
+5C 3C
79
Y0001263 Etacrynic acid for system suitability
10 mg
0457
Yes
+5C 3C
79
E1830000 Etamsylate
30 mg
1204
Yes
+5C 3C
79
E1840000 Ethacridine lactate monohydrate
50 mg
1591
Yes
+5C 3C
79
E1850000 Ethambutol hydrochloride
250 mg
0553
Yes
+5C 3C
79
Y0000803 Ethambutol for system suitability
10 mg
0553
Yes
+5C 3C
79
A1202800 Ethanol (anhydrous) - reference spectrum
n/a
1318
79
E1860100 Ethanol 96% - reference spectrum
n/a
E1900000 Ethinylestradiol
200 mg
Y0001124 Ethinylestradiol for system suitability
1.0124 mg
E2000000 Ethionamide
Y0001686 Ethionamide for system suitability
E2150000 Ethosuximide
E2250000 Ethosuximide impurity A
E2195000 Ethyl acetate - reference spectrum
Y0000617 Ethyl indole-3-carboxylate
E2425000 Ethyl parahydroxybenzoate
Y0000324 Esketamine hydrochloride - reference spectrum
n/a
Y0000338 Esketamine impurity D - * narc
10 mg
1742
Yes
Y0001660 Esomeprazole magnesium dihydrate
15 mg
2787
Yes
Y0001028 Esomeprazole magnesium trihydrate
5 mg
2372
Y0000749 Essential oil
1000 mg
2098
E1600000 Estradiol benzoate
250 mg
Y0000852 Estradiol benzoate for system suitability
10 mg
Y0000045 Estradiol butyrate
10 mg
E1620000 Estradiol hemihydrate
100 mg
Y0000314 Estradiol for peak identification
Y0000046 Estradiol valerate
E1680000 Estriol
E1680005 Estriol impurity A
E1700000 Estrone
E1800000 Etacrynic acid
1742
(2R)-2-(2-chlorophenyl)-2-(methylamino)cyclohexanone ((R)-ketamine)
79
0140, 0821,
0940, 0926
1317
Yes
+5C 3C
79
0140
Yes
+5C 3C
79
100 mg
0141
Yes
+5C 3C
79
10 mg
0141
Yes
+5C 3C
79
30 mg
0764
Yes
+5C 3C
79
30 mg
0764
Yes
+5C 3C
79
n/a
0899
79
10 mg
2102
Yes
+5C 3C
79
150 mg
0409,0431,0
900,
1262,1263,2
134
Yes
+5C 3C
79
See leaflet ; Batch 4 is valid until 30 November 2014
(2RS)-2-ethyl-2-methylbutanedioic acid
See leaflet CHO
29

Order
Code
Y0001633 Ethylcellulose
Reference Standard

per vial Unit
1
100 mg
1
Information
Monograph Leaflet
Storage
Extra
Price
charges
79
a
0822
Yes
+5C 3C
1351
Yes
+5C 3C
79
1272,1383
Yes
+5C 3C
79
E2202000 1-N-Ethylgaramine sulfate
50 mg
See leaflet
E2205500 1,1'-Ethylidenebistryptophan
0.002 mg
See leaflet CHNO
E2300000 Ethylmorphine hydrochloride - reference spectrum
n/a
0491
79
E2400000 Ethylnicotinamide
150 mg
0233
Yes
+5C 3C
79
Y0000572 Etidronate disodium
10 mg
1778
Yes
+5C 3C
79
E2450000 Etifenin
25 mg
0585
Yes
+5C 3C
79
E2451000 Etilefrine hydrochloride
75 mg
1205
Yes
+5C 3C
79
E2451010 Etilefrine impurity A
20 mg
1205
Yes
+5C 3C
79
E2470000 Etodolac
60 mg
1422
Yes
+5C 3C
79
E2470050 Etodolac impurity H
10 mg
1422
Yes
+5C 3C
79
Y0000768 Etodolac for peak identification
10 mg
1422
Yes
+5C 3C
79
E2499900 Etofenamate
40 mg
1513
Yes
+5C 3C
79
E2499914 Etofenamate impurity G
25 mg
1513
Yes
+5C 3C
79
E2499901 Etofenamate for peak identification
20 mg
1513
Yes
+5C 3C
79
E2500000 Etofylline
100 mg
0486
Yes
+5C 3C
79
E2503000 Etomidate
50 mg
1514
Yes
+5C 3C
79
E2503004 Etomidate impurity B
25 mg
methyl 1-[(1RS)-1-phenylethyl]-1H-imidazole-5-carboxylate
1514
Yes
+5C 3C
79
E2600000 Etoposide
150 mg
0823
Yes
+5C 3C
79
Y0001365 Etoposide for system suitability
10 mg
0823
Yes
+5C 3C
79
Y0001605 Eucommia bark HRS
2100 mg
2412
Yes
+5C 3C
79
E5000000 Eugenol
500 l
1100
Yes
+5C 3C
79
F0005000 Famotidine
100 mg
1012
Yes
+5C 3C
79
Y0000409 Famotidine impurity D
10 mg
3-[[[2-[(diaminomethylene)amino]thiazol-4-yl]methyl]sulphanyl]propanamide
1012
Yes
+5C 3C
79
Y0000382 Famotidine for system suitability
15 mg
1012
Yes
+5C 3C
79
Y0000556 Febantel
150 mg
2176
Yes
+5C 3C
79
Y0000660 Febantel for system suitability
10 mg
2176
Yes
+5C 3C
79
Y0000731 Felbinac
10 mg
2304
Yes
+5C 3C
79
Y0000732 Felbinac impurity A
20 mg
2304
Yes
+5C 3C
79
F0030000 Felodipine
120 mg
1013
Yes
+5C 3C
79
Y0000415 Felypressin
0.994 mg
See leaflet CHNOS
1634
Yes
-20C 5C
79
F0040000 Fenbendazole
150 mg
1208,1458
Yes
+5C 3C
79
F0040010 Fenbendazole impurity A
20 mg
methyl(1-benzimidazol-2-yl)carbamate
1208
Yes
+5C 3C
79
F0040020 Fenbendazole impurity B
25 mg
methyl[5(6)-chlorobenzimidazol-2-yl]carbamate
1208
Yes
+5C 3C
79
F0041000 Fenbufen
100 mg
1209
Yes
+5C 3C
79
F0048000 Fenofibrate
100 mg
1322
Yes
+5C 3C
79
2-ethylamino-1-(3-hydroxyphenyl)ethanone
2-(7-ethylindol-3-yl)ethanol
2-hydroxyethyl 2-[[3-(trifluoromethyl)phenyl]amino]-benzoate
4-acetyl biphenyl
See leaflet CHClO

30

Order
Reference Standard
Code
F0048005 Fenofibrate impurity A

Information
per vial Unit
4
15 mg
1 (4-chlorophenyl)(4-hydroxyphenyl)methanone ; Batch 3 is valid until 30
September 2014
Monograph Leaflet
Storage
1322
Yes
+5C 3C
Extra
Price
charges
79
a
F0048010 Fenofibrate impurity B
10 mg
2[4-(4-chlorobenzoyl)phenoxy]-2-methylpropanoic acid (fenofibric acid)
1322
Yes
+5C 3C
79
F0048035 Fenofibrate impurity G
25 mg
1-methylethyl 2-[[2-[4-(4-chlorobenzoyl)phenoxy]-2-methylpropanoyl]
oxy]-2-methylpropanoate
1322
Yes
+5C 3C
79
F0050000 Fenoterol hydrobromide
50 mg
see leaflet ; Batch 2 is valid until 31 December 2014
0901
Yes
+5C 3C
79
Y0000756 Fenoterol for peak identification
1.2 mg
0901
Yes
+5C 3C
79
F0054990 Fentanyl - reference spectrum
n/a
1210
79
F0055000 Fentanyl citrate - reference spectrum
n/a
1103
79
Y0001509 Fentanyl for system suitability - * narc
15 mg
F0060000 Fenticonazole nitrate
50 mg
F0060040 Fenticonazole impurity D
0.01 mg
F0100000 Ferrous gluconate
100 mg
Y0001013 Ferulic acid
20 mg
See leaflet CHO
Y0000789 Fexofenadine hydrochloride
60 mg
Y0000751 Fexofenadine impurity A
5 mg
Y0000752 Fexofenadine impurity B
0.01 mg
Y0000753 Fexofenadine impurity C
Y0001173 Filgrastim
New Y0000090 Finasteride

()-1-[2-(2,4-dichlorophenyl)-2-hydroxyethyl]-3-[4-(phenyl suphanyl)
benzyl]imidazolium nitrate
1210,1103
Yes
+5C 3C
79
1211
Yes
+5C 3C
79
1211
Yes
+5C 3C
79
0493
Yes
+5C 3C
79
1834,2558
Yes
+5C 3C
79
See leaflet CHClNO
2280
Yes
+5C 3C
79
2-[4-[4-[4-(hydroxydiphenylmethyl)piperidin-1-yl]butanoyl]phenyl]-2methylpropanoic acid
2280
Yes
+5C 3C
79
2-[3-[(1RS)-1-hydroxy-4-[4-(hydroxydiphenylmethyl)piperidin-1-yl]butyl]
phenyl]-2-methylpropanoic acid
2280
Yes
+5C 3C
79
5 mg
(1RS)-4-[4-(hydroxydiphenylmethyl)piperidin-1-yl]-1-[4-(1-methylethyl)
phenyl]butan-1-ol
2280
Yes
+5C 3C
79
0.2 mL
2206
Yes
-80C 10C
79
1615
Yes
+5C 3C
79
1615
Yes
+5C 3C
79
120 mg
Y0001604 Finasteride for peak identification
15 mg
Y0000736 Flavoxate hydrochloride
10 mg
1692
Yes
+5C 3C
79
Y0000737 Flavoxate impurity A
10 mg
3-methyl-4-oxo-2-phenyl-4H-1-benzopyran-8-carboxylic acid
1692
Yes
+5C 3C
79
Y0000738 Flavoxate impurity B
10 mg
ethyl 3-methyl-4-oxo-2-phenyl-4H-1-benzopyran-8-carboxylate
1692
Yes
+5C 3C
79
F0120000 Flecainide acetate
10 mg
1324
Yes
+5C 3C
79
F0120005 Flecainide impurity A
50 mg
3-[2,5-bis(2,2,2-trifluoroethoxy)phenyl]-1,5,6,7,8,8a-hexahydroimidazo[1,5a]pyridine
1324
Yes
+5C 3C
79
F0120010 Flecainide impurity B
25 mg
(RS)-(piperidin-2-yl)methanamine
1324
Yes
+5C 3C
79
Y0001274 Flecainide for system suitability
10 mg
1324
Yes
+5C 3C
79
Y0001606 Fleeceflower root HRS
300 mg
2433
Yes
+5C 3C
79
Y0000138 Flubendazole
25 mg
1721
Yes
+5C 3C
79
Y0000139 Flubendazole for system suitability
20 mg
1721
Yes
+5C 3C
79
Y0000892 Flucloxacillin magnesium octahydrate
5 mg
2346
Yes
+5C 3C
79
Y0000889 Flucloxacillin impurity C
5 mg
2346
Yes
+5C 3C
79
6-aminopenicillanic acid
31

Order
Reference Standard
Code
Y0000890 Flucloxacillin impurity D
Y0000891 Flucloxacillin impurity E

Information
per vial Unit
1
5 mg
1 3-(2-chloro-6-fluorophenyl)-5-methylisoxazole-4-carboxylic acid
1
5 mg
1 6-aminopenicillanic acid flucloxacillin amide
Monograph Leaflet
2346
Yes
Storage
+5C 3C
Extra
Price
charges
79
a
2346
Yes
-20C 5C
79
0661,0663,0
668,2346
Yes
-20C 5C
79
2287
Yes
+5C 3C
79
See leaflet; 2-[2-fluoro-4-(1H-1,2,4-triazol-1-yl)phenyl]-1,3-bis(1H-1,2,4 triazol-1-yl)propan-2-ol
2287
Yes
+5C 3C
79
5 mg
1,1'-(1,3-phenylene)di-1H-1,2,4-triazole
2287
Yes
+5C 3C
79
10 mg
2287
Yes
+5C 3C
79
100 mg
0766
Yes
+5C 3C
79
0.3 mg
0766
Yes
+5C 3C
79
120 mg
1781
Yes
+5C 3C
79
15 mg
1781
Yes
+5C 3C
79
F0180000 Fludrocortisone acetate
100 mg
0767
Yes
+5C 3C
79
F0188000 Flumazenil - reference spectrum
n/a
1326
79
Y0000335 Flumazenil impurity B
5 mg
+5C 3C
79
F0189000 Flumequine
60 mg
F0189020 Flumequine impurity B
0.1 mg
F0188500 Flumetasone pivalate
100 mg
F0189900 Flunarizine dihydrochloride
Y0000265 Flunarizine dihydrochloride - reference spectrum
Y0000266 Flunarizine dihydrochloride for system suitability

F0190000 Flunitrazepam - * psy
Y0000169 Flunitrazepam - reference spectrum
Y0000443 Flunixin meglumine
F0150000 Flucloxacillin sodium
250 mg
See leaflet CHClFNNaOS
Y0000557 Fluconazole
50 mg
Y0000573 Fluconazole impurity B
10 mg
Y0000574 Fluconazole impurity C
Y0000558 Fluconazole for peak identification
F0175000 Flucytosine
Y0001262 Flucytosine for system suitability
Y0000419 Fludarabine phosphate

Y0001536 Fludarabine for system suitability
see leaflet ; Batch 2 is valid until 30 April 2015
1326
Yes
1517
Yes
+5C 3C
79
1517
Yes
+5C 3C
79
1327
Yes
+5C 3C
79
100 mg
0816
Yes
+5C 3C
79
n/a
1722
79
20 mg
1722
Yes
+5C 3C
79
100 mg
1280
Yes
+5C 3C
79
n/a
0717
79
10 mg
1696
Yes
+5C 3C
79
Y0000444 Flunixin impurity B
10 mg
2-methyl-3-(trifluoromethyl)aniline
1696
Yes
+5C 3C
79
Y0000445 Flunixin impurity C
55 mg
ethyl 2-chloropyridine-3-carboxylate
1696
Yes
+5C 3C
79
F0200000 Fluocinolone acetonide
110 mg
see leaflet ; Batch 3 is valid until 31 August 2014

0494
Yes
+5C 3C
79
Y0001711 Fluocinolone acetonide for peak identification
10 mg
0494
Yes
+5C 3C
79
Y0001710 Fluocinolone acetonide for system suitability
10 mg
0494
Yes
+5C 3C
79
F0230000 Fluocortolone pivalate
100 mg
1212
Yes
+5C 3C
79
Y0000796 Fluorescein
120 mg
See leaflet CHO
2348
Yes
+5C 3C
79
Y0000804 Fluorescein impurity C
0.01 mg
2-(2,4-dihydroxybenzoyl)benzoic acid
2348
Yes
+5C 3C
79
F0245000 Fluoresceine sodium - reference spectrum
n/a
79
40 mg
F0250000 Fluorouracil
ethyl 8-hydroxy-5-methyl-6-oxo-5,6-dihydro-4H-imidazo[1,5-a][1,4]
benzodiazepine-3-carboxylate ; Batch 1 is valid until 30 September 2015
ethyl(RS)-9-fluoro-5-methyl-1-oxo-6,7-dihydro-1H,5H-benzo[i,j]
quinolizine-2-carboxylate
1213
32
79
0611,0766
Yes
+5C 3C
a

Order
Reference Standard
Code
Y0000762 Fluorouracil impurity A
Y0000763 Fluorouracil impurity B

Information
per vial Unit
1
10 mg
1 pyrimidine-2,4,6(1H,3H,5H)-trione (barbituric acid)
1
15 mg
1 dihydropyrimidine-2,4,5(3H)-trione (isobarbituric acid or 5-hydroxyuracil)
Monograph Leaflet
Storage
0611
Yes
+5C 3C
Extra
Price
charges
79
a
0611
Yes
+5C 3C
79
10 mg
pyrimidine-2,4(1H,3H)-dione (uracil)
0611
Yes
+5C 3C
79
10 mg
2-ethoxy-5-fluoropyrimidin-4(1H)-one (2-ethoxy-5-fluorouracil)
0611
Yes
+5C 3C
79
0.0002 mg
0611
Yes
+5C 3C
79
F0253000 Fluoxetine hydrochloride
250 mg
See leaflet
1104
Yes
+5C 3C
79
F0253020 Fluoxetine impurity B
10 mg
methyl(3-phenylpropyl)amine ; Batch 5 is valid until 30 April 2015
1104
Yes
+5C 3C
79
F0253030 Fluoxetine impurity C
5 mg
()-methyl-[3-phenyl-3-(3-trifluoromethylphenoxy)-propyl] amine
1104
Yes
+5C 3C
79
Y0000064 Flupentixol dihydrochloride
100 mg
See leaflet
1693
Yes
+5C 3C
79
Y0000067 Flupentixol impurity D
15 mg
2-[2-[4-[3-[(EZ)-2-(trifluoromethyl)-9H-thioxanthen-9-ylidene]propyl]
piperazin-1-yl]ethoxy]ethanol ; Batch 1 is valid until 31 December 2014
1693
Yes
+5C 3C
79
Y0000078 Flupentixol impurity F
25 mg
See leaflet CHFNOS; 2-[4-[(EZ)-3-[(9RS)-2-(trifluoromethyl)-9Hthioxanthen-9-yl] prop-2-enyl]piperazin-1-yl]ethanol
1693
Yes
+5C 3C
79
F0260000 Fluphenazine decanoate
60 mg
1014,1015
Yes
+5C 3C
79
F0280000 Fluphenazine dihydrochloride
50 mg
0904,1014
Yes
+5C 3C
79
Y0000708 Fluphenazine impurity mixture
0.07 mg
0904
Yes
+5C 3C
79
Y0000009 Fluphenazine enantate
100 mg
1014,1015
Yes
+5C 3C
79
Y0000298 Fluphenazine octanoate
20 mg
1014,1015
Yes
+5C 3C
79
Y0000299 Fluphenazine sulfoxide
10 mg
0904,1014,1
015
Yes
+5C 3C
79
Y0000211 Flurazepam monohydrochloride - reference spectrum
n/a
0905
79
F0285200 Flurbiprofen
50 mg
F0285202 Flurbiprofen impurity A
25 mg
Y0000236 Fluspirilene
20 mg
Y0000375 Fluspirilene impurity C
10 mg
8-[4,4-bis(4-fluorophenyl)butyl]-3-(hydroxymethyl)-1-phenyl-1,3,8triazaspiro[4.5]decan-4-one
F0285600 Flutamide
100 mg
See leaflet
Y0001591 Flutamide for system suitability
10 mg
Y0000284 Fluticasone propionate
100 mg
5 mg
5 mg
Y0000764 Fluorouracil impurity C
Y0000765 Fluorouracil impurity F

Y0000791 Fluorouracil impurity mixture
New Y0001754 Fluticasone propionate for impurity C identification

Y0000221 Fluticasone impurity D
New Y0001755 Fluticasone propionate for impurity G identification
(2RS)-2-(biphenyl-4-yl)propanoic acid
See leaflet CHFOS
1519
Yes
+5C 3C
79
1519
Yes
+5C 3C
79
1723
Yes
+5C 3C
79
1723
Yes
+5C 3C
79
1423
Yes
+5C 3C
79
1423
Yes
+5C 3C
79
1750
Yes
+5C 3C
79
+5C 3C
79
1750
Yes
+5C 3C
79
1750
S-methyl 6a,9a-difluoro-11b-hydroxy-16a-methyl-3-oxo-17apropionyloxy-androsta-1,4-diene-17-carbothioate
(S-methyl derivative) ; Batch 2 is valid until 31 December 2014
5 mg
1750
Yes
+5C 3C
79
F0290000 Flutrimazole
100 mg
1424
Yes
+5C 3C
79
F0290010 Flutrimazole impurity B
60 mg
1424
Yes
+5C 3C
79
Y0001090 Fluvastatin sodium
110 mg
2333
Yes
+5C 3C
79
Y0001082 Fluvastatin for system suitability
0.5 mg
2333
Yes
+5C 3C
79
(RS)-(2-fluorophenyl)(4-fluorophenyl)phenylmethanol
33

Order
Reference Standard
Code
Y0000854 Fluvoxamine maleate

per vial Unit
1
5 mg
1
Information
Monograph Leaflet
Storage
1977
Yes
+5C 3C
Extra
Price
charges
79
a
Y0000853 Fluvoxamine for system suitability
1.004 mg
1977
Yes
+5C 3C
79
Y0000916 Fluvoxamine impurity D
10 mg
5-methoxy-1-[4-(trifluoromethyl)phenyl]pentan-1-one
1977
Yes
+5C 3C
79
Y0000386 Foeniculin for peak identification
100 mg
Anise oil
0804
Yes
+5C 3C
79
F0300000 Folic acid
300 mg
See leaflet CHNO
0067
Yes
+5C 3C
79
Y0001242 Folic acid impurity A
15 mg
(2S)-2-[(4-aminobenzoyl)amino]pentanedioic acid (N-(4-aminobenzoyl)-lglutamic acid)
0067
Yes
+5C 3C
79
Y0001243 Folic acid impurity D
70 mg
4-[[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino]benzoic acid
(pteroic acid) ; Batch 2 is valid until 28 February 2015
0067
Yes
+5C 3C
79
Y0001629 Follitropin
0.2 mL
See leaflet
2285, 2286
Yes
-20C 5C
79
Y0001627 Follitropin for peptide mapping and glycan analysis
0.5 mL
2285
Yes
-20C 5C
79
F0372000 Formoterol fumarate dihydrate
10 mg
1293,1724
Yes
+5C 3C
79
Y0000339 Formoterol for impurity I identification
10 mg
1724
Yes
+5C 3C
79
Y0000340 Formoterol fumarate for system suitability
10 mg
F0380000 Formylfolic acid
30 mg
F0389000 Foscarnet sodium hexahydrate
50 mg
F0389004 Foscarnet impurity B
10 mg
Y0001222 Foscarnet impurity D
50 mg
Y0001213 Foscarnet impurity mixture
0.012 mg
Y0000782 Fosfomycin calcium
F0399950 Fosfomycin sodium - reference spectrum
F0400000 Fosfomycin trometamol

Y0001227 Fosinopril sodium
1724
Yes
+5C 3C
79
0978,1606
Yes
-20C 5C
79
1520
Yes
+5C 3C
79
1520
Yes
+5C 3C
79
1520
Yes
+5C 3C
79
1520
Yes
+5C 3C
79
10 mg
1328
Yes
+5C 3C
79
n/a
1329
79
1500 mg
60 mg
Y0001228 Fosinopril impurity A
5 mg
Y0001229 Fosinopril impurity B
5 mg
Y0001230 Fosinopril impurity C
Y0001231 Fosinopril impurity D
See leaflet CHNO; 10-Formylfolic acid

disodium (ethoxyoxydophosphanyl)formate
1425
Yes
+5C 3C
79
1751
Yes
+5C 3C
79
(2S,4S)-4-cyclohexyl-1-[[(R)-hydroxy(4-phenylbutyl)phosphoryl]acetyl]
pyrrolidine-2-carboxylic acid
1751
Yes
+5C 3C
79
(2RS,4RS)-4-cyclohexyl-1-[[(RS)-[(1SR)-2-methyl-1-(1-oxopropoxy)
propoxy](4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid
1751
Yes
+5C 3C
79
10 mg
mixture of (2S,4S)-4-cyclohexyl-1-[[(S)-[(1S)-2-methyl-1-(1-oxopropoxy)
propoxy](4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid and
(2S,4S)-4-cyclohexyl-1-[[(R)-[(1R)-2-methyl-1-(1-oxopropoxy)propoxy](4phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid
1751
Yes
+5C 3C
79
10 mg
(2S,4R)-4-cyclohexyl-1-[[(R)-[(1S)-2-methyl-1-(1-oxopropoxy)propoxy](4phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid
1751
Yes
+5C 3C
79
Y0001232 Fosinopril impurity I
5 mg
[(RS)-[(1SR)-2-methyl-1-(1-oxopropoxy)propoxy](4-phenylbutyl)phosphoryl]
acetic acid
1751
Yes
+5C 3C
79
Y0001233 Fosinopril impurity K
5 mg
(2S,4S)-4-cyclohexyl-1-(2,2-dimethyl-1-oxopropyl)pyrrolidine-2-carboxylic
acid
1751
Yes
+5C 3C
79
Y0001212 Fosinopril impurity mixture
0.02 mg
1751
Yes
+5C 3C
79
See leaflet
34

Order
Reference Standard
Code
F0450000 Framycetin sulfate

per vial Unit
6
25 mg
2 See leaflet
Information
Monograph Leaflet
Storage
Extra
Price
charges
79
a
0180,0197,2
0702
Yes
-20C 5C
0177,0178,0
187,
0188,0204,0
209,
0924,1061,1
570
Yes
+5C 3C
79
2443
Yes
+5C 3C
79
F0550000 Fructose
100 mg
Y0001399 Fulvestrant
120 mg
Y0001413 Fulvestrant for system suitability
40 mg
2443
Yes
+5C 3C
79
F0600000 Fumaric acid
120 mg
0365,0902,1
190
Yes
+5C 3C
79
F0700000 Furosemide
100 mg
0391,2185
Yes
+5C 3C
79
F0702000 Furosemide impurity A
5 mg
0391
Yes
+5C 3C
79
Y0001493 Furosemide for peak identification
10 mg
0391
Yes
+5C 3C
79
Y0001411 Fusidic acid
10 mg
0798
Yes
-20C 5C
79
Y0001394 Fusidic acid for peak identification
5 mg
0798,0848
Yes
-20C 5C
79
New Y0001384 Fusidic acid impurity mixture
See leaflet CHFOS
2-chloro-4-(furfurylamino)-5-sulphamoylbenzoic acid
0.048 mg
0798,0848
Yes
-20C 5C
79
Y0001280 Gabapentin
300 mg
See leaflet CHNO
2173
Yes
+5C 3C
79
Y0001281 Gabapentin impurity A
20 mg
2-azaspiro[4.5]decan-3-one
2173
Yes
+5C 3C
79
Y0001348 Gabapentin impurity B
20 mg
(1-cyanocyclohexyl)acetic acid ; Batch 1 is valid until 31 August 2015
2173
Yes
-20C 5C
79
Y0001349 Gabapentin impurity D
10 mg
[1-[(3-oxo-2-azaspiro[4.5]dec-2-yl)methyl]cyclohexyl]acetic acid
2173
Yes
+5C 3C
79
G0049000 Galactitol
50 mg
1381
Yes
+5C 3C
79
G0050000 Galactose
60 mg
1215
Yes
+5C 3C
79
Y0001279 Galantamine hydrobromide
10 mg
2366
Yes
+5C 3C
79
Y0001190 Galantamine natural for system suitability
10 mg
2366
Yes
+5C 3C
79
Y0001201 Galantamine racemic mixture
10 mg
2366
Yes
+5C 3C
79
Y0001191 Galantamine synthetic for system suitability
5 mg
G0150000 Gammacyclodextrin
60 mg
Y0001129 Ganciclovir
220 mg
Y0001144 Ganciclovir impurity mixture
0.005 mg
Y0000675 Gemcitabine hydrochloride
50 mg
Y0000676 Gemcitabine impurity A
20 mg
Y0001682 Gemcitabine impurity C
5 mg
Y0000513 Gemfibrozil
5 mg
Y0000514 Gemfibrozil for system suitability
0.196 mg
G0200000 Gentamicin sulfate
25 mg
Y0001363 Gentamicin for peak identification
10 mg
2366
Yes
+5C 3C
79
1070,1487
Yes
+5C 3C
79
1752
Yes
+5C 3C
79
1752
Yes
+5C 3C
79
See leaflet
2306
Yes
+5C 3C
79
4-aminopyrimidin-2(1H)-one (cytosine)
2306
Yes
+5C 3C
79
2',2'-difluoro-2'-deoxyuridine
2306
Yes
+5C 3C
79
1694
Yes
+5C 3C
79
See leaflet CHO
see leaflet ; Batch 8 is valid until 30 November 2014
35
1694
Yes
+5C 3C
79
0331,20702
Yes
-20C 5C
79
0331
Yes
-20C 5C
79

Order
Code
Y0001112 Gestodene
Reference Standard
Y0001116 Gestodene impurity I

Information
Monograph Leaflet
per vial Unit
2
100 mg
1 see leaflet ; Batch 1 is valid until 31 January 2015
1726
Yes
1
0.01 mg
1 13-ethyl-17-hydroxy-5-methoxy-18,19-dinor-5alpha,17alpha-pregn-15-en-201726
Yes
yn-3-one
Storage
+5C 3C
Extra
Price
charges
79
a
+5C 3C
79
Y0001110 Gestodene for system suitability
10 mg
1726
Yes
+5C 3C
79
Y0001012 Ginkgo dry extract for peak identification
150 mg
1827
Yes
-20C 5C
79
Y0001010 Ginkgolic Acids
20 mg
See leaflet
1827
Yes
-20C 5C
79
Y0001029 Ginseng dry extract HRS
500 mg
2356
Yes
-20C 5C
79
Y0001347 Ginsenoside Rb1
30 mg
G0300000 Gitoxin
30 mg
G0325000 Glibenclamide
100 mg
G0325010 Glibenclamide impurity A
10 mg
4-[2-(5-chloro-2-methoxybenzamido)ethyl]benzene- sulphonamide
Y0000242 Glibenclamide impurity B
20 mg
See leaflet; methyl [[4-[2-[(5-chloro-2-methoxybenzoyl)amino]ethyl]phenyl]

sulphonyl]carbamate
Y0001511 Glibenclamide for peak identification
30 mg
Y0001406 Glucosamine hydrochloride
15 mg
G0326000 Gliclazide
20 mg
G0326004 Gliclazide impurity B
25 mg
2-nitroso-octahydrocyclopenta[c]pyrrole
New G0326012 Gliclazide impurity F
50 mg
1-(hexahydrocyclopenta[c]pyrrol-2(1H)-yl)-3-[(2-methylphenyl) sulphonyl]
urea ; Batch 4 is valid until 31 December 2015
2356
Yes
+5C 3C
79
0078,2168
Yes
+5C 3C
79
0718
Yes
+5C 3C
79
0718
Yes
+5C 3C
79
0718
Yes
+5C 3C
79
0718
Yes
+5C 3C
79
2446
Yes
+5C 3C
79
1524
Yes
+5C 3C
79
1524
Yes
+5C 3C
79
1524
Yes
+5C 3C
79
2708
Yes
+5C 3C
79
2223
Yes
+5C 3C
79
See leaflet CHO
Y0001685 Glucosamine sulfate potassium chloride
10 mg
Y0000515 Glimepiride
110 mg
Y0001742 Glimepiride for impurity A identification
5 mg
2223
Yes
+5C 3C
79
Y0000516 Glimepiride for system suitability
0.012 mg
2223
Yes
+5C 3C
79
G0340000 Glipizide
50 mg
0906
Yes
+5C 3C
79
G0342000 Glipizide impurity A
10 mg
4-[2-(5-methylpyrazine-2-carboxamido)ethyl]benzene sulphonamide
0906
Yes
+5C 3C
79
Y0000523 Glipizide impurity C
10 mg
ethyl [2-[4-[(cyclohexylcarbamoyl)sulphamoyl]phenyl]ethyl] carbamate
0906
Yes
+5C 3C
79
Y0000643 Glipizide impurity D
10 mg
6-methyl-N-[2-(4-sulphamoylphenyl)ethyl]pyrazine-2-carboxamide
0906
Yes
+5C 3C
79
Y0001140 Glipizide impurity mixture
0.002 mg
0906
Yes
+5C 3C
79
Y0001407 Glucosamine sulfate sodium chloride
15 mg
2447
Yes
+5C 3C
79
Y0001381 Glucosamine for system suitability
40 mg
2446,2447,2
708
Yes
+5C 3C
79
G0350500 Glucose
100 mg
0177,0178,0
187,
0188,0204,0
209,
1061,1215,1
570
Yes
+5C 3C
79
750 mg
0178
Yes
+5C 3C
79
New Y0001745 Glucose monohydrate

See leaflet CHO,HO

36

Order
Code
G0355000 Glutamic acid
Reference Standard

per vial Unit
2
50 mg
1
Information
Monograph Leaflet
Storage
Extra
Price
charges
79
a
0750,0797,1
445, 2076
Yes
+5C 3C
1670
Yes
+5C 3C
79
Yes
+5C 3C
79
79
Y0000517 Glutathione
10 mg
G0360000 Glutethimide - * psy
50 mg
1291
G0400000 Glycerol (85 per cent) - reference spectrum
n/a
0496,0497
Y0001391 Glycerol formal
20 mg
1671
Yes
+5C 3C
79
Y0000794 Glycerol monocaprylate
400 mg
2213
Yes
+5C 3C
79
Y0000795 Glycerol monocaprylocaprate
500 mg
2392
Yes
+5C 3C
79
G0400006 Glycerol monolinoleate
2000 mg
1429
Yes
+5C 3C
79
G0400007 Glycerol mono-oleate
2500 mg
1430
Yes
+5C 3C
79
G0400008 Glycerol monostearate 40-55
2000 mg
0495
Yes
+5C 3C
79
G0400100 Glyceryl trinitrate solution
0.5 mL
1331,1355
Yes
+5C 3C
79
G0400101 Glyceryl trinitrate - reference spectrum
n/a
1331
79
G0450000 Glycine
50 mg
0614, 0813
Yes
+5C 3C
79
Y0001308 Glycopyrronium bromide
10 mg
1783
Yes
+5C 3C
79
Y0001358 Glycopyrronium impurity N
10 mg
See leaflet CHBrNO; (3RS)-3-[(2RS)-(2-cyclopentyl-2-hydroxy-2phenylacetyl)oxy]-1,1-dimethylpyrrolidinium
1783
Yes
+5C 3C
79
Y0000433 Ammonium glycyrrhizate
70 mg
1772
Yes
+5C 3C
79
Y0001309 Glycopyrronium for peak identification
10 mg
1783
Yes
+5C 3C
79
G0460000 Glycyrrhizate (monoammonium)
300 mg
0277, 2378
Yes
+5C 3C
79
G0525000 Gonadorelin
5 mg
See leaflet CHNO
0827
Yes
-20C 5C
79
Y0000125 Goserelin
1.87 mg
See leaflet CHNO
1636
Yes
-20C 5C
79
Y0000126 Gosereline - reference spectrum
n/a
79
Y0001473 Goserelin for NMR identification
14 mg
Y0000194 Goserelin validation mixture
1 mg
Y0000019 4-D-Ser-goserelin
0.1 mg
G0550000 Gramicidin
250 mg
See leaflet
Y0000396 Granisetron hydrochloride
120 mg
Y0000477 Granisetron impurity A
1 mg
Y0000478 Granisetron impurity B
1 mg
Y0000395 Granisetron impurity E
G0600000 Griseofulvin
Y0000619 Guaiacol
G0700000 Guaifenesin
1636
1636
Yes
-20C 5C
79
1636
Yes
-20C 5C
79
1636
Yes
-20C 5C
79
0907,1662,2
0702
Yes
+5C 3C
79
1695
Yes
+5C 3C
79
2-methyl-N-[(1R,3r,5S)-9-methyl-9-azabicyclo[3.3.1]non-3-yl]-2Hindazole-3-carboxamide ; Batch 2 is valid until 30 June 2015
1695
Yes
+5C 3C
79
N-[(1R,3r,5S)-9-methyl-9-azabicyclo[3.3.1]non-3-yl]-1H-indazole-3carboxamide ; Batch 2 is valid until 30 April 2015
1695
Yes
+5C 3C
79
15 mg
(1R,3r,5S)-9-methyl-9-azabicyclo[3.3.1]nonan-3-amine
1695
Yes
+5C 3C
79
50 mg
0182
Yes
+5C 3C
79
1500 mg
1978
Yes
+5C 3C
79
100 mg
0615
Yes
+5C 3C
79
Supplied with the Ph. Eur. reference chromatogram ; Batch 1 is valid until 31
July 2015
See leaflet CHO

37

Order
Reference Standard
Code
Y0000117 Halofantrine hydrochloride
Y0000118 Halofantrine impurity C
H0100000 Haloperidol
New Y0001518 Haloperidol for peak identification

Information
per vial Unit
1
125 mg
1 See leaflet CHClFNO
1
10 mg
1 [1,3-dichloro-6-(trifluoromethyl)phenantren-9-yl]methanol
2
60 mg
Monograph Leaflet
Storage
1979
Yes
+5C 3C
Extra
Price
charges
79
a
1979
Yes
+5C 3C
79
0616,1178
Yes
+5C 3C
79
20 mg
0616
Yes
+5C 3C
79
Y0001517 Haloperidol for system suitability
25 mg
0616
Yes
+5C 3C
79
H0100100 Haloperidol decanoate
60 mg
1397,1431
Yes
+5C 3C
79
H0150000 Halothane - reference spectrum
n/a
0393
79
Y0000673 Harpagoside
1.03 mg
See leaflet CHO
1095, 1871
Yes
+5C 3C
79
H0200000 Heparin sodium BRP
2 ml
See leaflet
0569, 20705
Yes
+5C 3C
79
Y0001283 Heparin sodium for NMR identification
30 mg
0333
Yes
+5C 3C
79
Y0001287 Heparin calcium for NMR identification
30 mg
0332
Yes
+5C 3C
79
Y0001282 Heparin for physico-chemical analysis
300 mg
0332, 0333
Yes
+5C 3C
79
H0185000 Heparin Low-Molecular-Mass for assay BRP
1 mg
See leaflet
0828
Yes
+5C 3C
90
H0190000 Heparin Low-Molecular-Mass for calibration CRS
25 mg
See leaflet
0828
Yes
+5C 3C
90
H0205010 Hepatitis A vaccine (inactivated, adsorbed) Type B BRP
0.5 ml
See leaflet; Please contact us for information on the type needed for your use
See leaflet,
20714
Yes
+5C 3C
90
Y0001192 Hepatitis A Vaccine (Inactivated, Non-Adsorbed) BRP
1 mL
To be stored below -50C ; Batch 1 is valid until 30 April 2015
20714,1526,
1935, 1107
Yes
-80C 10C
90
Y0001624 Hepatitis A virus Coating Reagent for ELISA - BRR
1 mL
Yes
-20C 5C
79
New Y0001623 Set of Hepatitis A virus Detection Antibodies for ELISA BRR
275 L
See leaflet ; Batch 1 is valid until 31 May 2015

Yes
-20C 5C
79
Y0000389 Hepatitis B vaccine (rDNA) BRP method A (thiomersal

free)
0.5 ml
See leaflet; Ph. Eur. BRPs are established in the context of specific methods.
The method used to establish this BRP (refer to leaflet) is no longer available.
Reference to the BRP has therefore been removed from the relevant
monograph and general chapter of the Ph. Eur. and upon depletion of stocks
this BRP will not be replaced. Users are encouraged to find alternative
reference material to address their future needs.
See leaflet,
20715
Yes
+5C 3C
90
H0210010 Hepatitis B vaccine (rDNA) BRP method B
1 ml
See leaflet; Ph. Eur. BRPs are established in the context of specific methods.
The method used to establish this BRP (refer to leaflet) is no longer available.
Reference to the BRP has therefore been removed from the relevant
monograph and general chapter of the Ph. Eur. and upon depletion of stocks
this BRP will not be replaced. Users are encouraged to find alternative
reference material to address their future needs.
See leaflet,
1056
Yes
+5C 3C
90
H0215000 Hepatitis C Virus RNA for NAT testing BRP
40 mg
See leaflet; For plasma pool testing by NAT
See leaflet,
20621
Yes
-20C 5C
e(d)
242
Y0000063 Heptaminol hydrochloride
150 mg
1980
Yes
+5C 3C
79
Y0000057 Heptaminol impurity A
20 mg
See leaflet CHN; (2RS)-6-methylhept-5-en-2-amine
1980
Yes
+5C 3C
79
Y0001203 Hesperidin
20 mg
See leaflet CHO
2430
Yes
+5C 3C
79
H0330000 Hexamidine diisetionate
20 mg
1436
Yes
+5C 3C
79
H0325000 Hexetidine
100 mg
1221
Yes
+5C 3C
79
38

Order
Reference Standard
Code
H0420000 Hexylresorcinol
New Y0001746 Hexylresorcinol for system suitability

per vial Unit
1
100 mg
1
Information
Monograph Leaflet
Storage
1437
Yes
+5C 3C
Extra
Price
charges
79
a
1 mg
1437
Yes
-20C 5C
79
H0500000 Hide powder
500 mg
20814
Yes
+5C 3C
79
H0600000 Histamine dihydrochloride
250 mg
0143
Yes
+5C 3C
79
H0750000 Histidine
25 mg
0911
Yes
+5C 3C
79
H0755000 Histidine hydrochloride monohydrate
100 mg
0910
Yes
+5C 3C
79
H0800000 Homatropine hydrobromide
100 mg
0500,0720
Yes
+5C 3C
79
H0830000 Homatropine methylbromide
25 mg
0720
Yes
+5C 3C
79
H0837000 L-Homocysteine thiolactone hydrochloride - reference

spectrum
n/a
1617
79
Y0001383 Homatropine methylbromide for system suitability
5 mg
0720
Yes
+5C 3C
79
Y0001290 Honokiol
20 mg
See leaflet CHO
2567,2568
Yes
-20C 5C
79
H0900000 Human albumin for electrophoresis BRP
1 ml
See leaflet
0255
Yes
-20C 5C
79
Y0000219 Human anti-D immunoglobulin BRP
40 mg
See leaflet
See leaflet,
20713
Yes
-20C 5C
90
Y0000667 Human coagulation factor VII concentrate BRP
25 mg
See leaflet
See leaflet,
20710
Yes
-20C 5C
79
Y0001663 Human coagulation factor VIIa (rDNA)
42 mg
See leaflet
2534
Yes
-20C 5C
79
H0920000 Human coagulation factor VIII concentrate BRP
37 mg
See leaflet
See leaflet,
20704
Yes
-20C 5C
90
H0920500 Human coagulation factor IX concentrate BRP
30 mg
See leaflet; Common standard with FDA and WHO (4th IS)
2.7.11
Yes
-20C 5C
90
Y0001659 Human coagulation factor IX (rDNA)
10 mg
see leaflet
2522
Yes
-20C 5C
79
Y0000191 Human glucagon
2.94 mg
See leaflet CHNOS
1635
Yes
-20C 5C
79
H0950000 Human hepatitis A immunoglobulin BRP
10 mg
See leaflet
See leaflet,
0338, 0769,
1646
Yes
-20C 5C
90
Y0001414 Human Hepatitis B immunoglobulin BRP
100 mg
See leaflet
0722, 1016
Yes
-20C 5C
90
Y0001504 Human immunoglobulin BRP (ACA and Molecular size)
6000 mg
See leaflet,
0338, 0918
Yes
+5C 3C
90
Y0001512 Human Immunoglobulin BRP (Fc Function and

Molecular size)
9000 mg
See leaflet,
0338, 0918
Yes
+5C 3C
90
Y0000488 Human immunoglobulin (molecular size) BRP
700 mg
Each vial contains 0.7 gram of immunoglobulin G
See leaflet,
0338,
0918,1928
Yes
+5C 3C
90
H1000000 Human immunoglobulin for electrophoresis BRP
50 mg
See leaflet
0338,0918
Yes
+5C 3C
79
H1005000 Human Plasma Pools for NAT validation
3502 mg
Set of 103 plasma pool samples
See leaflet,
20621
Yes
-20C 5C
400
H1100000 Human rabies immunoglobulin BRP
170 mg
See leaflet
See leaflet,
0723
Yes
-20C 5C
90
87 mg
See leaflet
H1110000 Human tetanus immunoglobulin BRP

39
90
0398
Yes
-20C 5C
c

Order
Reference Standard
Code
Y0000502 Human vaccinia immunoglobulin
H1115000 Hyaluronidase BRP

per vial Unit
1
1 ml
3 See leaflet
1
50 mg
1 See leaflet
H1120000 Hydralazine hydrochloride
Y0001151 Hydrastine hydrochloride

H1200000 Hydrochlorothiazide
Information
Monograph Leaflet
Storage
Extra
Price
charges
270
b
See leaflet
Yes
-20C 5C
0912
Yes
+5C 3C
79
0829
Yes
+5C 3C
79
20 mg
20 mg
See leaflet CHClNO
1831,2500
Yes
-20C 5C
79
300 mg
See leaflet CHClNOS
0394
Yes
+5C 3C
79
Y0001494 Hydrochlorothiazide for peak identification
10 mg
0394
Yes
+5C 3C
79
Y0000646 Hydrocodone hydrogen tartrate 2.5-hydrate - * narc
10 mg
1784
Yes
+5C 3C
79
Y0000710 Hydrocodone for peak identification - * narc
10 mg
1784
Yes
+5C 3C
79
H1300000 Hydrocortisone
100 mg
0335
Yes
+5C 3C
79
Y0001092 Hydrocortisone for peak identification
5 mg
H1400000 Hydrocortisone acetate
125 mg
Y0001482 Hydrocortisone acetate for peak identification
15 mg
H1425000 Hydrocortisone hydrogen succinate
100 mg
H1426000 Hydrogenated wool fat
Y0000446 Hydromorphone hydrochloride - * narc
B0650000 Hydrous benzoyl peroxide - reference spectrum

H1428000 Hydroxocobalamin
0335
Yes
+5C 3C
79
0321,0334,0
335,
0734,0767
Yes
+5C 3C
79
0334
Yes
+5C 3C
79
0768,1131
Yes
-20C 5C
79
250 mg
0969
Yes
+5C 3C
79
10 mg
2099
Yes
+5C 3C
79
n/a
0704
79
10 mg
0913,0914,0
915
Yes
-20C 5C
79
Y0000119 Hydroxycarbamide
360 mg
1616
Yes
+5C 3C
79
H1429400 Hydroxyethyl salicylate
125 mg
1225
Yes
+5C 3C
79
Y0001322 Hydroxyethyl starch (high Mw)
800 mg
See leaflet
1785
Yes
+5C 3C
79
Y0001277 Hydroxyethyl starch (medium MW)
1200 mg
See leaflet
1785
Yes
+5C 3C
79
H1430000 D-alpha-(4-Hydroxy-phenyl)glycine
50 mg
(2R)-2-amino-2-(4-hydroxyphenyl)acetic acid - Cefadroxyl impurity A
0813
Yes
+5C 3C
79
H1429700 4-Hydroxyphenoxymethylpenicillin potassium
20 mg
See leaflet CHKNOS
0148,0149
Yes
-20C 5C
79
Y0000186 Hydroxypropylbetadex
200 mg
1804
Yes
+5C 3C
79
Y0001720 Hydroxypropylcellulose
150 mg
0337, 2083
Yes
+5C 3C
79
H1435000 Hydroxyzine hydrochloride
600 mg
0916,1086
Yes
+5C 3C
79
Y0000011 Hymecromone
100 mg
1786
Yes
+5C 3C
79
Y0000012 Hymecromone impurity A
25 mg
Resorcinol
1786
Yes
+5C 3C
79
Y0000013 Hymecromone impurity B
25 mg
7-hydroxy-2-methyl-4H-1-benzopyran-4-one.
1786
Yes
+5C 3C
79
Y0000483 Hyoscine
10 mg
2167
Yes
+5C 3C
79
Y0000484 Hyoscine impurity A
15 mg
(1R,2R,4S,5S,7s)-3-oxa-9-azatricyclo[3.3.1.02,4]non-7-yl
(2S)-3-hydroxy-2-phenylpropanoate (norhyoscine)
2167
Yes
+5C 3C
79
H1450000 Hyoscine butylbromide
20 mg
Y0000447 Hyoscine butylbromide impurity E
10 mg
79
0737
Yes
+5C 3C
a
(1R,2R,4S,5S,7s)-9-butyl -3-oxa-9-azatricyclo[3.3.1.02,4]nonan-7-yl (2S)-379
0737
Yes
+5C 3C
a
hydroxy-2-phenylpropanoate (N-butylhyoscine)
40
See leaflet

Order
Reference Standard
Code
H1500000 Hyoscine hydrobromide

per vial Unit
1
50 mg
1
Y0000448 Hyoscine hydrobromide impurity B
10 mg
H1600000 Hyoscyamine sulfate
100 mg
Y0000449 Hyoscyamine impurity E
10 mg
Y0000915 Hypromellose phthalate
10 mg
I0020000 Ibuprofen
Information
Monograph Leaflet
(1R,2R,4S,5S,7s)-3-oxa-9-azatricyclo[3.3.1.02,4]non-7-yl
(2S)-3-hydroxy-2-phenylpropanoate
(1R,3r,5S)-8-azabicyclo[3.2.1]oct-3-yl(2S)-3-hydroxy-2-phenyl
-propanoate
Storage
Extra
Price
charges
79
a
0106,0500
Yes
+5C 3C
0106
Yes
+5C 3C
79
0501
Yes
+5C 3C
79
0501
Yes
+5C 3C
79
347
Yes
+5C 3C
79
250 mg
0721
Yes
+5C 3C
79
New B1220000 Ibuprofen impurity B
1.15 mL
See leaflet; (2RS)-2-(4-Butylphenyl)propanoic acid ; Batch 7 is valid until 31

January 2015
0721
Yes
+5C 3C
79
Y0000140 Ibuprofen impurity F
5 mg
3-[4-(2-methylpropyl)phenyl]propanoic acid
0721
Yes
+5C 3C
79
Y0000881 Ibuprofen for peak identification
0.09 mg
0721
Yes
+5C 3C
79
I0050000 Idoxuridine
50 mg
0669
Yes
+5C 3C
79
I0060000 Ifosfamide
50 mg
1529
Yes
+5C 3C
79
I0060100 Ifosfamide - reference spectrum
n/a
79
I0060002 Ifosfamide impurity A
100 mg
3-[(2-chloroethyl)amino]propyl dihydrogen phosphate
1529
Yes
-20C 5C
79
I0060004 Ifosfamide impurity B
40 mg
bis[3-[(2-chloroethyl)amino]propyl] dihydrogen diphosphate
1529
Yes
+5C 3C
79
I0060010 Ifosfamide impurity E
20 mg
3-chloro-N-(2-chloroethyl)propan-1-amine
1529
Yes
+5C 3C
79
I0060012 Ifosfamide impurity F
10 mg
(RS)-2-chloro-3-(2-chloroethyl)-1,3,2-oxazaphosphinane 2-oxide
1529
Yes
+5C 3C
79
Y0001691 Imatinib mesilate
120 mg
see leaflet CHNSO
2736
Yes
+5C 3C
79
See leaflet CHClNOP
1529
Y0001695 Imatinib impurity A
0.03 mg
(2E)-3-(dimethylamino)-1-(pyridin-3-yl)prop-2-ene-1-one
2736
Yes
-20C 5C
79
New Y0001693 Imatinib impurity F
10 mg
2736
Yes
+5C 3C
79
Y0001694 Imatinib impurity H
130 mg
1-(pyridin-3-yl)ethan-1-one
2736
Yes
+5C 3C
79
Y0001692 Imatinib for system suitability
5 mg
2736
Yes
+5C 3C
79
I0086000 Imidazole
60 mg
0757,1424,
2270
Yes
+5C 3C
79
I0090000 Imipenem
100 mg
see leaflet
1226
Yes
-20C 5C
79
I0100000 Imipramine hydrochloride
50 mg
0029, 0408,
0889,1787
Yes
+5C 3C
79
Y0001689 Immunoglobulin (anti-A, anti-B antibodies test)

Negative control
50 mg
20620
Yes
-20C 5C
79
Y0001688 Immunoglobulin (anti-A, anti-B antibodies test) Positive

control
46 mg
20620
Yes
-20C 5C
79
Y0000893 Imipramine for system suitability
10 mg
0029
Yes
+5C 3C
79
Y0001153 Immunoglobulin for anti-A, anti-B antibodies limit test

BRP
45 mg
20620
Yes
-20C 5C
79
Y0000540 Immunoglobulin panel for anti-D antibodies test BRP
2000 mg
See leaflet,
20626
Yes
-20C 5C
90
41

Order
Code
Y0001205 Imperatorin
Reference Standard
I0150000 Indapamide

per vial Unit
1
20 mg
1 See leaflet CHO
5
150 mg
1 See leaflet CHClNOS
Information
Monograph Leaflet
2556
Yes
Storage
+5C 3C
Extra
Price
charges
79
a
1108
Yes
+5C 3C
79
I0150020 Indapamide impurity B
5 mg
4-chloro-N-(2-methyl-1H-indol-1-yl]-3-sulphamoylbenzamide ; Batch 3 is
valid until 31 August 2014
1108
Yes
+5C 3C
79
Y0000788 Indinavir
100 mg
see leaflet
2214
Yes
+5C 3C
79
Y0000880 Indinavir sulfate - reference spectrum
n/a
2214
79
Y0000746 Indinavir for system suitability
20 mg
2214
Yes
+5C 3C
79
I0200000 Indometacin
50 mg
0092,0922,1
686
Yes
+5C 3C
79
Y0001640 Indometacine impurity mixture
0.002 mg
0092
Yes
+5C 3C
79
Y0000349 Insulin aspart
8 mg
See leaflet
2084
Yes
-20C 5C
90
I0305000 Insulin (bovine)
7.99 mg
See leaflet CHNOS
0854,1637
Yes
-20C 5C
90
Y0001542 Insulin glargine
15 mg
See leaflet
2571
Yes
-20C 5C
79
Y0001544 Insulin glargine for peak identification
3.2 mg
2571
Yes
-20C 5C
79
I0310000 Insulin (human)
8 mg
see leaflet
0838, 0854,
1637, 1638
Yes
-20C 5C
90
Y0000348 Insulin lispro
5.75 mg
See leaflet CHNOS
2085
Yes
-20C 5C
90
I0320000 Insulin (porcine)
8.61 mg
See leaflet CHNOS; For qualitative use see insulin porcine for system
suitability CRS Y0001717
0838,0854,1
637,1638
Yes
-20C 5C
90
Y0001717 Insulin porcine for system suitability
9 mg
For intended use: see leaflet. ; Batch 1 is valid until 31 August 2015
0838,0854,1
637
Yes
-20C 5C
79
I0320301 Interferon alfa-2b
200 L
About 9.74 mg per mL ; Batch 5 is valid until 31 August 2014
1110
Yes
-80C 10C
90
Y0001101 Interferon beta-1a
0.6 mL
1639
Yes
-80C 10C
90
I0320330 Interferon gamma-1b
0.5 mL
about 1 mg per ml
1440
Yes
-80C 10C
90
Y0001664 Interferon gamma-1b for system suitability
0.6 mg
1440
Yes
-20C 5C
79
I0328000 Iobenguane sulfate
25 mg
1111,1112,11
13,2351
Yes
+5C 3C
79
Y0000839 Iobenguane sulfate - reference spectrum
n/a
2351
79
Y0001294 Iodixanol
60 mg
2215
Yes
+5C 3C
79
Y0001292 Iodixanol impurity C
10 mg
5-[acetyl[3-[[3,5-bis[(2,3-dihydroxypropyl)carbamoyl]-2,4,6-triiodophenyl]
amino]-2-hydroxypropyl]amino]-N,N'-bis(2,3-dihydroxypropyl)-2,4,6triiodobenzene-1,3-dicarboxamide
2215
Yes
+5C 3C
79
Y0001291 Iodixanol impurity E
10 mg
5-[acetyl[3-[acetyl[3-carbamoyl-5-[(2,3-dihydroxypropyl)carbamoyl]-2,4,6triiodophenyl]amino]-2-hydroxypropyl]amino]-N,N'-bis(2,3dihydroxypropyl)-2,4,6-triiodobenzene-1,3-dicarboxamide
2215
Yes
+5C 3C
79
Y0001293 Iodixanol impurity H
10 mg
5-[acetyl[3-[acetyl[3-[[3-[3-[acetyl[3,5-bis[(2,3-dihydroxypropyl)
carbamoyl]-2,4,6-triiodophenyl]amino]-2-hydroxypropoxy]-2-hydroxypropyl]
carbamoyl]-5-[(2,3-dihydroxypropyl)carbamoyl]-2,4,6-triiodophenyl]
amino]-2-hydroxypropyl]amino]-N,N'-bis(2,3-dihydroxypropyl)-2,4,6triiodobenzene-1,3-dicarboxamide
2215
Yes
+5C 3C
79
See leaflet
42

Order
Code
I0320800 Iohexol
Reference Standard

per vial Unit
1
150 mg
1
Information
Monograph Leaflet
Storage
Extra
Price
charges
79
a
1114
Yes
+5C 3C
1114
Yes
+5C 3C
79
1114,2215
Yes
+5C 3C
79
I0320810 Iohexol impurity A
50 mg
5-acetamido-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-tri-iodo benzene-1,3dicarboxamide
I0320820 Iohexol impurity J
125 mg
5-amino-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-tri-iodobenzene-1,3dicarboxamide
Y0000672 Iohexol for peak identification
10 mg
1114
Yes
+5C 3C
79
I0329000 Iopamidol
50 mg
1115
Yes
+5C 3C
79
I0329010 Iopamidol impurity A
10 mg
N,N'-bis[2-hydroxy-1-(hydroxymethyl)ethyl]-5-amino-2,4,6-triiodoisophthalamide
1115, 1754
Yes
+5C 3C
79
Y0000406 Iopamidol impurity H
10 mg
4-chloro-N,N'-bis(2-hydroxy-1-(hydroxymethyl)ethyl)-5-(2hydroxypropanoyl)amino)2,6-diiodobenzenz-1,3-dicarboxamide
1115
Yes
+5C 3C
79
I0330000 Iopanoic acid
100 mg
0700
Yes
+5C 3C
79
Y0001297 Iopentol
10 mg
2215
Yes
+5C 3C
79
Y0001020 Iopromide
100 mg
See leaflet CHINO
1753
Yes
+5C 3C
79
Y0001077 Iopromide impurity A
0.125 mg
5-amino-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-N-methylbenzene-1,3dicarboxamide
1753
Yes
+5C 3C
79
Y0001021 Iopromide for system suitability 1
5 mg
1753
Yes
+5C 3C
79
Y0001022 Iopromide for system suitability 2
5 mg
1753
Yes
+5C 3C
79
Y0000555 Iotrolan
100 mg
1754
Yes
+5C 3C
79
Y0000658 Iotrolan for system suitability
5 mg
1754
Yes
+5C 3C
79
Y0000141 Ioxaglic acid
125 mg
2009
Yes
+5C 3C
79
Y0000142 Ioxaglic acid impurity A
20 mg
2009
Yes
+5C 3C
79
I0360000 Ipratropium bromide
120 mg
0919
Yes
+5C 3C
79
I0361000 Ipratropium impurity B
10 mg
(1R,3r,5S,8s)-3-[[(2RS)-3-hydroxy-2-phenylpropanoyl]oxy]-8-methyl-8-(1methylethyl)-8-azoniabicyclo[3.2.1]octane
0919
Yes
+5C 3C
79
Y0000276 Ipratropium impurity A
15 mg
(1R,3r,5S,8r)-3-hydroxy-8-methyl-8-(1-methylethyl)-8-azoniabicyclo[3.2.1]
octane ; Batch 1 is valid until 31 March 2015
0919
Yes
+5C 3C
79
Y0001166 Irbesartan
60 mg
2465
Yes
+5C 3C
79
Y0001156 Irbesartan impurity A
10 mg
1-(pentylamino)-N-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]
cyclopentanecarboxamide ; Batch 2 is valid until 31 July 2015
2465
Yes
+5C 3C
79
Y0001616 Irisflorentin
15 mg
See leaflet CHO
2561
Yes
+5C 3C
79
I0375000 Isoconazole
200 mg
1018
Yes
+5C 3C
79
I0380000 Isoconazole nitrate
200 mg
1017
Yes
+5C 3C
79
I0400000 Isoemetine hydrobromide
25 mg
0081
Yes
+5C 3C
79
1.4 mL
1666
Yes
+5C 3C
79
New Y0000858 Isoflurane
See leaflet
3-amino-5-[(2-hydroxyethyl)carbamoyl]-2,4,6-triiodobenzoic acid
Y0000037 Isoflurane - reference spectrum
n/a
1673
79
I0460000 Isoleucine
50 mg
0770
Yes
+5C 3C
79
I0465000 Isomalt
3000 mg
1531
Yes
+5C 3C
79
See leaflet
43

Order
Reference Standard
Code
Y0000070 Isomaltooligosaccharide

per vial Unit
1
0.9 mg
1
Information
Monograph Leaflet
Storage
1506
Yes
+5C 3C
Extra
Price
charges
79
a
I0500000 Isoniazid
100 mg
0146
Yes
+5C 3C
79
I0599990 Isoprenaline hydrochloride
50 mg
1332
Yes
+5C 3C
79
Y0001577 Isoprenaline impurity A
15 mg
1-(3,4-dihydroxyphenyl)-2-[(1-methylethyl)amino]ethanone
1332
Yes
+5C 3C
79
I0600000 Isoprenaline sulfate
510 mg
0502
Yes
+5C 3C
79
Y0001728 Isopropyl alcohol
100 mg
0970
Yes
+5C 3C
79
I0725000 Isopropyl hexadecanoate
100 mg
See leaflet CHO
0839
Yes
+5C 3C
79
I0750000 Isopropyl tetradecanoate
2 ml
See leaflet CHO
0725
Yes
+5C 3C
79
Y0001568 Isoquercitroside
15 mg
See leaflet CHO
2528
Yes
+5C 3C
79
I0775000 Isosorbide dinitrate
350 mg
See leaflet CHNO
1117,1118
Yes
+5C 3C
79
I0775010 Isosorbide mononitrate
150 mg
See leaflet CHNO; Isosorbide-5-nitrate. Can only be sent by road.
1117,1118
Yes
+5C 3C
79
I0775020 Isosorbide-2-nitrate
50 mg
1118
Yes
+5C 3C
79
I0800000 Isotretinoin
60 mg
0693,1019
Yes
+5C 3C
79
Y0001218 Isotretinoin for peak identification
10 mg
1019
Yes
+5C 3C
79
I0900000 Isoxsuprine hydrochloride
50 mg
1119
Yes
+5C 3C
79
Y0000366 Isradipine
125 mg
See leaflet CHNO
2110
Yes
+5C 3C
79
Y0000367 Isradipine impurity D
5 mg
methyl 1-methylethyl 4-(2,1,3-benzoxadiazol-4-yl)

-2,6-dimethylpyridine-3,5-dicarboxylate
2110
Yes
+5C 3C
79
I7000000 Itraconazole
20 mg
1335
Yes
+5C 3C
79
Y0001100 Itraconazole for system suitability
25 mg
1335
Yes
+5C 3C
79
I8000010 Ivermectin
150 mg
See leaflet
1336
Yes
+5C 3C
79
Y0001592 Ivy leaf dry extract HRS
70 mg
See leaflet
2148
Yes
-20C 5C
79
Y0000041 Josamycin
150 mg
See leaflet
1982,1983,2
0702
Yes
-20C 5C
79
Y0001315 Josamycin for peak identification
25 mg
1983
Yes
+5C 3C
79
Y0000042 Josamycin propionate
150 mg
1982,1983,2
0702
Yes
+5C 3C
79
K0100000 Kanamycin B sulfate
20 mg
0032,0033,0
645
Yes
+5C 3C
79
K0200000 Kanamycin monosulfate
150 mg
0032,0033,0
053,
0485,0645,1
289,
1290,20702
Yes
+5C 3C
79
Y0000450 Ketamine hydrochloride - * narc
10 mg
1020
Yes
+5C 3C
79
K0551000 Ketamine impurity A
50 mg
1020,1742
Yes
+5C 3C
79
Y0000246 Ketobemidone hydrochloride - reference spectrum
n/a
79
Y0000244 Ketobemidone impurity B
5 mg
79
See leaflet
See leaflet CHNOS,HO ; Batch 2 is valid until 30 June 2015
1-[(2-chlorophenyl)(methylimino)methyl]cyclopentanol
1746
1-[4-(3-hydroxyphenyl)-1-methylpiperidin-4-yl]ethanone
44
1746
Yes
+5C 3C

Order
Reference Standard
Code
Y0000245 Ketobemidone impurity C

Information
per vial Unit
1
5 mg
1 1-[4-(3-hydroxyphenyl)piperidin-4-yl]propan-1-one
Monograph Leaflet
1746
Yes
Storage
+5C 3C
Extra
Price
charges
79
a
K0600000 Ketoconazole
150 mg
0921,1270
Yes
+5C 3C
79
K2000000 Ketoprofen
50 mg
0922,1157,1
209
Yes
+5C 3C
79
K2000010 Ketoprofen impurity A
10 mg
1-(3-benzoylphenyl)ethanone ; Batch 4 is valid until 31 March 2015
0922
Yes
+5C 3C
79
K2000015 Ketoprofen impurity C
15 mg
3-[(1RS)-1-carboxyethyl]benzoic acid
0922
Yes
+5C 3C
79
Y0000486 Ketorolac trometamol
10 mg
1755
Yes
+5C 3C
79
Y0000626 Ketorolac trometamol for peak identification
5 mg
1755
Yes
+5C 3C
79
Y0001619 Ketotifen hydrogen fumarate
10 mg
1592
Yes
+5C 3C
79
Y0000161 Ketotifen impurity G
0.0225 mg
1592
Yes
+5C 3C
79
Y0001617 Ketotifen for peak identification
15 mg
Y0001200 Kudzuvine root dry extract
200 mg
See leaflet
L0050000 Labetalol hydrochloride
120 mg
Y0001548 Labetalol impurity A
10 mg
L0129000 Lactitol monohydrate
60 mg
Y0000257 Lactobionic acid
100 mg
L0100000 Lactose
100 mg
A1206000 Lactose (anhydrous)
1
1
L0130000 Lactulose
Y0001510 Lactulose for peak identification
4-(1-methylpiperidin-4-ylidene)-4H-benzo(4,5)cyclohepta(1,2-b)
thiophen-9,10-dione
1592
Yes
+5C 3C
79
2434,2483
Yes
-20C 5C
79
See leaflet CHClNO
0923
Yes
+5C 3C
79
2-hydroxy-5-[1-hydroxy-2-[(1-methyl-3-phenylpropyl)-amino]ethyl]benzoic
acid
0923
Yes
+5C 3C
79
See leaflet CHO
1337
Yes
+5C 3C
79
1647
Yes
+5C 3C
79
0177,0178,0
187,
0188,0204,0
209,
1215,1570
Yes
+5C 3C
79
100 mg
1061
Yes
+5C 3C
79
100 mg
0187
Yes
+5C 3C
79
3000 mg
0924,1230
Yes
+5C 3C
79
2600 mg
0924
Yes
+5C 3C
79
Y0000425 Lamivudine
150 mg
2217
Yes
+5C 3C
79
Y0000518 Lamivudine for system suitability 1
10 mg
2217
Yes
+5C 3C
79
Y0000426 Lamivudine for system suitability 2
10.3 mg
2217
Yes
+5C 3C
79
Y0001030 Lamotrigine
10 mg
1756
Yes
+5C 3C
79
Y0001032 Lamotrigine impurity E
15 mg
1756
Yes
+5C 3C
79
Y0001031 Lamotrigine for peak identification
20 mg
1756
Yes
+5C 3C
79
Y0001085 Lamotrigine for system suitability
10 mg
1756
Yes
+5C 3C
79
Y0000773 Lansoprazole
60 mg
2219
Yes
+5C 3C
79
Y0000774 Lansoprazole for peak identification
1.01 mg
2219
Yes
+5C 3C
79
Y0001474 Lauric acid
1500 mg
see leaflet
1848, 2579
Yes
+5C 3C
79
Y0000654 Leflunomide
100 mg
see leaflet
2330
Yes
+5C 3C
79
New Y0001750 Lactose monohydrate

See leaflet CHNOS
2,3-dichlorobenzoic acid
45

Order
Reference Standard
Code
Y0000487 Leflunomide impurity A

per vial Unit
2
25 mg
1 4-(trifluoromethyl)aniline
Information
Monograph Leaflet
Storage
Extra
Price
charges
79
a
2330
Yes
+5C 3C
2330
Yes
+5C 3C
79
2334
Yes
+5C 3C
79
0771,0874
Yes
+5C 3C
79
1442
Yes
-20C 5C
79
Y0000674 Leflunomide for peak identification
1 mg
Y0000685 Letrozole
70 mg
L0375000 Leucine
50 mg
L0376000 Leuprorelin
1 mg
L0376001 Leuprorelin - reference spectrum
n/a
1442
79
Y0000048 Levamisole - reference spectrum
n/a
1728
79
L0380000 Levamisole hydrochloride
50 mg
Y0000047 Levamisole hydrochloride for system suitability
15 mg
Y0001253 Levetiracetam
110 mg
Y0001254 Levetiracetam impurity A
10 mg
Y0001255 Levetiracetam impurity B
15 mg
Y0001256 Levetiracetam impurity C
15 mg
Y0001257 Levetiracetam impurity D
L0390000 Levocabastine hydrochloride
Y0001636 Levocabastine for system suitability 1
Y0001637 Levocabastine for system suitability 2
L0399900 Levocarnitine
L0399905 Levocarnitine impurity A
See leaflet CHN

See leaflet CHNO
0726
Yes
+5C 3C
79
0726,1728
Yes
+5C 3C
79
2535
Yes
+5C 3C
79
(2RS)-2-(2-oxopyrrolidin-1-yl)butanoic acid
2535
Yes
+5C 3C
79
(2Z)-2-(2-oxopyrrolidin-1-yl)but-2-enamide
2535
Yes
+5C 3C
79
pyridin-2-ol / 2-hydroxypyridine
2535
Yes
+5C 3C
79
15 mg
(2R)-2-(2-oxopyrrolidin-1-yl)butanamide ((R)-etiracetam)
2535
Yes
+5C 3C
79
125 mg
1484
Yes
+5C 3C
79
5.028 mg
1484
Yes
+5C 3C
79
5.005 mg
1484
Yes
+5C 3C
79
125 mg
1339
Yes
+5C 3C
79
50 mg
1339
Yes
+5C 3C
79
L0400000 Levodopa
100 mg
0038
Yes
+5C 3C
79
L0420000 Levodropropizine
60 mg
1535
Yes
+5C 3C
79
L0420002 Levodropropizine impurity A
25 mg
(2R)-3-(4-phenylpiperazin-1-yl)propan-1,2-diol (dextrodropropizine)
1535
Yes
+5C 3C
79
Y0001033 Levodropropizine impurity B
50 mg
1-phenylpiperazine
1535
Yes
+5C 3C
79
Y0001048 Levodropropizine impurity C
300 mg
2,3-epoxypropan-1-ol
1535
Yes
-20C 5C
79
L0500000 Levomepromazine hydrochloride
100 mg
0505
Yes
+5C 3C
79
L0505000 Levomepromazine maleate
50 mg
0925
Yes
+5C 3C
79
L0551000 Levonorgestrel
30 mg
0926
Yes
+5C 3C
79
Y0001379 Levonorgestrel impurity B
15 mg
13-ethyl-17-hydroxy-18,19-dinor-17-alpha-pregn-5(10)-en-20-yn-3-one ;
0926
Yes
+5C 3C
79
Y0001431 Levonorgestrel for system suitability 1
10 mg
0926
Yes
+5C 3C
79
Y0001618 Levonorgestrel for system suitability 2
10 mg
L0570000 Levothyroxine sodium
100 mg
Y0001382 Levothyroxine for peak identification
10 mg
L0595000 Lidocaine
10 mg
L0600000 Lidocaine hydrochloride
40 mg
see leaflet; (E)- or (Z)-4-(trimethylammonio)but-2-enoate ; Batch 2 is valid

until 30 June 2015
see leaflet ; Batch 3 is valid until 31 January 2015
46
0926
Yes
+5C 3C
79
0401,0728
Yes
-20C 5C
79
0401
Yes
-20C 5C
79
0727
Yes
+5C 3C
79
0227,1242,1
363
Yes
+5C 3C
79

Order
Reference Standard
Code
L0650000 Lincomycin hydrochloride
Y0001393 Lincomycin hydrochloride for system suitability
New L0700000 Liothyronine sodium

Information
per vial Unit
4
100 mg
1 See leaflet ; Batch 3 is valid until 30 October 2014
2
10 mg
60 mg
Y0000860 Liothyronine for peak identification
0.0046 mg
L0702000 Lisinopril dihydrate
50 mg
Y0001234 Lisinopril impurity F
0.01 mg
Y0001701 Lisinopril for peak identification
10 mg
Y0001709 Lisinopril for system suitability A
10 mg
L0720000 Lithium clavulanate
125 mg
L0720800 Lithocholic acid
60 mg
Y0000112 Lobeline hydrochloride
L0745000 Lomustine
Y0001438 Long pepper for system suitability HRS

L0750000 Loperamide hydrochloride
Monograph Leaflet
(2S)-1-[(2S)-6-amino-2-[[(1S)-1-carboxy-3-cyclohexylpropyl]amino]
hexanoyl]pyrrolidine-2-carboxylic acid (cyclohexyl analogue)
Storage
Extra
Price
charges
79
a
0582,0583,0
996
Yes
+5C 3C
0583
Yes
-20C 5C
79
0401,0728
Yes
-20C 5C
79
0728
Yes
-20C 5C
79
1120
Yes
+5C 3C
79
1120
Yes
+5C 3C
79
1120
Yes
+5C 3C
79
1120
Yes
+5C 3C
79
1140,1653
Yes
+5C 3C
79
1189,1275
Yes
+5C 3C
79
50 mg
1988
Yes
+5C 3C
79
50 mg
0928
Yes
+5C 3C
79
600 mg
2477, 2453
Yes
+5C 3C
79
50 mg
0921,0929,1
729
Yes
+5C 3C
79
Y0000322 Loperamide hydrochloride for system suitability
15 mg
0929
Yes
+5C 3C
79
Y0000341 Loperamide oxide monohydrate
20 mg
1729
Yes
+5C 3C
79
Y0001498 Lopinavir
200 mg
2615
Yes
+5C 3C
79
Y0001506 Lopinavir for peak identification
10 mg
2615
Yes
+5C 3C
79
Y0001505 Lopinavir for system suitability
10 mg
2615
Yes
+5C 3C
79
Y0000688 Loratadine
60 mg
2124
Yes
+5C 3C
79
Y0000604 Loratadine impurity F
10 mg
ethyl 4-[(11RS)-8-chloro-11-fluoro-6,11-dihydro-5H-benzo[5,6]cyclohepta
[1,2-b]pyridin-11-yl]piperidine-1-carboxylate
2124
Yes
+5C 3C
79
Y0000605 Loratadine impurity H
50 mg
ethyl 4-oxopiperidine-1-carboxylate
2124
Yes
+5C 3C
79
Y0000603 Loratadine for system suitability
20 mg
2124
Yes
+5C 3C
79
L0750500 Lorazepam - * psy
15 mg
1121
Yes
+5C 3C
79
Y0000718 Lorazepam impurity D
10 mg
(5RS)-7-chloro-5-(2-chlorophenyl)-4,5-dihydro-1H-1,4-benzodiazepine-2,3dione
1121
Yes
+5C 3C
79
Y0000576 Lorazepam for system suitability - * psy
0.8 mg
1121
Yes
+5C 3C
79
Y0001062 Losartan potassium
50 mg
2232
Yes
+5C 3C
79
Y0001072 Losartan impurity D
10 mg
2-butyl-4-chloro-1H-imidazole-5-carbaldehyde ; Batch 2 is valid until 31

August 2015
2232
Yes
+5C 3C
79
Y0001076 Losartan for system suitability
0.0015 mg
L0790000 Lovastatin
60 mg
See leaflet CHO
Y0001136 Lovastatin for peak identification
20 mg
See leaflet; 1 mg of CHLiNO corresponds to 1.157 mg of CHKNO ; Batch

5 is valid until 30 November 2014

See leaflet CHNO
47
2232
Yes
+5C 3C
79
1538,1563
Yes
-20C 5C
79
1538
Yes
-20C 5C
79

Order
Code
Y0001284 Lufenuron
Reference Standard

per vial Unit
1
140 mg
1 See leaflet CHClFNO
Information
Monograph Leaflet
Storage
+5C 3C
Extra
Price
charges
79
a
2177
Yes
2177
Yes
+5C 3C
79
2177
Yes
+5C 3C
79
Y0001261 Lufenuron for peak identification
0.4028 mg
Y0001265 Lufenuron impurity G
15 mg
L0800000 Lynestrenol
50 mg
0558
Yes
+5C 3C
79
Y0001034 Lynestrenol for peak identification
20 mg
0558
Yes
+5C 3C
79
Y0000397 Lysine acetate
60 mg
2114
Yes
+5C 3C
79
L0900000 Lysine hydrochloride
50 mg
0930, 1654
Yes
+5C 3C
79
Y0001369 Macrogol 30 dipolyhydroxystearate
100 mg
2584
Yes
+5C 3C
79
Y0000745 Macrogol 40 sorbitol heptaoleate
20 mg
2396
Yes
+5C 3C
79
Y0001684 High-molecular-mass macrogol CRS
10 mg
2444
Yes
+5C 3C
79
Y0001157 Macrogol polyvinyl alcohol grafted copolymer
400 mg
2523
Yes
+5C 3C
79
M0088000 Magnesium aspartate dihydrate
60 mg
1445
Yes
+5C 3C
79
Y0001289 Magnolol
20 mg
See leaflet CHO
2567,2568
Yes
-20C 5C
79
M0120000 Malathion
250 mg
See leaflet CHOPS
1343
Yes
-20C 5C
79
M0120005 Malathion impurity A
15 mg
see leaflet; diethyl (2RS)-2-[(methoxy)(methylsulfanyl)-S-phosphinothioyl]

butane dioate ; Batch 2 is valid until 30 April 2015
1343
Yes
-20C 5C
79
M0120010 Malathion impurity B
10 mg
diethyl (2RS)-2-(dimethoxy-S-phosphinothioyl)-butanedioate
1343
Yes
-20C 5C
79
M0100000 Maleic acid
100 mg
0365,0925
Yes
+5C 3C
79
Y0000143 Malic acid - reference spectrum
n/a
79
M0160000 Maltitol
1200 mg
See leaflet CHO
1235,1236
Yes
+5C 3C
79
M0200000 Mannitol
1200 mg
See leaflet CHO
0435,0559,1
381, 1531
Yes
+5C 3C
79
M0206000 Maprotiline hydrochloride
100 mg
1237
Yes
+5C 3C
79
M0206040 Maprotiline impurity D
25 mg
1237
Yes
+5C 3C
79
Y0000819 Marbofloxacin
10 mg
2233
Yes
+5C 3C
79
Y0000820 Marbofloxacin for peak identification
20 mg
2233
Yes
+5C 3C
79
M0210000 Measles vaccine (live) BRP
400 mg
1057,0213,2
442
Yes
-20C 5C
90
M0215000 Mebendazole
20 mg
1208,1254,
0845
Yes
+5C 3C
79
Y0000144 Mebendazole for system suitability
20 mg
0845
Yes
+5C 3C
79
Y0001086 Mebrofenin
120 mg
2393
Yes
+5C 3C
79
M0220000 Meclozine dihydrochloride
150 mg
0622
Yes
+5C 3C
79
Y0001310 Meclozine impurity B
15 mg
4-chlorobenzhydrol
0622
Yes
+5C 3C
79
Y0001311 Meclozine impurity H
15 mg
1-(4-chlorobenzhydryl)piperazine
0622
Yes
+5C 3C
79
M0240000 Medronic acid
20 mg
0641, 2350
Yes
+5C 3C
79
60 l
Y0001107 Medronic acid impurity A

2,5-dichloro-4-[[[(2,6-difluorophenyl)carbonyl]carbamoyl]amino]phenyl
phenyl carbonate
2080
3-(9,10-dihydro-9,10-ethanoanthracen-9-yl)-N-methylprop-2- en-1-amine
See leaflet; One sale unit is composed of a bag of 5 vials. The unit quantity of
each vial is 80 mg.
Tris(1-methylethoxy)phosphane
48
79
2350
Yes
+5C 3C
a

Order
Reference Standard
Code
Y0001106 Medronic acid impurity B

Information
per vial Unit
1
40 l
1 Tetrakis(1-methylethyl)methhylenediphosphonate
Monograph Leaflet
Storage
2350
Yes
+5C 3C
Extra
Price
charges
79
a
M0250000 Medroxyprogesterone acetate
100 mg
0673
Yes
+5C 3C
79
Y0001484 Medroxyprogesterone acetate for peak identification
25 mg
0673
Yes
+5C 3C
79
Y0000598 Medroxyprogesterone acetate for system suitability
10 mg
0673
Yes
-20C 5C
79
M0252600 Mefenamic acid
50 mg
1240
Yes
+5C 3C
79
Y0001081 Mefenamic acid impurity A
100 mg
1240
Yes
+5C 3C
79
M0253000 Mefloquine hydrochloride
100 mg
1241
Yes
+5C 3C
79
Y0001514 Megestrol acetate
120 mg
1593
Yes
+5C 3C
79
Y0001594 Megestrol acetate for impurity K identification
0.01 mg
1593
Yes
+5C 3C
79
Y0001507 Megestrol acetate for peak identification
25 mg
1593
Yes
+5C 3C
79
Y0001524 Megestrol acetate for system suitability
50 mg
1593
Yes
+5C 3C
79
Y0001209 Meglumine
10 mg
2055
Yes
+5C 3C
79
Y0001670 Meldonium dihydrate
10 mg
2624
Yes
+5C 3C
79
Y0001671 Meldonium impurity A
25 mg
Trimethylammonium bromide
2624
Yes
+5C 3C
79
Y0001672 Meldonium impurity B
25 mg
1,1,1-trimethylhydrazinium bromide
2624
Yes
+5C 3C
79
Y0001673 Meldonium impurity C
25 mg
see leaflet CHNOBr; 2-(3-methoxy-3-oxopropyl)-1,1,1trimethylhydrazin-1-ium
2624
Yes
+5C 3C
79
Y0001674 Meldonium impurity D
25 mg
see leaflet CHNOBr; 3-(2,2,2,-trimethylhydrazinium)ethylpropionate

bromide
2624
Yes
+5C 3C
79
Y0001675 Meldonium impurity E
25 mg
see leaflet CHBrNO; 3-(2,2,2,-trimethylhydrazinium)prop-2-yl-propionate

bromide
2624
Yes
+5C 3C
79
Y0001676 Meldonium impurity F
25 mg
see leaflet CHNO; 3-hydroxy-1,1-dimethyl-4,5,-dihydro-1H-pyrazolium-1betaine hydrate
2624
Yes
+5C 3C
79
Y0001080 Meloxicam
50 mg
2373
Yes
+5C 3C
79
Y0001035 Meloxicam impurity A
5 mg
ethyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide ;

2373
Yes
+5C 3C
79
Y0001036 Meloxicam impurity B
5 mg
5-methylthiazol-2-amine ; Batch 1 is valid until 31 July 2014
2373
Yes
+5C 3C
79
Y0001037 Meloxicam impurity C
5 mg
N-[(2Z)-3,5-dimethylthiazol-2(3H)-ylidene]-4-hydroxy-2-methyl-2H-1,2benzothiazine-3-carboxamide 1,1-dioxide
2373
Yes
+5C 3C
79
Y0001039 Meloxicam impurity D
5 mg
N-[(2Z)-3-ethyl-5-methylthiazol-2(3H)-ylidene]-4-hydroxy-2-methyl-2H-1,2benzothiazine-3-carboxamide 1,1-dioxide
2373
Yes
+5C 3C
79
Y0001158 Melphalan hydrochloride
100 mg
see leaflet
1698
Yes
+5C 3C
79
Y0001513 Melphalan - reference spectrum
1 uc
1698
79
Y0001457 Melphalan for system suitability
10 mg
1698
Yes
+5C 3C
79
M0300000 Menadione
100 mg
0507
Yes
+5C 3C
79
M0350000 Menthol
150 mg
0619,0623
Yes
+5C 3C
79
M0370000 Mepivacaine hydrochloride
100 mg
1242
Yes
+5C 3C
79
M0370020 Mepivacaine impurity B
60 mg
+5C 3C
79
2,3-dimethylaniline
See leaflet CHO
(RS)-N-(2,6-dimethylphenyl)piperidine-2-carboxamide
49
1242

Order
Reference Standard
Code
M0400000 Meprobamate - * psy

per vial Unit
1
100 mg
1
Information
Monograph Leaflet
Storage
0407,1689
Yes
+5C 3C
Extra
Price
charges
79
j
M0500000 Mepyramine maleate
1000 mg
0278
Yes
+5C 3C
79
Y0000679 Mepyramine impurity A
10 mg
N-(4-methoxybenzyl)pyridin-2-amine
0278
Yes
+5C 3C
79
Y0000680 Mepyramine impurity C
10 mg
pyridin-2-amine
0278
Yes
+5C 3C
79
Y0001252 Meropenem trihydrate
110 mg
See leaflet
2234
Yes
+5C 3C
79
Y0000297 Mesalazine
125 mg
1699,1993
Yes
+5C 3C
79
Y0001563 Mesalazine impurity A
15 mg
1699
Yes
+5C 3C
79
Y0001569 Mesalazine impurity C
15 mg
1699
Yes
+5C 3C
79
Y0001574 Mesalazine for system suitability
10 mg
1699
Yes
+5C 3C
79
Y0001040 Mesityl oxide
100 mg
2358
+5C 3C
79
Y0000337 Mesna - reference spectrum
n/a
1674
79
Y0000316 Mesna impurity C
10 mg
2-(acetylsulphanyl)ethanesulphonic acid
1674
Yes
+5C 3C
79
Y0000317 Mesna impurity D
10 mg
2,2'-(disulphanediyl)bis(ethanesulphonic acid)
1674
Yes
+5C 3C
79
Y0000227 Meso-rich exametazime
0.5 mg
1925
Yes
+5C 3C
79
Y0000097 Mesterolone
120 mg
See leaflet CHO
1730
Yes
+5C 3C
79
Y0000096 Mesterolone impurity A
30 mg
17-hydroxy-1alpha-methylandrost-4-en-3-one
1730
Yes
+5C 3C
79
M0600000 Mestranol
100 mg
0509
Yes
+5C 3C
79
Y0000301 Metacresol - reference spectrum
n/a
2077
79
M0600900 Metamizole sodium
10 mg
1346
Yes
+5C 3C
79
M0600905 Metamizole impurity A
15 mg
4-formylamino-1,5-dimethyl-2-phenyl-1,2-dihydro-3H-pyrazol-3-one ; Batch 3
is valid until 20 February 2015
1346
Yes
+5C 3C
79
Y0001481 Metamizole impurity E
0.01 mg
[(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)amino]
methanesulfonic acid (4-N-desmethylmetamizole). ; Batch 2 is valid until 30
September 2015
1346
Yes
+5C 3C
79
M0605000 Metformin hydrochloride
50 mg
0931
Yes
+5C 3C
79
Y0001590 Metformin impurity A
25 mg
Cyanoguanidine
0931
Yes
+5C 3C
79
Y0001600 Metformin impurity F
2 mL
Dimethylamine hydrochloride
N-methylmethanamine ; Batch 1 is valid until 30 June 2015
0931
Yes
+5C 3C
79
Y0000770 Methacrylic acid-ethyl acrylate copolymer (1:1) - type A
200 mg
1128
Yes
+5C 3C
79
Y0000323 Methacrylic acid-ethyl acrylate copolymer (1:1) - type B
200 mg
1128
Yes
+5C 3C
79
M0610030 Methacrylic acid-ethylacrylate copolymer (1:1),

dispersion 30%-ref.sp
n/a
1129
79
M0620000 Methacrylic acid-methylmethacrylate copolymer(1:1)reference spectrum
n/a
1127
79
M0630000 Methacrylic acid-methylmethacrylate copolymer(1:2)reference spectrum
n/a
1130
79
M0800000 Methadone hydrochloride - reference spectrum
n/a
0408,1787
79
Y0000428 Methanol - reference spectrum
n/a
1989
79
2-aminophenol
50

Order
Code
Y0000754 Methenamine
Reference Standard

per vial Unit
1
10 mg
1
Information
Monograph Leaflet
Storage
1545
Yes
+5C 3C
Extra
Price
charges
79
a
M0960000 Methionine
50 mg
0788,1027
Yes
+5C 3C
79
M0950000 DL-Methionine
50 mg
0624
Yes
+5C 3C
79
M1000000 Methotrexate
100 mg
See leaflet CHNO ; Batch 6 is valid until 30 June 2015
0560
Yes
+5C 3C
79
Y0000663 Methotrexate impurity C
10 mg
(2S)-2-[[4-[[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]methylamino]
benzoyl]amino]pentanedioic acid (N-methylfolic acid, methopteridine) ; Batch
1 is valid until 30 September 2015
0560
Yes
+5C 3C
79
M1000008 Methotrexate impurity D
10 mg
4-[[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]methylamino]benzoic
acid (N10-methylpteroic acid)
0560
Yes
+5C 3C
79
Y0000664 Methotrexate impurity E
10 mg
4-[[(2,4-diaminopteridin-6-yl)methyl]methylamino]benzoic acid (4-aminoN10-methylpteroic acid, APA)
0560
Yes
+5C 3C
79
Y0000602 Methotrexate for peak identification
20 mg
0560
Yes
+5C 3C
79
Y0001668 Methotrexate for system suitability
100 mg
0560
Yes
+5C 3C
79
M1470000 Methyl 2-(4-chlorophenoxy)-2-methylpropionate
0.5 ml
0318
Yes
+5C 3C
79
M1556000 Methyl 12-hydroxystearate
100 mg
1497
Yes
+5C 3C
79
Y0001488 Methyl methacrylate
50 mg
1975
Yes
+5C 3C
79
Y0000398 Methyl nicotinate
25 mg
2129
Yes
+5C 3C
79
M1650000 Methyl parahydroxybenzoate
150 mg
0409,1262,2
134,1999
Yes
+5C 3C
79
M1770180 Methyl ricinoleate
125 mg
0051,2367
Yes
+5C 3C
79
M1770200 Methyl stearate
100 mg
0051,1497,
2367
Yes
+5C 3C
79
M1300000 Methylatropine bromide
100 mg
0919
Yes
+5C 3C
79
M1500000 Methyldopa
50 mg
0045
Yes
+5C 3C
79
Y0001083 Methyldopa for system suitability
0.024 mg
0045
Yes
+5C 3C
79
Y0001374 Racemic methyldopa
5 mg
0045
Yes
+5C 3C
79
M1550000 Methylene chloride
2 ml
0932
Yes
+5C 3C
79
Y0000776 Methylergometrine maleate
10 mg
1788
Yes
+5C 3C
79
Y0000777 Methylergometrine for system suitability
0.53 mg
1788
Yes
+5C 3C
79
M1625000 Methylnitrosoindoline
110 mg
1108
Yes
+5C 3C
79
Y0001017 Methylphenidate hydrochloride - * narc
40 mg
2235
Yes
+5C 3C
79
Y0001490 Methylphenidate impurity C
10 mg
2235
Yes
+5C 3C
79
Y0000910 Methylphenidate impurity mixture
0.04 mg
2235
Yes
+5C 3C
79
M1700000 Methylphenobarbital - * psy
500 mg
M1750000 Methylprednisolone
120 mg
Y0001602 Methylprednisolone for system suitability
10 mg
M1755000 Methylprednisolone acetate
100 mg
M1755200 Methylprednisolone hydrogen succinate
125 mg
(2RS)-2-phenyl-2-[(2R)-piperidin-2-yl]ethanamide
0189
Yes
+5C 3C
79
0312, 0561
Yes
+5C 3C
79
0561
Yes
+5C 3C
79
0933
Yes
+5C 3C
79
0768,1131
Yes
+5C 3C
79
See leaflet
51

Order
Reference Standard
Code
M1755220 Methylprednisolone hydrogen succinate for
performance test

per vial Unit
1
50 mg
1
Information
Monograph Leaflet
1131
Yes
+5C 3C
Yes
+5C 3C
Y0001376 2-methylpyrazine
100 mg
2446,2447,2
708
Y0000190 N-Methylpyrrolidone - reference spectrum
n/a
1675
Y0000418 Methylrosanilinium chloride
40 mg
1990
Yes
Y0000407 Methylrosanilinium for system suitability
10 mg
1990
Yes
M1800000 Methyltestosterone
100 mg
0410
Y0000861 Methyltestosterone for system suitability
10 mg
0410
M1800900 Methylthioninium chloride
50 mg
15 mg
M1800902 Methylthioninium impurity A
20 mg
M1808000 Metixene hydrochloride
75 mg
M1824990 Metoclopramide
100 mg
M1825000 Metoclopramide hydrochloride
50 mg
M1824995 Metoclopramide impurity A
25 mg
M1825010 Metoclopramide impurity E
40 mg
Y0000701 Metolazone
80 mg
Y0000702 Metolazone for system suitability
10 mg
Y0000171 Metoprolol succinate - reference spectrum
n/a
M1830000 Metoprolol tartrate
60 mg
Y0000145 Metoprolol impurity A
5 mg
M1845000 Metrifonate
100 mg
M1850000 Metronidazole
50 mg
Y0000087 Metronidazole impurity A
10 mg
M1851000 Metronidazole benzoate
50 mg
Y0000069 Metronidazole benzoate - reference spectrum
n/a
0934
M1860000 Mexiletine hydrochloride
100 mg
Y0000202 Mexiletine impurity C
2 mg
Y0000203 Mexiletine impurity D
2 mg
M1875000 Mianserin hydrochloride
100 mg
Y0001041 Mianserin impurity B
Y0000862 Mianserin for system suitability

M1880000 Miconazole
New Y0001744 Methylthioninium for system suitability
M1900000 Miconazole nitrate

See leaflet CHClNS,xHO
Storage
Extra
Price
charges
79
a
a
79
79
+5C 3C
79
+5C 3C
79
Yes
+5C 3C
79
Yes
+5C 3C
79
1132
Yes
+5C 3C
79
1132
Yes
+5C 3C
79
1132
Yes
+5C 3C
79
1347
Yes
+5C 3C
79
1348
Yes
+5C 3C
79
0674,0856,1
303
Yes
+5C 3C
79
4-(acetylamino)-5-chloro-N-(2-diethylaminoethyl)-2-methoxy benzamide
1348
Yes
+5C 3C
79
N,N-diethylethane-1,2-diamine
1575
Yes
+5C 3C
79
See leaflet CHClNOS
1757
Yes
+5C 3C
79
1757
Yes
+5C 3C
79
1448
79
3-(dimethylamino)-7-(methylamino)phenothiazin-5-ylium
1028
Yes
+5C 3C
79
1028,1448
Yes
+5C 3C
79
1133
Yes
+5C 3C
79
0675,0934
Yes
+5C 3C
79
0675, 0934
Yes
+5C 3C
79
1424
Yes
+5C 3C
79
79
1029
Yes
+5C 3C
79
see leaflet CHNO; 1,1'-[(3,3',5,5'-tetramethylbiphenyl-4,4'-diyl)bisoxy]

dipropan-2-amine ; Batch 1 is valid until 4 February 2015
1029
Yes
+5C 3C
79
(2RS)-2-(2,6-dimethylphenoxy)propan-1-amine
1029
Yes
+5C 3C
79
0846
Yes
+5C 3C
79
10 mg
(14bRS)-2-methyl-1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]
azepine-8-sulfonic acid
0846
Yes
+5C 3C
79
1.01 mg
0846
Yes
+5C 3C
79
70 mg
0935
Yes
+5C 3C
79
150 mg
(2RS)-1-(ethylamino)-3-[4-(2-methoxyethyl)phenoxy]propan-2-ol
2-methyl-4-nitroimidazole ; Batch 2 is valid until 30 September 2015
52
79
0513,1148
Yes
+5C 3C
a

Order
Reference Standard
Code
M2200000 Midazolam - * psy

per vial Unit
2
50 mg
1
Y0000562 Midazolam impurity C
Y0000599 Midazolam for system suitability - * psy

Y0001687 Milk thistle dry extract HRS
Information
0.08 mg
1 mg
120 mg
See leaflet
M2280000 Minocycline hydrochloride
125 mg
See leaflet CHClNO
M2300000 Minoxidil
50 mg
Y0001432 Minoxidil for system suitability
10 mg
Y0000705 Mirtazapine
10 mg
Y0000721 Mirtazapine for system suitability
10 mg
Y0000490 Misoprostol
60 mg
Y0001162 Misoprostol for system suitability
5 mg
Y0000378 Mitomycin
120 mg
See leaflet CHNO
New M2305000 Mitoxantrone hydrochloride
Monograph Leaflet
acide 8-chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1,5-a]
[1,4]benzodiazepine-3-carboxylique
Storage
0936,1065
Yes
+5C 3C
0936
Yes
+5C 3C
Extra
Price
charges
79
j
a
79
0936
Yes
+5C 3C
79
1860,2071
Yes
-20C 5C
79
1030
Yes
+5C 3C
79
0937
Yes
+5C 3C
79
0937
Yes
+5C 3C
79
2338
Yes
+5C 3C
79
2338
Yes
+5C 3C
79
1731
Yes
-20C 5C
79
1731
Yes
-20C 5C
79
1655
Yes
+5C 3C
79
See leaflet CHO
60 mg
1243
Yes
+5C 3C
79
M2305005 Mitoxantrone impurity A
5 mg
1-amino-5,8-dihydroxy-4-[[2-[(2-hydroxyethyl)amino]ethyl] amino]
anthracene-9,10-dione
1243
Yes
+5C 3C
79
Y0000635 Modafinil
110 mg
See leaflet CHNOS
2307
Yes
+5C 3C
79
Y0000636 Modafinil for system suitability
0.1 mg
2307
Yes
+5C 3C
79
Y0000251 Molgramostim
0.3 ml
1641
Yes
-80C 10C
79
Y0000821 Molsidomine
5 mg
1701
Yes
+5C 3C
79
Y0000822 Molsidomine impurity B
10 mg
N-nitrosomorpholine
1701
Yes
+5C 3C
79
Y0000823 Molsidomine impurity D
10 mg
morpholine-4-carbaldehyde
1701
Yes
+5C 3C
79
M2900000 Mometasone furoate
100 mg
1449
Yes
+5C 3C
79
Y0001436 Montelukast dicyclohexylamine
150 mg
2583
Yes
+5C 3C
79
Y0001433 Montelukast racemate
10 mg
2583
Yes
+5C 3C
79
Y0001434 Montelukast sodium
20 mg
2583
Yes
+5C 3C
79
Y0001435 Montelukast for peak identification
20 mg
2583
Yes
+5C 3C
79
Y0000028 Morantel hydrogen tartrate
50 mg
Y0000451 Morphine hydrochloride trihydrate - * narc
25 mg
Y0000452 Morphine sulfate - * narc
40 mg
Y0000830 Morphine for system suitability - * narc
15 mg
Y0000772 Moxidectin
70 mg
Y0000747 Moxidectin for system suitability
10 mg
Y0000703 Moxifloxacin hydrochloride
110 mg
10 mg

53
Y0000717 Moxifloxacin for peak identification

13.45 mg protein per ml CHNOS
1546
Yes
+5C 3C
79
0097, 1839,
1841,
01/2015:184
0, 0777
Yes
+5C 3C
79
1244,1784
Yes
+5C 3C
79
1244, 0097
Yes
+5C 3C
79
1656
Yes
-20C 5C
79
1656
Yes
+5C 3C
79
See leaflet CHClFNO
2254
Yes
+5C 3C
79
See leaflet
79
2254
Yes
+5C 3C
a

Order
Code
Y0000226 Moxonidine
Reference Standard
Y0000222 Moxonidine impurity A

Information
per vial Unit
1
50 mg
1 See leaflet CHClNO
1
10 mg
1 4,6-dichloro-N-(imidazolidin-2-ylidene)-2-methylpyrimidin-5-amine
M3600000 Mumps vaccine (live) BRP
165 mg
M3805000 Mupirocin - reference spectrum
n/a
M3805500 Mupirocin calcium - reference spectrum
n/a
M3806000 Mupirocin lithium
100 mg
See leaflet CHOLi
Y0000489 Mycophenolate mofetil
30 mg
Y0000519 Mycophenolate mofetil for peak identification
10 mg
Y0000692 Mycoplasma fermentans BRP
1 ml
Y0000690 Mycoplasma hyorhinis BRP
1 ml
Y0000691 Mycoplasma orale BRP
Y0000689 Mycoplasma synoviae BRP
Y0000485 Myo-inositol
N0020000 Nabumetone
See leaflet
Monograph Leaflet
Storage
+5C 3C
Extra
Price
charges
79
a
1758
Yes
1758
Yes
+5C 3C
79
0538,1057,
2442
Yes
-80C 10C
90
79
1450
79
1450,1451
Yes
+5C 3C
79
1700
Yes
+5C 3C
79
1700
Yes
+5C 3C
79
20607
Yes
-80C 10C
120
20607
Yes
-80C 10C
120
1 ml
20607
Yes
-80C 10C
120
1 ml
20607
Yes
-80C 10C
120
1020 mg
See leaflet
1805
Yes
+5C 3C
79
60 mg
See leaflet CHO
1350
Yes
+5C 3C
79
N0020020 Nabumetone impurity D
10 mg
(E)-4-(6-methoxynaphthalen-2-yl)but-3-en-2-one
1350
Yes
+5C 3C
79
New N0020030 Nabumetone impurity F
10 mg
See leaflet; 6,6'-dimethoxy-2,2'-binaphthalenyl ; Batch 4 is valid until 31

October 2015
1350
Yes
+5C 3C
79
Y0000146 Nadolol
100 mg
1789
Yes
+5C 3C
79
Y0001215 Nadolol impurity mixture
0.01 mg
1789
Yes
+5C 3C
79
N0025000 Nadroparin calcium
250 mg
0828,1134
Yes
+5C 3C
79
Y0000077 Naftidrofuryl - reference spectrum
n/a
79
Y0000120 Naftidrofuryl impurity A
10 mg
2-[(naphtalen-1-yl)methyl]-3-(tetrahydrofuran-2-yl)propanoic acid
1594
Yes
+5C 3C
79
Y0000121 Naftidrofuryl impurity B
25 mg
ethyl 2-[(naphtalen-1-yl)methyl]- 3-(tetrahydrofuran-2-yl)propanoate
1594
Yes
+5C 3C
79
Y0000331 Naftidrofuryl impurity F
10 mg
2-[(diethylamino)ethyl 2-[(naphthalen-2-yl)methyl]-3- (tetrahydrofuran-2-yl)

propanoate
1594
Yes
+5C 3C
79
N0050000 Nalidixic acid
100 mg
0701
Yes
+5C 3C
79
N0075000 Naloxone hydrochloride dihydrate
100 mg
0729,2099
Yes
+5C 3C
79
25 mg
0729
Yes
+5C 3C
79
Y0000695 Naloxone for peak identification
5.075 mg
0729
Yes
+5C 3C
79
Y0000400 Naltrexone hydrochloride
50 mg
1790
Yes
+5C 3C
79
Y0000410 Naltrexone impurity C
15 mg
1790
Yes
+5C 3C
79
Y0000542 Nandrolone decanoate
5 mg
1992
Yes
-20C 5C
79
Y0000547 Nandrolone decanoate for peak identification
10 mg
1992
Yes
-20C 5C
79
Y0000548 Nandrolone decanoate for system suitability
10 mg
1992
Yes
-20C 5C
79
N0080000 Naphazoline hydrochloride
50 mg
0730,1162
Yes
+5C 3C
79
N0100000 Naphazoline nitrate
10 mg
0147
Yes
+5C 3C
79
New Y0001571 Naloxone impurity D
1451
1594
N-(3-butenyl)-noroxymorphone
54

Order
Reference Standard
Code
N0200000 Naphazoline impurity A

Information
per vial Unit
5
15 mg
1 N-(2-aminoethyl)-2-(naphthalen-1-yl)acetamide
(naphthylacetylethylenediamine)
Monograph Leaflet
Storage
Extra
Price
charges
79
a
0147,0730
Yes
+5C 3C
0731,1702
Yes
+5C 3C
79
0731,1702
Yes
+5C 3C
79
0731,1702
Yes
+5C 3C
79
N0250000 Naproxen
50 mg
Y0000399 Naproxen (racemic)
10 mg
Y0000631 Naproxen impurity L
10 mg
1-(6-methoxynaphthalen-2-yl)ethanone
Y0001378 Naringin
20 mg
See leaflet CHO
2563
Yes
+5C 3C
79
Y0001437 Nateglinide
200 mg
See leaflet CHNO
2575
Yes
+5C 3C
79
Y0001440 Nateglinide impurity A
10 mg
trans-4-(1-methylethyl)cyclohexanecarboxylic acid
2575
Yes
+5C 3C
79
Y0001441 Nateglinide impurity B
15 mg
N-[[trans-4-(1-methylethyl)cyclohexyl]carbonyl]-Lphenylalanine (Lphenylalanine isomer)
2575
Yes
+5C 3C
79
Y0001442 Nateglinide impurity C
10 mg
N-[[cis-4-(1-methylethyl)cyclohexyl]carbonyl]-D-phenylalanine (cis-isomer)
2575
Yes
+5C 3C
79
N0300000 Neamine
0.5 mg
0180,0197
Yes
+5C 3C
79
N0399000 Neohesperidin-dihydrochalcone
125 mg
See leaflet CHO
1547
Yes
-20C 5C
79
N0399004 Neohesperidin-dihydrochalcone impurity B
10 mg
See leaflet CHO ; 7-[[2-O-(6-deoxy--L-mannopyranosyl) --Dglucopyranosyl]oxy]-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-4H-1benzopyran-4-one (neodiosmin)
1547
Yes
+5C 3C
79
N0400000 Neomycin sulfate
50 mg
Not to be used for microbiological assay
0032,0033,0
053,
0180,0197,0
485, 0645
Yes
-20C 5C
79
N0401000 Neomycin sulfate for microbiological assay
25 mg
See leaflet
20702
Yes
-20C 5C
79
N0500000 Neostigmine bromide
50 mg
0046
Yes
+5C 3C
79
N0550000 Neostigmine metilsulfate
50 mg
0626
Yes
+5C 3C
79
Y0001639 Neostigmine impurity A
0.0025 mg
0046,0626
Yes
+5C 3C
79
N0559000 Netilmicin sulfate
25 mg
See leaflet; This Reference Standard will be removed from monographs 1351
on 01/07/2015.
1351,20702
Yes
-20C 5C
79
Y0000520 Nevirapine (Anhydrous)
30 mg
See leaflet CHNO
2255, 2479
Yes
+5C 3C
79
Y0001499 Nevirapine hemihydrate
15 mg
2479
Yes
+5C 3C
79
Y0000521 Nevirapine for peak identification
0.058 mg
2255, 2479
Yes
+5C 3C
79
Y0000388 Newcastle Disease Vaccine (inactivated) BRP
40 mg
0870
Yes
-20C 5C
180
Y0001373 Nicergoline
50 mg
1998
Yes
+5C 3C
79
Y0001356 Nicergoline impurity D
20 mg
1998
Yes
+5C 3C
79
Y0001362 Nicergoline for peak identification
1 mg
1998
Yes
+5C 3C
79
Y0001352 Nicergoline for system suitability
10 mg
1998
Yes
+5C 3C
79
N0560000 Niclosamide (anhydrous)
50 mg
0679,0680
Yes
+5C 3C
79
New Y0001761 Nicorandil
5 mg
2332
Yes
-20C 5C
79
New Y0001762 Nicorandil impurity A
5 mg
2332
Yes
-20C 5C
79
The kit contains :1 vial BRP1 NDV reference antigen, 1 vial BRP1 NDV control
antigen, 1 vial BRP1 NDV coating antibody, 1 vial BRP1 NDV conjugated,
detection antibody
5-bromopyridine-3-carboxylic acid
55

Order
Code
N0600000 Nicotinamide
Reference Standard

per vial Unit
1
50 mg
1
Information
Monograph Leaflet
0047
Storage
Extra
Price
charges
79
a
Yes
+5C 3C
79
1792
Yes
+5C 3C
79
N0590000 Nicotine - reference spectrum
n/a
N0590200 Nicotine ditartrate
120 mg
Y0001425 Nicotine ditartrate dihydrate
15 mg
2599
Yes
+5C 3C
79
Y0001023 Nicotine for system suitability
1 mg
1452, 1792,
2599
Yes
-20C 5C
79
N0700000 Nicotinic acid
100 mg
0459
Yes
+5C 3C
79
Y0001268 Nicotinic acid impurity mixture
0.12 mg
0459
Yes
+5C 3C
79
N0750000 Nifedipine
50 mg
0627,1013
Yes
+5C 3C
79
N0750010 Nifedipine impurity A
25 mg
Dimethyl 2,6-dimethyl-4-(2-nitrophenyl)pyridine-3,5-dicarboxylate
0627
Yes
+5C 3C
79
N0750015 Nifedipine impurity B
25 mg
Dimethyl 2,6-dimethyl-4-(2-nitrosophenyl)pyridine-3,5-dicarboxylate
0627
Yes
+5C 3C
79
Y0000824 Niflumic acid
10 mg
2115
Yes
+5C 3C
79
Y0000825 Niflumic acid impurity A
10 mg
2-chloropyridine-3-carboxylic acid
2115
Yes
+5C 3C
79
Y0000826 Niflumic acid impurity B
10 mg
2-hydroxy-N-(3-(trifluoromethyl)phenyl)pyridine-3-carboxamide
2115
Yes
+5C 3C
79
Y0000827 Niflumic acid impurity E
15 mg
6-((3-(trifluoromethyl)phenyl)amino)pyridine-3-carboxylic acid
2115
Yes
+5C 3C
79
Y0000836 Nifuroxazide
10 mg
1999
Yes
+5C 3C
79
N0800000 Nikethamide
1 ml
0233
Yes
+5C 3C
79
Y0000829 Nilutamide
110 mg
See leaflet CHFNO
2256
Yes
+5C 3C
79
Y0000894 Nilutamide impurity B
5 mg
4-nitro-3-(trifluoromethyl)aniline
2256
Yes
+5C 3C
79
N0845000 Nimesulide
100 mg
1548
Yes
+5C 3C
79
N0845008 Nimesulide impurity D
0.004 mg
1548
Yes
+5C 3C
79
Y0001237 Nimesulide for peak identification
10 mg
1548
Yes
+5C 3C
79
N0850000 Nimodipine
50 mg
1245
Yes
+5C 3C
79
N0850010 Nimodipine impurity A
1 mL
2-methoxyethyl 1-methylethyl 2,6-dimethyl-4-(3-nitrophenyl)

pyridine-3,5-dicarboxylate
1245
Yes
+5C 3C
79
N0900000 Nitrazepam - * psy
100 mg
0415,0898
Yes
+5C 3C
79
N0905000 Nitrendipine
60 mg
1246
Yes
+5C 3C
79
N0905005 Nitrendipine impurity A
30 mg
1246
Yes
+5C 3C
79
Y0001456 Nitrendipine for peak identification
10 mg
1246
Yes
+5C 3C
79
N0930000 Nitric oxide - reference spectrum
n/a
1550
79
N0950000 Nitrofural
150 mg
See leaflet CHNO ; Batch 1 is valid until 31 August 2015
1135
Yes
+5C 3C
79
Y0001570 Nitrofural impurity B
30 mg
See leaflet CHON; (5-nitrofuran-2-yl)methylene diacetate
1135
Yes
+5C 3C
79
Y0001377 Nitrofural for peak identification
0.11 mg
1135
Yes
+5C 3C
79
N1000000 Nitrosotriaminopyrimidine
50 mg
0058
Yes
+5C 3C
79
N1090000 Nizatidine
250 mg
1453
Yes
+5C 3C
79
1452,1792
See leaflet CHN x 2 CHO
4-nitro-2-phenoxyaniline
ethyl methyl-2,6-dimethyl-4-(3-nitrophenyl)pyridine-3,5- dicarboxylate;

(nitrophenylpyridine analogue)
See leaflet CHNOS

56

Order
Reference Standard
Code
N1090060 Nizatidine impurity F

Information
per vial Unit
1
10 mg
1 (EZ)-N-methyl-N'-[2-[[[4-[[[2-[[(EZ)-1-(methylamino)-2-nitroethenyl]amino]
ethyl]sulfanyl]methyl]thiazol-2-yl]methyl]sulfanyl]ethyl]-2-nitroethene-1,1diamine
Monograph Leaflet
Storage
1453
Yes
+5C 3C
Extra
Price
charges
79
a
Y0001278 Nizatidine for system suitability
10 mg
1453
Yes
+5C 3C
79
N1080000 Nomegestrol acetate
100 mg
1551
Yes
+5C 3C
79
N1080005 Nomegestrol acetate impurity A
50 mg
Y0001314 1-nonadecanol
425 mg
Y0000670 Nonivamide
10 mg
Y0000755 Nonoxinol 9
10 mg
N1100000 Noradrenaline tartrate
Y0000681 Noradrenaline impurity D

Y0000682 Noradrenaline impurity E
1551
Yes
+5C 3C
79
0801,0802,0
847
Yes
+5C 3C
79
1859,2336,2
337, 2529
Yes
+5C 3C
79
1454
Yes
+5C 3C
79
200 mg
0254,0285,0
732, 2303
Yes
+5C 3C
79
15 mg
+5C 3C
79
10 mg
4[(1R)-2-amino-1-methoxyethyl]benzene-1,2-diol (noradrenaline methyl ether) 0285,0732

2-chloro-1-(3,4-dihydroxyphenyl)ethanone
0285,0732
Yes
Yes
+5C 3C
79
Y0000686 Noradrenaline impurity F
10 mg
N-benzyl-1-phenylmethanamine
0285,0732
Yes
+5C 3C
79
N1130000 Norcyclobenzaprine
25 mg
0941
Yes
+5C 3C
79
N1140000 Nordazepam -* psy
50 mg
Dipotassium clorazepate impurity B. This reference standard will be deleted

from mono 1466 on july 2015 1st
0898,1466
Yes
+5C 3C
79
N1200000 Norethisterone
25 mg
0234,1212,0
926
Yes
+5C 3C
79
Y0000522 Norethisterone for system suitability
10 mg
0234
Yes
-20C 5C
79
N1225000 Norethisterone acetate
100 mg
0850
Yes
+5C 3C
79
Y0001532 Norethisterone acetate for system suitability
2.585 mg
0850
Yes
+5C 3C
79
N1230000 Norfloxacin
50 mg
1248
Yes
+5C 3C
79
N1230010 Norfloxacin impurity A
20 mg
1460
Yes
+5C 3C
79
Y0001301 Norfloxacin for peak identification
10 mg
1248
Yes
+5C 3C
79
Y0001015 Norfloxacin for system suitability
8 mg
1248
Yes
+5C 3C
79
Y0001609 Norflurane - reference spectrum
1 mg
79
Y0000724 Norgestimate
10 mg
1732
Yes
+5C 3C
79
Y0000725 Norgestimate for system suitability
5 mg
1732
Yes
+5C 3C
79
N1250000 Norgestrel
30 mg
0940
Yes
+5C 3C
79
N1279000 Norpseudoephedrine hydrochloride - * psy
50 mg
0683
Yes
+5C 3C
79
N1280000 Nortriptyline hydrochloride
10 mg
0941
Yes
+5C 3C
79
Y0001296 Nortriptyline for system suitability
20 mg
0941
Yes
+5C 3C
79
N1300000 Noscapine
100 mg
0102,0515,0
516
Yes
+5C 3C
79
6alpha-methyl-3,20-dioxo-19-norpregn-4-en-17-yl acetate
See leaflet CHNO
7-chloro-1-ethyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
(corresponding also to pefloxacin impurity F)
Cathine hydrochloride
57

Order
Code
N1400000 Nystatin
Reference Standard

per vial Unit
7
100 mg
1 See leaflet
O0100900 Octoxinol 10
Y0000368 Octyl gallate

O0101000 Octyldodecanol
Information
Monograph Leaflet
Storage
Extra
Price
charges
79
c
0517,1292,2
0702
Yes
-20C 5C
1553
Yes
+5C 3C
79
2057
Yes
+5C 3C
79
1136
Yes
+5C 3C
79
300 mg
30 mg
400 mg
O0120000 Ofloxacin
50 mg
1455
Yes
+5C 3C
79
O0120010 Ofloxacin impurity A
20 mg
(RS)-9,10-difluoro-3-methyl-7-oxo-2,3-dihydro-7H-pyrido [1,2,3-de][1,4]
benzoxazine-6-carboxylic acid (FPA) ; Batch 2 is valid until 31 August 2015
1455
Yes
+5C 3C
79
O0120050 Ofloxacin impurity E
20 mg
(RS)-9-fluoro-3-methyl-10-(piperazin-1-yl)-7-oxo-2,3-dihydro-7H-pyrido
[1,2,3-de][1,4]benzoxazine-6-carboxylic acid
1455
Yes
+5C 3C
79
Y0001370 Olanzapine
200 mg
2258
Yes
+5C 3C
79
Y0001392 Olanzapine impurity A
5 mg
5-methyl-2-[(2-nitrophenyl)amino]thiophene-3-carbonitrile
2258
Yes
+5C 3C
79
Y0001380 Olanzapine for system suitability
10 mg
2258
Yes
+5C 3C
79
Y0001204 Oleanolic acid
20 mg
See leaflet
2463
Yes
+5C 3C
79
Y0001479 Oleic acid
2000 mg
See leaflet CHO
2579, 1848
Yes
+5C 3C
79
Y0000805 Oleuropein
20 mg
See leaflet CHO
1878
Yes
+5C 3C
79
Y0001405 Olmesartan medoxomil
100 mg
see leaflet ; Batch 1 is valid until 31 May 2015
2600
Yes
+5C 3C
79
Y0001424 Olmesartan medoxomil for system suitability
10 mg
2600
Yes
+5C 3C
79
O0146000 Olsalazine sodium
70 mg
1457
Yes
+5C 3C
79
O0146010 Olsalazine sodium for performance test
60 mg
O0150000 Omeprazole
50 mg
Y0001043 Omeprazole magnesium
10 mg
O0151000 Omeprazole impurity D
10 mg
Y0000218 Ondansetron hydrochloride dihydrate
Y0001042 Omeprazole for peak identification
Y0001345 Ondansetron impurity A
See leaflet CHO
1457
Yes
+5C 3C
79
See leaflet
0942,1032,2
372,
2374,2787
Yes
-20C 5C
79
2374
Yes
+5C 3C
79
Omeprazole sulphone
0942,1032,
2372, 2374,
2787
Yes
-20C 5C
79
200 mg
See leaflet CHClNO
10 mg
10 mg
Y0000195 Ondansetron impurity D
15 mg
Y0001326 Ondansetron impurity E
Y0001320 Ondansetron impurity F
Y0001346 Ondansetron impurity G

Y0000197 Ondansetron for LC system suitability
2016
Yes
+5C 3C
79
0942, 1032,
2372, 2374,
2787
Yes
-20C 5C
79
(3RS)-3-[(dimethylamino)methyl]-9-methyl-1,2,3,9-tetrahydro-4Hcarbazol-4-one
2016
Yes
+5C 3C
79
9-methyl-3-methylene-1,2,3,9-tetrahydro-4H-carbazol-4-one ; Batch 2 is valid

until 31 August 2014
2016
Yes
+5C 3C
79
10 mg
Imidazole
2016
Yes
+5C 3C
79
10 mg
2016
Yes
+5C 3C
79
10 mg
2016
Yes
+5C 3C
79
10 mg
(3RS)-3-[(1H-imidazol-1-yl)methyl]-9-methyl-1,2,3,9-tetrahydro-4Hcarbazol-4-one (C-demethylondansetron)
58
79
2016
Yes
+5C 3C
a

Order
Reference Standard
Code
Y0000196 Ondansetron for TLC system suitability

Information
per vial Unit
2
30 mg
1 Batch 1 is valid until 30 September 2015
Monograph Leaflet
Storage
2016
Yes
+5C 3C
Extra
Price
charges
79
a
Y0001125 Orbifloxacin
200 mg
2259
Yes
+5C 3C
79
Y0001147 Orbifloxacin impurity mixture
0.0008 mg
2259
Yes
+5C 3C
79
O0180000 Orciprenaline sulfate
100 mg
1033,1332
Yes
+5C 3C
79
Y0000895 Orciprenaline for system suitability
5 mg
1033
Yes
+5C 3C
79
Y0001501 Orientvine stem HRS
600 mg
2450
Yes
+5C 3C
79
Y0000101 Orphenadrine citrate
100 mg
1759
Yes
+5C 3C
79
Y0000100 Orphenadrine hydrochloride
100 mg
Y0000102 Orphenadrine impurity E
60 mg
Y0001181 Orphenadrine for peak identification
0.42 mg
Y0001337 Oseltamivir phosphate (impurity B free)
300 mg
Y0001338 Oseltamivir impurity A
10 mg
Y0001339 Oseltamivir impurity B
10 mg
Y0001340 Oseltamivir impurity C
Y0001341 Oseltamivir impurity H
Y0001207 Osthole
O0200000 Ouabain
1760
Yes
+5C 3C
79
1759,1760
Yes
+5C 3C
79
1759,1760
Yes
+5C 3C
79
See leaflet CHNOP
2422
Yes
+5C 3C
79
(3R,4R,5S)-5-acetamido-4-amino-3-(1-ethylpropoxy)cyclohex-1-ene-1carboxylic acid
2422
Yes
+5C 3C
79
ethyl (1R,2R,3S,4R,5S)-4-acetamido-5-amino-2-azido-3(1-ethylpropoxy)cyclohexanecarboxylate
2422
Yes
+5C 3C
79
10 mg
(3R,4R,5S)-4-acetamido-5-amino-3-(1-ethylpropoxy)cyclohex-1-ene-1carboxylic acid
2422
Yes
+5C 3C
79
30 mg
tributylphosphane oxide
2422
Yes
+5C 3C
79
20 mg
See leaflet CHO
2557
Yes
+5C 3C
79
150 mg
See leaflet CHO
0048
Yes
+5C 3C
79
Y0000638 Oxacillin sodium monohydrate
110 mg
See leaflet CHNNaOS
2260
Yes
+5C 3C
79
Y0000560 Oxacillin for peak identification
10 mg
2260
Yes
+5C 3C
79
Y0000271 Oxaliplatin
250 mg
See leaflet CHNOPt
2017
Yes
+5C 3C
79
Y0000272 Oxaliplatin impurity B
22 mg
See leaflet CHNOPtS; ditosylato diaminocyclohexane platinum complex
2017
Yes
+5C 3C
79
New Y0000273 Oxaliplatin impurity C
25 mg
(OC-6-33)-[(1R,2R)-cyclohexane-1,2-diamine-kN,kN'][ethane-dioato(2-)kO1,kO2]dihydroxyplatinum ; Batch 5 is valid until 31 October 2015
2017
Yes
+5C 3C
79
Y0000274 Oxaliplatin impurity D
10 mg
(SP-4-2)-[(1S,2S)-cyclohexane-1,2-diamine-kN,kN'][ethanedioato(2-)-kO1,kO2]platinum (S,S-enantiomer of oxaliplatin)
2017
Yes
+5C 3C
79
O0225000 Oxazepam - * psy
50 mg
0778
Yes
+5C 3C
79
Y0000543 Oxazepam for peak identification
0.008 mg
0778
Yes
+5C 3C
79
Y0001576 Oxcarbazepine
120 mg
2577
Yes
+5C 3C
79
Y0001549 Oxcarbazepine impurity mixture
0.008 mg
2577
Yes
+5C 3C
79
Y0000350 Oxeladin hydrogen citrate
50 mg
1761
Yes
+5C 3C
79
Y0000404 Oxeladin impurity C
10 mg
2-(diethylamino)ethyl 2-ethyl-2-phenylbutanoate
1761
Yes
+5C 3C
79
Y0000390 Oxeladin impurity D
20 mg
2-(2-diethylaminoethoxy)ethyl 2-phenyl-butyrate dihydrogen citrate
1761
Yes
+5C 3C
79
O0225800 Oxfendazole CRS
50 mg
1458
Yes
+5C 3C
79
Y0000224 Oxfendazole impurity B
10 mg
1458
Yes
+5C 3C
79
(RS)-N,N-dimethyl-2-[(3-methylphenyl)phenylmethoxy] ethanamine (metamethylbenzyl isomer)
See leaflet CHNO
See leaflet; methyl [5-(phenylsulphonyl)-1H-benzimidazole-2-yl]carbamate

59

Order
Reference Standard
Code
Y0000225 Oxfendazole with impurity D

per vial Unit
1
10 mg
1
Information
Monograph Leaflet
Storage
1458
Yes
+5C 3C
Extra
Price
charges
79
a
O0260000 Oxibendazole
100 mg
1386
Yes
+5C 3C
79
Y0000709 Oxitropium bromide
50 mg
2170
Yes
+5C 3C
79
Y0000715 Oxitropium bromide impurity B
15 mg
(1R,2R,4S,5S,7s)-7-[[(2S)-3-hydroxy-2-phenylpropanoyl]oxy]-9,9dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonane (methylhyoscine)
2170
Yes
+5C 3C
79
Y0000713 Oxitropium bromide impurity D
10 mg
(1R,2R,4S,5S,7s,9r)-9-ethyl-9-methyl-7-[(2-phenylprop-2-enoyl)oxy]-3oxa-9-azoniatricyclo[3.3.1.02,4]nonane (apo-N-ethylhyoscine)
2170
Yes
+5C 3C
79
O0240000 Oxolinic acid
50 mg
1353
Yes
+5C 3C
79
O0240005 Oxolinic acid impurity A
20 mg
8-hydroxy-1,3-dioxolo[4,5-g]quinoline-7-carboxylic acid
1353
Yes
+5C 3C
79
O0240010 Oxolinic acid impurity B
20 mg
ethyl 5-ethyl-8-oxo-5,8-dihydro-1,3-dioxolo[4,5-g]quinoline-7- carboxylate
O0250000 Oxprenolol hydrochloride
50 mg
O0270000 Oxybuprocaine hydrochloride
100 mg
O0288000 Oxybutynin hydrochloride
50 mg
O0288005 Oxybutynin impurity A
20 mg
Y0000492 Oxycodone hydrochloride - * narc
100 mg
Y0000453 Oxycodone impurity D
50 mg
O0290000 Oxymetazoline hydrochloride
80 mg
Y0001044 Oxymetazoline impurity A
15 mg
N-(2-aminoethyl)-2-[4-(1,1-dimethylethyl)-3-hydroxy-2,6-dimethylphenyl]
acetamide
O0400000 Oxytetracycline
100 mg
See leaflet CHNO
O0500000 Oxytetracycline hydrochloride
20 mg
O0700000 Oxytocin
41 mg
O0770000 Oxytocin/Desmopressin validation mixture
20 mg
Y0000698 Paclitaxel
40 mg
Y0000699 Paclitaxel impurity C
5 mg
Y0000700 Paclitaxel natural for peak identification
10 mg
Y0000719 Paclitaxel semi-synthetic for peak identification
10 mg
Y0000739 Paclitaxel semi-synthetic for system suitability
1.013 mg
P0090000 Palmitic acid
100 mg
Y0000524 Pamidronate disodium pentahydrate
10 mg
Y0001632 Pancreas powder (amylase) BRP
2000 mg
See leaflet
Y0001631 Pancreas powder (lipase) BRP
2000 mg
P0200000 Pancreas powder (protease) BRP
2000 mg
1353
Yes
+5C 3C
79
0628,0876,1
072
Yes
+5C 3C
79
1251
Yes
+5C 3C
79
1354
Yes
+5C 3C
79
See leaflet CHClNO; 4-(diethylamino)but-2-ynyl(RS)-2-(cyclohex-3enyl)-2- cyclohexyl-2-hydroxyacetate hydrochloride
1354
Yes
+5C 3C
79
1784, 1793
Yes
+5C 3C
79
1793
Yes
+5C 3C
79
0943
Yes
+5C 3C
79
0943
Yes
+5C 3C
79
0198,0199
Yes
+5C 3C
79
0198,1030
Yes
+5C 3C
79
0779,0780
Yes
-20C 5C
90
0712,0779,0
780
Yes
-20C 5C
79
See leaflet CHNO
1794
Yes
+5C 3C
79
N-debenzoyl-N-hexanoylpaclitaxel
1794
Yes
+5C 3C
79
1794
Yes
+5C 3C
79
1794
Yes
+5C 3C
79
1794
Yes
+5C 3C
79
0229,0882,1
474,
1663,2058
Yes
+5C 3C
79
1779
Yes
+5C 3C
79
0350
Yes
+5C 3C
79
See leaflet
0350
Yes
+5C 3C
79
See leaflet
0350
Yes
+5C 3C
79
7,8-didehydro-4,5 alpha-epoxy-14-hydroxy-3-methoxy -17methylmorphinan-6-one (14-hydroxycodeinone)
60

Order
Reference Standard
Code
P0250000 Pancuronium bromide

per vial Unit
2
20 mg
1 Vecuronium impurity B
Information
Monograph Leaflet
Storage
0681,1769
Yes
+5C 3C
Extra
Price
charges
79
a
Y0000577 Pancuronium bromide for system suitability
20 mg
0681
Yes
+5C 3C
79
Y0000835 Pantoprazole sodium sesquihydrate
20 mg
2296
Yes
+5C 3C
79
New Y0001001 Pantoprazole for system suitability
0.506 mg
2296
Yes
+5C 3C
79
P0270000 Papaverine hydrochloride
25 mg
0102,0573
Yes
+5C 3C
79
P0300000 Paracetamol
50 mg
0049
Yes
+5C 3C
79
Y0000780 Paraffin (hard)
10 mg
1034
Yes
+5C 3C
79
Y0000058 Paraffin (liquid) - reference spectrum
n/a
0239,0240
79
Y0000913 Paraffin (White soft)
10 mg
1799
Yes
+5C 3C
79
Y0000912 Paraffin (Yellow soft)
10 mg
1554
Yes
+5C 3C
79
P0305000 Parnaparin sodium
200 mg
1252
Yes
+5C 3C
79
Y0000578 Paroxetine hydrochloride (anhydrous)
100 mg
2283
Yes
+5C 3C
79
Y0000579 Paroxetine hydrochloride (anhydrous) impurity C
10 mg
(3S,4R)-3-[(1,3-benzodioxol-5-yloxy)methyl]-1-benzyl-4-(4-fluorophenyl)
piperidine (N-benzylparoxetine)
2283
Yes
+5C 3C
79
Y0000581 Paroxetine hydrochloride (anhydrous) impurity H
10 mg
[(3S,4R)-1-benzyl-4-(4-fluorophenyl)piperidin-3-yl]methanol
2283
Yes
+5C 3C
79
Y0000281 Paroxetine hydrochloride hemihydrate
200 mg
See leaflet CHClFNO
2018,2283
Yes
+5C 3C
79
Y0000233 Paroxetine impurity A
15 mg
(3S,4R)-3-[[1,3-benzodioxol-5-yloxy]methyl]-4-phenylpiperidine
(desfluoroparoxetine) ; Batch 4 is valid until 30 September 2015
2018,2283
Yes
+5C 3C
79
New Y0000256 Paroxetine impurity D
10 mg
See leaflet; (3R,4S)-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)

piperidine
((+)-trans-paroxetine) ; Batch 2 is valid until 30 October 2015
2018,2283
Yes
+5C 3C
79
Y0000580 Paroxetine impurity E
5 mg
(3RS,4RS)-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4fluorophe- nyl)piperidine
(cis-paroxetine)
2283
Yes
+5C 3C
79
Y0000630 Paroxetine for system suitability
5 mg
2018
Yes
+5C 3C
79
P0309000 Pefloxacin mesilate dihydrate
200 mg
1460
Yes
+5C 3C
79
P0309020 Pefloxacin impurity B
10 mg
1-ethyl-6-chloro-7-(4-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3carboxylic acid (chlorinated homologue of pefloxacin)
1460
Yes
+5C 3C
79
P0309030 Pefloxacin impurity C
0.01 mg
1-ethyl-6-fluoro-5-(4-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3carboxylic acid (isopefloxacin)
1460
Yes
+5C 3C
79
Y0001539 Pemetrexed disodium heptahydrate
200 mg
See leaflet
2637
Yes
+5C 3C
79
Y0001538 Pemetrexed for system suitability
20 mg
2637
Yes
+5C 3C
79
2637
Yes
+5C 3C
79
1461
Yes
+5C 3C
79
1461
Yes
+5C 3C
79
New Y0001535 Pemetrexed impurity mixture
0.002 mg
P0307000 Penbutolol sulfate
100 mg
P0307005 Penbutolol impurity A
20 mg
P0310000 Penicillamine
100 mg
0566
Yes
+5C 3C
79
P0320000 Penicillamine disulfide
100 mg
See leaflet CHNOS; 3,3-(disulphanediyl)bis[(2S)-2-amino-3methylbutanoic] acid
0566
Yes
+5C 3C
79
P0400100 Pentaerythrityl tetranitrate diluted
600 mg
See leaflet CHNO
1355
Yes
+5C 3C
79

See leaflet CHNO; (2S)-1-[2-(cyclopent-1-enyl)phenoxy]-3-[(1,1dimethylethyl) amino]propan-2-ol
61

Order
Reference Standard
Code
P0405000 Pentamidine diisetionate

per vial Unit
2
30 mg
1
Information
Monograph Leaflet
1137,1436
Yes
Storage
+5C 3C
Extra
Price
charges
79
a
P0405500 Pentazocine - reference spectrum
n/a
1462
79
P0405510 Pentazocine hydrochloride - reference spectrum
n/a
1463
79
Y0000417 Pentazocine lactate - reference spectrum
n/a
2000
Y0001051 Pentetate sodium calcium
100 mg
2353
Yes
+5C 3C
P0500000 Pentobarbital - * psy
500 mg
0200,0419
Yes
P0510000 Pentoxifylline
100 mg
0851
Yes
Y0000076 Pentoxyverine hydrogen citrate - reference spectrum
n/a
Y0000098 Pentoxyverine impurity A
10 mg
1-phenylcyclopentanecarboxylic acid
1621
Y0000099 Pentoxyverine impurity B
10 mg
2-(diethylamino)ethyl 1-phenylcyclopentanecarboxylate (caramiphen)
P0525000 Pepsin powder
2000 mg
See leaflet
Y0000010 Pergolide mesilate
150 mg
See leaflet CHNOS
Y0000238 Perindopril tert-butylamine
40 mg
Y0000237 Perindopril impurity A
10 mg
Y0000771 Perindopril for peak identification
5 mg
Y0000207 Perindopril for stereochemical purity
40 mg
Y0001733 Permethrin (25:75)
350 mg
Y0001741 Permethrin for system suitability
60 mg
P0550000 Perphenazine
100 mg
Y0001045 Perphenazine for system suitability
5 mg
Y0000021 Pertussis toxin BRP
0.05 mg
P0600000 Pethidine hydrochloride - reference spectrum
n/a
P0600002 Pethidine impurity A
20 mg
P0800000 Phenazone
20 mg
Y0001138 Phenazone impurity A
20 mg
P0850000 Pheniramine maleate
250 mg
Y0001428 Pheniramine impurity A
20 mg
P0900000 Phenobarbital - * psy
200 mg
Y0001350 Phenobarbital impurity A
15 mg
Y0001351 Phenobarbital impurity B
15 mg
P0950000 Phenoxyethanol
1 mL
P1000000 Phenoxymethylpenicillin
250 mg
79
79
+5C 3C
79
+5C 3C
79
79
Yes
+5C 3C
79
1621
Yes
+5C 3C
79
0682
Yes
+5C 3C
79
1555
Yes
+5C 3C
79
2019
Yes
+5C 3C
79
2019
Yes
+5C 3C
79
2019
Yes
+5C 3C
79
2019
Yes
+5C 3C
79
1762
Yes
+5C 3C
79
1762
Yes
+5C 3C
79
0629,0904
Yes
+5C 3C
79
0629
Yes
+5C 3C
79
See leaflet,
1356, 1595,
1931, 1932,
1933, 1934,
2065, 2067,
2329
Yes
-20C 5C
90
79
1621
(2S,3aS,7aS)-octahydro-1Hindole-2-carboxylic acid
see leaflet
See leaflet
0420
1-methyl-4-phenylpiperidine (MPP)
5-methyl-2-phenyl-2,4-dihydro-3-pyrazol-3-one
0420
Yes
+5C 3C
79
0421
Yes
+5C 3C
79
0421
Yes
+5C 3C
79
1357, 0977
Yes
+5C 3C
79
1357
Yes
+5C 3C
79
0189,0201,0
630
Yes
+5C 3C
79
0201
Yes
+5C 3C
79
0201
Yes
+5C 3C
79
0781
Yes
+5C 3C
79
0148
Yes
+5C 3C
79
2-benzylpyridine
See leaflet CHNO
62

Order
Reference Standard
Code
P1100000 Phenoxymethylpenicillin potassium

per vial Unit
4
250 mg
1 See leaflet CHKNOS
Y0001127 Phentolamine mesilate
P1109000 Phentolamine mesilate - reference spectrum

Y0001251 Phentolamine for system suitability
P1150000 Phenylalanine
P1200000 Phenylbutazone
Information
Monograph Leaflet
Storage
Extra
Price
charges
79
a
0113,0114,0
148, 0149
Yes
+5C 3C
Yes
+5C 3C
79
10 mg
1138
n/a
1138
79
10 mg
1138
Yes
+5C 3C
79
60 mg
0782,2575
Yes
+5C 3C
79
100 mg
0422,1574
Yes
+5C 3C
79
Y0000147 Phenylbutazone impurity B
20 mg
0422
Yes
+5C 3C
79
P1240000 Phenylephrine
60 mg
1035
Yes
+5C 3C
79
P1250000 Phenylephrine hydrochloride
50 mg
0632,1205
Yes
+5C 3C
79
Y0000683 Phenylephrine hydrochloride for peak identification
2.0044 mg
0632,1035
Yes
+5C 3C
79
Y0000229 Phenylmercuric acetate - reference spectrum
n/a
2042
79
P1255100 Phenylmercuric borate - reference spectrum
n/a
0103
79
P1260000 Phenylpropanolamine hydrochloride - * Drug Precursor
50 mg
P1290000 Phenytoin
100 mg
P1300000 Phenytoin sodium
250 mg
Y0001167 Phenytoin for system suitability
20 mg
Y0000493 Phloroglucinol (anhydrous)
220 mg
Y0000761 Pholcodine - * narc
10 mg
Y0000798 Pholcodine for peak identification - * narc
10 mg
Y0000766 Phthalic acid
20 mg
P1500000 Phthalylsulfathiazole
100 mg
P1600000 Physostigmine salicylate
100 mg
P1609000 Phytomenadione
150 mg
Y0001104 Picosulfate for system suitability
0.5 mg
P1645000 Picotamide monohydrate
125 mg
P1645005 Picotamide impurity A
25 mg
Y0001508 Picrotin
40 mg
Y0001528 Picrotoxinin
40 mg
See leaflet CHO
Y0000124 Pidolate impurity B
110 mg
(2S)-2-[[[(2S)-5-oxopyrrolidin-2-yl]carbonyl]amino]pentane-dioic acid
Y0000123 Pidolic acid
125 mg
P1650000 Pilocarpine hydrochloride
50 mg
P1700000 Pilocarpine nitrate
50 mg
Y0000106 Pilocarpine nitrate for system suitability
Y0000525 Pimobendan
Y0000401 Pimobendan for system suitability
(4-butyl-4-hydroxy-1,2-diphenyl-3,5)-pyrazolidinedione
Norephedrin hydrochloride
0683
Yes
+5C 3C
79
1253,1988
Yes
+5C 3C
79
0521
Yes
+5C 3C
79
0521,1253
Yes
+5C 3C
79
2301,2302
Yes
+5C 3C
79
0522
Yes
+5C 3C
79
0522
Yes
+5C 3C
79
2348
Yes
+5C 3C
79
0352
Yes
+5C 3C
79
0286
Yes
+5C 3C
79
1036
Yes
+5C 3C
79
1031
Yes
+5C 3C
79
1358
Yes
+5C 3C
79
1358
Yes
+5C 3C
79
2486
Yes
+5C 3C
79
2486
Yes
+5C 3C
79
1619
Yes
+5C 3C
79
1619
Yes
+5C 3C
79
0633
Yes
+5C 3C
79
0104
Yes
+5C 3C
79
20 mg
0104,0633
Yes
+5C 3C
79
10 mg
2179
Yes
+5C 3C
79
0.1 mg
2179
Yes
+5C 3C
79

benzene-1,2-dicarboxylic acid
see leaflet; Vitamin K1
4-methoxybenzene-1,3-dicarboxylic acid
63

Order
Code
P1750000 Pimozide
Reference Standard

per vial Unit
1
150 mg
1
Information
Monograph Leaflet
Storage
Extra
Price
charges
79
a
1254
Yes
+5C 3C
0634,0871
Yes
+5C 3C
79
2601
Yes
+5C 3C
79
P1800000 Pindolol
100 mg
Y0001520 Pioglitazone hydrochloride
120 mg
Y0001519 Pioglitazone for system suitability
15 mg
2601
Yes
+5C 3C
79
Y0001476 Pipemidic acid trihydrate
15 mg
1743
Yes
+5C 3C
79
Y0000061 Pipemidic acid trihydrate - reference spectrum
n/a
79
P1890000 Piperacillin
100 mg
1168,1169
Yes
+5C 3C
79
P1900000 Piperazine adipate
250 mg
0423
Yes
+5C 3C
79
P2000000 Piperazine citrate
250 mg
0424
Yes
+5C 3C
79
P2100000 Piperazine hydrate
250 mg
0425
Yes
+5C 3C
79
Y0001217 Piperine
30 mg
See leaflet CHNO
2453,2477
Yes
+5C 3C
79
Y0000288 Piracetam
150 mg
See leaflet CHNO
1733
Yes
+5C 3C
79
Y0000038 Pirenzepine dihydrochloride monohydrate
250 mg
2001
Yes
+5C 3C
79
P2120000 Piretanide
100 mg
1556
Yes
+5C 3C
79
Y0001458 Piretanide for system suitability
10 mg
1556
Yes
+5C 3C
79
P2130000 Piroxicam
50 mg
0944
Yes
+5C 3C
79
Y0001475 Piroxicam for system suitability
15 mg
0944
Yes
+5C 3C
79
P2150000 Pivampicillin
50 mg
see leaflet
0808,0852
Yes
+5C 3C
79
P2152000 Pivmecillinam hydrochloride
100 mg
See leaflet CHClNOS
1359
Yes
-20C 5C
79
P2152015 Pivmecillinam impurity C
10 mg
methylene 2,2-dimethylpropanoate (2RS,4S)-2-[[[(hexahydo- 1H-azepin-1-yl)

methylene]amino]methyl]-5,5-dimethylthiazolidin-4-carboxylate
1359
Yes
+5C 3C
79
P2155001 Plastic additive 01
2 ml
(2RS)-2-ethylhexyl) benzene-1,2-dicarboxylate
90001,9000
2, 30114
Yes
+5C 3C
79
100 mg
N,N'-ethylenedialcanamide
90001,30114
Yes
+5C 3C
79
E0800000 Plastic additive 04
500 mg
Epoxidised soya oil
90001,30114
Yes
+5C 3C
79
500 mg
Epoxidised linseed oil
90001,30114
Yes
+5C 3C
79
500 mg
ethylene bis[3,3-bis[3-(1,1-dimethylethyl)-4-hydroxyphenyl]butanoate]
Yes
+5C 3C
79
250 mg
See leaflet; pentaerythrityl tetrakis[3-(3,5-di-tert-butyl-4-hydroxyphenyl)

propionate]
30103,3010
4,
30105,3010
30103,3010
Yes
+5C 3C
79
250 mg
4,4',4''-(2,4,6-trimethylbenzene-1,3,5-triyltrismethylene)trio[2,6-bis(1,1dimethylethyl)phenol]
Yes
+5C 3C
79
500 mg
Octadecyl 3-(3,5-di-tert-butyl-4-hydroxyphenyl)-propionate
Yes
+5C 3C
79
250 mg
Tris (2,4-di-1,1-dimethylethylphenyl) phosphite R
Yes
+5C 3C
79
250 mg
1,3,5-tris(3,5-di-1,1-dimethylethyl-4-hydroxybenzyl)-1H,3H,5H-1,3,5triazine-2,4,6-trione
Yes
+5C 3C
79
See leaflet CHClNOS
1743
See leaflet CHNOS
64
5,
30106,3010
30103,3010
5,
30106,3010
30103,3010
5,
30106,3010
30103,3010
5,
30106,3010
30103,3010
5, 30106

Order
Reference Standard
Code

Information
per vial Unit
2
250 mg
1 2,2'-Di(octadecycloxy)-5,5'-spirobi(1,3,2-dioxaphosphorinane) R
Monograph Leaflet
Storage
Extra
Price
charges
79
a
30103,3010
5, 30106
Yes
+5C 3C
30103,3010
4,
30105,3010
30103,3010
Yes
+5C 3C
79
Yes
+5C 3C
79
30103,3010
5, 30106
Yes
+5C 3C
79
30103
Yes
+5C 3C
79
30103,3010
5,
30106,3010
30103,
Yes
+5C 3C
79
Yes
+5C 3C
79
Yes
+5C 3C
79
500 mg
Dioctadecyl disulphide
250 mg
Didodecyl 3,3'-thiodipropionate R
250 mg
Dioctadecyl 3,3'-thiodipropionate R
50 mg
O0140000 Plastic additive 20
100 mg
Oleamide R
E1260000 Plastic additive 21
100 mg
Erucamide R
100 mg
Copolymer of dimethyl butanedioate and 1-(2-hydroxyethyl)-2,2,6,6tetramethylpiperidin-4-ol

Synonyms: copolymer of dimethyl succinate and (4-hydroxy-2,2,6,6tetramethylpiperidin-1-yl)ethanol
200 mg
di(isooctyl)2,2'-[(dioctylstannylene)bis(thio)]diacetate
containing about 27% of (tri(isooctyl)2,2',2''- [monooctyl- stannylidyne)tris
(thio)] triacetate.
30110,30111
Yes
+5C 3C
79
P2160000 Poliomyelitis vaccine (inactivated) BRP
0.5 ml
See leaflet
0214,2066,2
065,
2328,2061,2
067,
1934,2329,2
0720
Yes
-80C 10C
90
P2161000 Poliomyelitis vaccine (oral) BRP
1 ml
See leaflet
See leaflet,
0215
Yes
-20C 5C
90
P2163920 Poloxamer 124
30 mg
1464
Yes
+5C 3C
79
100 mg
1464
Yes
+5C 3C
79
100 mg
1464
Yes
+5C 3C
79
100 mg
1464
Yes
+5C 3C
79
100 mg
1464
Yes
+5C 3C
79
Y0001557 Poly (vinyl acetate)
100 mg
1962
Yes
+5C 3C
79
Y0000792 Poly(vinyl acetate) dispersion 30 per cent
1500 mg
2152
Yes
+5C 3C
79
Y0001550 Poly(vinyl alcohol)
100 mg
1961
Yes
+5C 3C
79
P2600000 Poly(vinyl chloride)
100 mg
90001,9000
2, 30114
Yes
+5C 3C
79
P2170000 Polyacrylate - reference spectrum
n/a
79
P2400000 Polymyxin B sulfate
25 mg
Yes
+5C 3C
79
25 mg
See leaflet
Y0000355 Polymyxin B sulfate for microbiological assay

5, 30106
30105,
30106,
30107
30103
0733
65
0203
79
20702
Yes
-20C 5C
a

Order
Reference Standard
Code
Y0001712 Polyoxypropylene stearyl ether

per vial Unit
1
250 mg
1
Information
Monograph Leaflet
2602
Yes
Storage
+5C 3C
Extra
Price
charges
79
a
Y0000289 Polysorbate 20 - reference spectrum
n/a
0426
79
n/a
1914
79
n/a
0427
79
n/a
0428
79
P2649610 Potassium clavulanate - reference spectrum
n/a
Y0001168 Potassium clavulanate impurity G
5 mg
Y0000315 Potassium hydrogen aspartate hemihydrate
50 mg
P2650000 Potassium sorbate
100 mg
Y0001275 Potassium sucrose octasulfate
100 mg
P2660000 Povidone
50 mg
Y0000466 Povidone (iodinated)
10 mg
Y0001266 Pramipexole dihydrochloride monohydrate
5 mg
Y0001267 Pramipexole impurity D
5 mg
Y0001187 Pramipexole for system suitability
15 mg
Y0000215 Pravastatin sodium - reference spectrum
n/a
Y0000223 Pravastatin impurity A
0.1 mg
(3R,5R)-3,5-dihydroxy-7-[(1S,2S,6R,8S,8aR)-6-hydroxy-2-methyl-8[[(2S)-2-methylbutanoyl]oxy]-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]
heptanoic acid (6'-epipravastatin)
2059
Yes
Y0000204 Pravastatin 1,1,3,3-tetramethylbutylamine
30 mg
See leaflet CHO
2059
P2669000 Prazepam -* psy
50 mg
P2670000 Praziquantel
200 mg
Y0001533 Praziquantel for system suitability
10 mg
P2680000 Prazosin hydrochloride
30 mg
P2698000 Prednicarbate
100 mg
See leaflet CHO
Y0001630 Prednicarbate for system suitability A
10 mg
P2700000 Prednisolone
150 mg
Y0001359 Prednisolone for peak identification
10 mg
Y0001355 Prednisolone for system suitability
10 mg
P2800000 Prednisolone acetate
120 mg
Y0000582 Prednisolone acetate for peak identification
P2804000 Prednisolone hexanoate
P2805000 Prednisolone pivalate
79
1653,1140
1140
Yes
-20C 5C
79
2076
Yes
+5C 3C
79
0618
Yes
+5C 3C
79
1796
Yes
+5C 3C
79
0685
Yes
+5C 3C
79
1142
Yes
+5C 3C
79
2416
Yes
+5C 3C
79
2416
Yes
+5C 3C
79
2416
Yes
+5C 3C
79
2059
79
-20C 5C
79
Yes
-20C 5C
79
1466
Yes
+5C 3C
79
0855
Yes
+5C 3C
79
0855
Yes
+5C 3C
79
0856
Yes
+5C 3C
79
1467
Yes
+5C 3C
79
1467
Yes
+5C 3C
79
0335,0353,0
354, 0735
Yes
+5C 3C
79
0353
Yes
+5C 3C
79
0353
Yes
+5C 3C
79
0734,0736,0
933,
0975,1467,0
334
Yes
+5C 3C
79
10 mg
0734
Yes
+5C 3C
79
10 mg
1212
Yes
+5C 3C
79
120 mg
0734,0736
Yes
+5C 3C
79
See leaflet CHKOS
(6R)-6-N-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine ; Batch 1 is
See leaflet
66

Order
Reference Standard
Code
P2810000 Prednisolone sodium phosphate

per vial Unit
4
100 mg
1
Information
Monograph Leaflet
Storage
Extra
Price
charges
79
a
0549,0735,0
810
Yes
+5C 3C
0354
Yes
+5C 3C
79
P2900000 Prednisone
100 mg
P2920000 Pregnenolone isobutyrate
200 mg
0593,0993,2
397
Yes
-20C 5C
79
Y0000263 Prekallikrein activator in albumin BRP
200 mg
See leaflet,
20615
Yes
-20C 5C
90
P2939000 Prilocaine
150 mg
1362
Yes
+5C 3C
79
P2939060 Prilocaine hydrochloride
100 mg
1363
Yes
+5C 3C
79
Y0001408 Prilocaine impurity B
80 mg
2-methylbenzenamine hydrochloride
1362,1363
Yes
+5C 3C
79
P2939025 Prilocaine impurity E
25 mg
(RS)-N-(methylphenyl)-2-(propylamino)propanamide
1362,1363
Yes
+5C 3C
79
Y0001681 Prilocaine for peak identification
20 mg
1363
Yes
+5C 3C
79
P2940000 Primaquine diphosphate
500 mg
0635
Yes
+5C 3C
79
P2950000 Primidone
150 mg
0584
Yes
+5C 3C
79
Y0000369 Primidone for peak identification
10 mg
0584
Yes
+5C 3C
79
P3000000 Probenecid
100 mg
0243
Yes
+5C 3C
79
P3050000 Procainamide hydrochloride
100 mg
0567
Yes
+5C 3C
79
P3090000 Procaine benzylpenicillin
250 mg
P3100000 Procaine hydrochloride
100 mg
P3200000 Prochlorperazine maleate
100 mg
P3300000 Progesterone
110 mg
See leaflet
Y0001667 Progesterone for impurity H identification
20 mg
see leaflet
Y0001666 Progesterone for peak identification
5 mg
Y0001665 Progesterone for system suitability
5 mg
Y0000179 Proguanil hydrochloride - reference spectrum
n/a
Y0000181 Proguanil impurity C
10 mg
1,5-bis(4-chlorophenyl)biguanide
2002
Yes
Y0000182 Proguanil impurity D
10 mg
1,5-bis(1-methylethyl)biguanide
2002
Yes
P3350000 Proline
60 mg
P3390000 Promazine hydrochloride
40 mg
P3400000 Promethazine hydrochloride
50 mg
Y0000769 Promethazine impurity D
15 mg
Y0000797 Promethazine for peak identification
5 mg
P3490000 Propacetamol hydrochloride - reference spectrum
n/a
Y0000455 Propafenone hydrochloride
10 mg
Y0000456 Propafenone impurity B
10 mg
Y0000278 Propanol - reference spectrum
n/a
See leaflet
0115
Yes
+5C 3C
79
0050
Yes
+5C 3C
79
0244
Yes
+5C 3C
79
01/2015:0429
Yes
+5C 3C
79
0429
Yes
+5C 3C
79
0429
Yes
+5C 3C
79
0429
Yes
+5C 3C
79
2002
79
+5C 3C
79
+5C 3C
79
0785
Yes
+5C 3C
79
0475,1365
Yes
+5C 3C
79
0524
Yes
+5C 3C
79
0524
Yes
+5C 3C
79
0524
Yes
+5C 3C
79
1366
79

(2RS)-N,N-dimethyl-1-(10H-phenothiazin-10-yl)propan-2-amine S-oxide
(2E)-1-[2-[(2RS)-2-hydroxy-3-(propylamino)propoxy]phenyl]-3phenylprop-2-en-1-one
2103
Yes
+5C 3C
79
2103
Yes
+5C 3C
79
79
2036
67

Order
Code
Y0000016 Propofol
Reference Standard
Y0000018 Propofol impurity J

Information
per vial Unit
6
650 mg
1 See leaflet ; Batch 5 is valid until 31 December 2014
4
20 mg
1 2,6-bis (1-methylethyl)-1,4-benzoquinone ; Batch 3 is valid until 31 January
2015
Monograph Leaflet
Storage
Extra
Price
charges
79
a
1558
Yes
+5C 3C
1558
Yes
+5C 3C
79
Y0000017 Propofol for peak identification
0.1 ml
1558
Yes
+5C 3C
79
P3500000 Propranolol hydrochloride
30 mg
0568,0923
Yes
+5C 3C
79
P3600000 Propranolol hydrochloride for performance test
15 mg
0568
Yes
+5C 3C
79
Y0001547 Propylene glycol
150 mg
1403,1804,2
645
Yes
+5C 3C
79
Y0000318 Propylene glycol dilaurate
100 mg
2087
Yes
+5C 3C
79
Y0000319 Propylene glycol monolaurate
100 mg
1915
Yes
+5C 3C
79
P3640000 Propyl gallate
50 mg
1039
Yes
+5C 3C
79
P3650000 Propyl parahydroxybenzoate
150 mg
See leaflet CHO
0431,0852,1
263
Yes
+5C 3C
79
P3700000 Propylthiouracil
100 mg
0525
Yes
+5C 3C
79
P3750000 Propyphenazone
200 mg
0636
Yes
+5C 3C
79
P3760000 Protirelin
5.03 mg
See leaflet CHNO
1144
Yes
-20C 5C
79
P3760020 D-His-Protirelin
0.1 mg
approx. 0.1 mg per vial
1144
Yes
-20C 5C
79
P3800000 Proxyphylline
100 mg
0526
Yes
+5C 3C
79
P3850000 Pseudoephedrine hydrochloride - * Drug Precursor
50 mg
0487,1367
Yes
+5C 3C
79
Y0000387 Pseudoisoeugenyl 2-methylbutyrate for peak

identification
100 mg
2108
Yes
+5C 3C
79
Y0001537 Purified quillaia saponins
30 mg
1843
Yes
-20C 5C
79
P3900000 Purpureaglycoside A
25 mg
0117
Yes
+5C 3C
79
P4000000 Purpureaglycoside B
25 mg
0117
Yes
+5C 3C
79
Y0000402 Pyrantel embonate
10 mg
1680
Yes
+5C 3C
79
Y0000403 Pyrantel impurity A
20 mg
1680
Yes
+5C 3C
79
P4050000 Pyrazinamide
30 mg
0859
Yes
+5C 3C
79
P4099900 Pyridostigmine bromide
30 mg
1255
Yes
+5C 3C
79
P4099910 Pyridostigmine impurity A
20 mg
pyridin-3-yl-dimethylcarbamate
1255
Yes
+5C 3C
79
Y0001486 Pyridostigmine impurity B
10 mg
3-hydroxy-1-methylpyridinium
1255
Yes
+5C 3C
79
P4100000 Pyridoxine hydrochloride
100 mg
0245
Yes
+5C 3C
79
Y0001226 Pyridoxine impurity A
5 mg
6-methyl-1,3-dihydrofuro[3,4-c]pyridin-7-ol ; Batch 2 is valid until 31

December 2014
0245
Yes
+5C 3C
79
P4200000 Pyrimethamine
250 mg
0288
Yes
+5C 3C
79
Y0000659 Pyrrolidone
20 mg
2180
Yes
+5C 3C
79
Y0001009 Quercetin dihydrate
25 mg
1827
Yes
+5C 3C
79
Y0001657 Quetiapine fumarate
50 mg
2541
Yes
+5C 3C
79
2.005 mg
Y0001419 Quetiapine for system suitability

Star anise oil
1-methyl-2-[(Z)-2-(thiophen-2-yl)ethenyl]-1,4,5,6-tetrahydropyrimidine
See leaflet CHO ; Batch 2 is valid until 31 July 2015
68
79
2541
Yes
+5C 3C
a

Order
Reference Standard
Code
Y0001564 Quillaia saponin for assay

Information
per vial Unit
1
30 mg
1 See leaflet CHNO; monoammonium glycyrrhizate
Monograph Leaflet
Storage
1843
Yes
+5C 3C
Extra
Price
charges
79
a
Y0001491 Quinapril hydrochloride
30 mg
1763
Yes
+5C 3C
79
Y0001502 Quinapril for peak identification
5.075 mg
1763
Yes
+5C 3C
79
Y0001503 Quinapril for system suitability
5.125 mg
1763
Yes
+5C 3C
79
Q0100000 Quinidine sulfate
300 mg
0017,0018,0
019
Yes
+5C 3C
79
Q0200000 Quinine sulfate
300 mg
0017,0018,0
019
Yes
+5C 3C
79
R0100000 Rabies vaccine (inactivated) for veterinary use BRP
86 mg
See leaflet
See leaflet,
0451
Yes
-20C 5C
90
Y0000896 Racecadotril
110 mg
See leaflet CHNOS
2171
Yes
+5C 3C
79
Y0000897 Racecadotril impurity A
1.1 mL
See leaflet CHCOSH; ethanethioic acid
2171
Yes
+5C 3C
79
Y0000898 Racecadotril impurity G
10 mg
benzyl [[(2RS)-2-benzyl-3-sulfanylpropanoyl]amino]acetate
2171
Yes
+5C 3C
79
Y0000902 Racecadotril for peak identification
5 mg
2171
Yes
+5C 3C
79
Y0001134 Raloxifene hydrochloride
110 mg
2375
Yes
+5C 3C
79
Y0001135 Raloxifene for peak identification
10 mg
2375
Yes
+5C 3C
79
R0145000 Ramipril
20 mg
1368
Yes
+5C 3C
79
R0145005 Ramipril impurity A
10 mg
(2S,3aS,6aS)-1-[(S)-2-[[(S)-1-(methoxycarbonyl)-3- phenylpropyl]amino]
propanoyl]octahydrocyclopenta[b]pyrrole-2-carboxylic acid (ramipril
methylester)
1368
Yes
+5C 3C
79
R0145010 Ramipril impurity B
10 mg
(2S,3aS,6aS)-1-[(S)-2-[[(S)-1-[(methylethoxy)carbonyl]-3- phenylpropyl]
amino]propanoyl]octahydrocyclopenta[b]pyrrole- 2-carboxylic acid (ramipril
isopropyl ester)
1368
Yes
+5C 3C
79
R0145015 Ramipril impurity C
10 mg
(2S,3aS,6aS)-1-[(S)-2-[[(S)-1-(ethoxycarbonyl)-3-cyclohexylpropyl]amino]
propanoyl]octahydrocyclopenta[b]pyrrole-2- carboxylic acid
(hexahydroramipril)
1368
Yes
+5C 3C
79
R0145020 Ramipril impurity D
10 mg
1368
Yes
+5C 3C
79
R0150000 Ranitidine hydrochloride
100 mg
ethyl (2S)-2-[(3S,5aS,8aS,9aS)-3-methyl-1,4-dioxodecahydro -1Hcyclopenta[e]pyrrolo[1,2a]pyrazin-2-yl]-4-phenylbutanoate (ramipril

diketopiperazine)
0946,1453
Yes
+5C 3C
79
Y0000416 Ranitidine impurity J
0.00025
mg
0946
Yes
-20C 5C
79
Y0000411 Ranitidine for system suitability
20 mg
0946
Yes
-20C 5C
79
Y0001565 Recombinant Major Allergen rBet v 1
0.01025 mg 1
See leaflet
1063
Yes
-20C 5C
90
Y0001566 Recombinant Major Allergen rPhl p 5a
0.00856 mg 1
See leaflet
1063
Yes
-20C 5C
90
Y0000457 Repaglinide
20 mg
2135
Yes
+5C 3C
79
Y0000459 Repaglinide impurity E
10 mg
2-ethoxy-4-[2-[[(1R)-3-methyl-1-[2-(piperidin-1-yl)phenyl]butyl]amino]-2oxoethyl]benzoic acid
2135
Yes
+5C 3C
79
6 mg
2135
Yes
+5C 3C
79
100 mg
See leaflet CHNO
0528
Yes
+5C 3C
79
1.4 mL

69
New Y0000458 Repaglinide for system suitability

R0200000 Reserpine
New R0250000 Residual solvent solution class 1
See leaflet CHClNOS
1,1'-N-[methylenebis(sulphanediylethylene)]bis(N'-methyl-2-nitroethene-1,1diamine)
79
20424
Yes
+5C 3C
a

Order
Code
Y0000767 Resorcinol
Reference Standard
Y0001194 Resveratrol

per vial Unit
1
20 mg
1 benzene-1,3-diol
1
20 mg
1 See leaflet CHO
Information
Monograph Leaflet
2348
Yes
Storage
+5C 3C
Extra
Price
charges
79
a
2433
Yes
-20C 5C
79
0218,0219,0
220,
1192,1193,
2398
Yes
-20C 5C
79
0217,0218,0
219, 0220
Yes
+5C 3C
79
2109
Yes
+5C 3C
79
0292,0786
Yes
+5C 3C
79
0292
Yes
+5C 3C
79
0786
Yes
+5C 3C
79
2090
Yes
+5C 3C
79
See leaflet CHNO
1657
Yes
+5C 3C
79
1-(2-methylpropyl)piperidin-4-one
1657
Yes
+5C 3C
79
0052
Yes
+5C 3C
79
0052
Yes
+5C 3C
79
0432,20702
Yes
-20C 5C
79
0432
Yes
+5C 3C
79
0432
Yes
+5C 3C
79
2362
Yes
+5C 3C
79
2362
Yes
+5C 3C
79
79
2020
Yes
+5C 3C
79
2572
Yes
+5C 3C
79
2572
Yes
+5C 3C
79
2572
Yes
+5C 3C
79
1559
Yes
+5C 3C
79
3-[2-[4-(1,2-benzisoxazol-3-yl)piperidin-1-yl]ethyl]-2-methyl-6,7,8,9tetrahydro-4Hpyrido[1,2-a]pyrimidin-4-one (desfluoro risperidone)
1559
Yes
+5C 3C
79
1559
Yes
+5C 3C
79
See leaflet CHNOS
2136
Yes
+5C 3C
79
R0300000 Retinol acetate
1000 mg
R0290000 Retinol esters
100 mg
Y0000377 Ribavirin
150 mg
See leaflet CHNO
R0600000 Riboflavin
130 mg
Vitamin B2
Y0000757 Riboflavin for peak identification
0.12 mg
R0630000 Riboflavin sodium phosphate
250 mg
Y0000662 Ribonucleic acid
100 mg
See leaflet
Y0000149 Rifabutin
150 mg
Y0000184 Rifabutin impurity A
20 mg
R0700000 Rifampicin
100 mg
R0800000 Rifampicin quinone
100 mg
R1000000 Rifamycin sodium
150 mg
see leaflet CHNNaO ; Batch 3 is valid until 30 September 2015
R0900000 Rifamycin B
25 mg
See leaflet CHNO; Rifamycin impurity A ; Batch 2 is valid until 31 July

2015
R0950000 Rifamycin S
100 mg
Y0001074 Rifaximin
160 mg
Y0001075 Rifaximin for system suitability
10 mg
Y0000250 Rilmenidine dihydrogenophosphate - reference spectrum
n/a
2020
Y0000187 Rilmenidine for system suitability
30 mg
Y0001541 Risedronate sodium 2.5-hydrate
15 mg
Y0001558 Risedronate impurity A
15 mg
See leaflet
Y0001540 Risedronate impurity E
15 mg
2-(pyridin-3-yl)ethane-1,1-diyl]bis(phosphonic acid)
R1000600 Risperidone
50 mg
Y0001276 Risperidone impurity K
0.015 mg
Y0000370 Risperidone for system suitability
20 mg
Y0000714 Ritonavir
80 mg
See leaflet
See leaflet
Y0000706 Ritonavir for peak identification
10 mg
2136
Yes
+5C 3C
79
New Y0001516 Rivastigmine hydrogen tartrate
350 mg
See leaflet CHNO ; Batch 1 is valid until 30 September 2015
2629,2630
Yes
+5C 3C
79
Y0001515 Rivastigmine impurity D
10 mg
3-[(1R)-1-(dimethylamino)ethyl]phenyl ethyl(methyl)carbamate ((R)enantiomer)
2629,2630
Yes
+5C 3C
79
Y0001485 Rivastigmine for system suitability
1.0114 mg
2629,2630
Yes
+5C 3C
79
70

Order
Reference Standard
Code
Y0001302 Rizatriptan benzoate

per vial Unit
1
200 mg
1 See leaflet CHNO
Information
Monograph Leaflet
2585
Y0001303 Rizatriptan for system suitability
15 mg
R1300000 RK 13 cells
1 ml
Y0001580 Rocuronium bromide
10 mg
Y0000527 Rocuronium for peak identification
10 mg
Y0000742 Ropivacaine hydrochloride monohydrate
10 mg
Y0000743 Ropivacaine impurity G
5 mg
(+)-(2R)-N-(2,6-dimethylphenyl)-1-propylpiperidine-2-carboxamide ((R)ropivacaine)
Y0000786 Rosmarinic acid
50 mg
See leaflet CHO ; Batch 2 is valid until 30 September 2015
Y0001719 Rosuvastatin Calcium
100 mg
Y0001722 Rosuvastatin impurity G
10 mg
Y0001721 Rosuvastatin for system suitability
15 mg
R1500000 Roxithromycin
125 mg
Y0000220 Roxithromycin for system suitability
10 mg
R2000000 Rubella vaccine (live) BRP
90 mg
See leaflet; One sale unit is composed of a bag of 5 vials. The unit quantity of
each vial is 18 mg.
Y0000494 Ruscogenins
10 mg
See leaflet
Y0000105 Rutoside trihydrate
100 mg
See leaflet CHO
S0040000 Saccharin
30 mg
S0050000 Saccharin sodium
50 mg
S0100000 Salbutamol
50 mg
Y0000030 Salbutamol impurity B
10 mg
(1RS)-2-[(1,1-dimethylethyl)amino]-1-(4-hydroxyphenyl)ethanol
Y0000071 Salbutamol impurity D
10 mg
5-[(1RS)-2-[(1,1-dimethylethyl)amino]-1-hydroxyethyl]-2hydroxybenzaldehyde
Y0000031 Salbutamol impurity F
10 mg
See leaflet; 1,1'-[oxybis[methylene(4-hydroxy-1,3-phenylene)]]bis[2-[(1,1dimethylethyl)amino]ethanol] ; Batch 4 is valid until 31 August 2014
Y0000034 Salbutamol impurity G
5 mg
Y0000032 Salbutamol impurity I
0.006 mg
Y0001186 Salbutamol impurity J
S0150000 Salbutamol sulfate
50 mg
Y0001288 Salbutamol sulfate for system suitability
10 mg
Y0000669 Salicin
50 mg
See leaflet CHO
S0200000 Salicylic acid
100 mg
2585
cell lines (kidney, rabbit) titration of live measles, mumps and rubella vaccines 0162,1057
Yes
Storage
+5C 3C
Extra
Price
charges
79
a
Yes
+5C 3C
79
Yes
Liquid nitrogen
100
1764
Yes
-20C 5C
79
1764
Yes
-20C 5C
79
2335
Yes
+5C 3C
79
2335
Yes
+5C 3C
79
1447,2382,
2524
Yes
+5C 3C
79
See leaflet CHCaFNOS
2631
Yes
+5C 3C
79
(3S,5R,6E)-7-[4-(4-fluorophenyl)-6-(1-methylethyl)-2-[methyl
(methylsulfonyl)amino]pyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid
2631
Yes
+5C 3C
79
2631
Yes
+5C 3C
79
1146
Yes
+5C 3C
79
See leaflet CHNO
1146
Yes
+5C 3C
79
1057,0162,2
442
Yes
-80C 10C
90
1847
Yes
+5C 3C
79
1795,1874,2
184,
2427,2639
Yes
+5C 3C
79
0947
Yes
+5C 3C
79
0787
Yes
+5C 3C
79
0529,1033
Yes
+5C 3C
79
0529
Yes
+5C 3C
79
0529,0687
Yes
+5C 3C
79
0529,0687
Yes
+5C 3C
79
2-[benzyl(1,1-dimethylethyl)amino]-1-[4-hydroxy-3-(hydroxymethyl)phenyl]
ethanone
0529
Yes
+5C 3C
79
(1RS)-2-[(1,1-dimethylethyl)amino]-1-[3-(hydroxymethyl)-4benzyloxyphenyl]ethanol
0529
Yes
+5C 3C
79
0687
Yes
+5C 3C
79
0687
Yes
+5C 3C
79
0687
Yes
+5C 3C
79
2312,1583
Yes
+5C 3C
79
0366,1185
Yes
+5C 3C
79
0.00045 mg 1
71

Order
Reference Standard
Code
Y0000405 Salicylic acid impurity B
Y0000422 Salmeterol xinafoate

per vial Unit
2
10 mg
1 4-hydroxyisophthalic acid
2
70 mg
1 see leaflet
Information
Monograph Leaflet
Storage
Extra
Price
charges
79
a
0366
Yes
+5C 3C
1765
Yes
+5C 3C
79
1765
Yes
+5C 3C
79
Y0001625 Salmeterol xinafoate for peak identification
15 mg
Y0000423 Salmeterol xinafoate for system suitability
25 mg
1765
Yes
+5C 3C
79
Y0001559 Salvianolic acid B
15 mg
See leaflet CHO
2663
Yes
+5C 3C
79
Y0001052 Santonin
20 mg
See leaflet
1391,1809
Yes
+5C 3C
79
Y0001049 Saquinavir mesilate
70 mg
See leaflet CHNOS
2267
Yes
+5C 3C
79
Y0001056 Saquinavir for system suitability
0.3033 mg
2267
Yes
+5C 3C
79
Y0001483 Saw palmetto extract HRS
8000 mg
1848, 2579
Yes
-20C 5C
79
Y0000814 Selamectin
120 mg
2268
Yes
+5C 3C
79
Y0001734 Selamectin for peak identification
5 mg
2268
Yes
+5C 3C
79
Y0001661 Selamectin impurity B
0.005 mg
(2aE,2S,4E,5S,6S,6R,7S,8E,11R,15S,17aR,20Z,20aR,20bS)6-cyclohexyl-7-[(2,6-didsoxy-3-O-mthyl-L-arabino-hexopyranosyl)oxy]-20b-hydroxy20-(hydroxyimino)-5,6,8,19-ttramthyl5,6,6,7,10,11,14,15,17a,20,20a,20b-dodcahydrospiro[
2H,17H-11,15-mthanofuro[4,3,2-pq][2,6]benzodioxacyclooctadcine13,2-pyran]-17-one ((5Z,25R)-25cyclohexyl-4-O-d(2,6-didsoxy-3-O-mthyl--L-arabinohexopyranosyl)5-dmthoxy-25-d(1-mthylpropyl)-5(hydroxyimino)avermectine A1a)
2268
Yes
+5C 3C
79
Y0000815 Selamectin for system suitability
5 mg
This Reference Standard has been replaced with Selamectin impurity B CRS
Y0001661 and Selamectin for peak identification CRS Y00001734. ; Batch 1 is
2268
Yes
+5C 3C
79
S0360000 Selegiline hydrochloride
50 mg
1260
Yes
+5C 3C
79
S0360090 (RS)-Selegiline hydrochloride
25 mg
1260
Yes
+5C 3C
79
S0400000 Senna extract
50 mg
0206,0207,0
208, 1261
Yes
-20C 5C
79
S0450000 Serine
50 mg
0788,1027
Yes
+5C 3C
79
S0460000 Sertaconazole nitrate
125 mg
Y0000828 Sertraline hydrochloride
200 mg
Y0001285 Sertraline impurity E
15 mg
Y0000866 Sertraline for peak identification
5.4 mg
Y0000867 Sertraline for system suitability
6.18 mg
Y0000371 Sestamibi labelling kit
22 mg
Y0001046 Sevoflurane
1 mL
Y0001578 Sildenafil citrate
100 mg
1148
Yes
+5C 3C
79
1705
Yes
+5C 3C
79
1705
Yes
+5C 3C
79
1705
Yes
+5C 3C
79
1705
Yes
+5C 3C
79
1926
Yes
+5C 3C
79
2269
Yes
+5C 3C
79
See leaflet
2270
Yes
+5C 3C
79

72

Order
Reference Standard
Code
Y0001579 Sildenafil impurity A

Information
per vial Unit
1
10 mg
1 5-[2-ethoxy-5[(4-methylpiperazin-1-yl)sulfonyl]phenyl]-1-methyl-3-(2methylpropyl)-6,7-dihydro-1H-pyrazol[4,3-d]pyrimidin-7-one
S0500000 Silicone elastomer
2000 mg
S0600000 Silicone oil

S0650000 Simvastatin
1 mL
200 mg
Y0001066 Simvastatin for peak identification
10 mg
Y0001208 Sinomenine
20 mg
See leaflet CHNO
New S0660000 Sisomicin sulfate

See leaflet ; Batch 4 is valid until 30 June 2015
Monograph Leaflet
Storage
Extra
Price
charges
79
a
2270
Yes
+5C 3C
30109
Yes
+5C 3C
79
30108
Yes
+5C 3C
79
1563
Yes
-20C 5C
79
1563
Yes
-20C 5C
79
2450
Yes
+5C 3C
79
60 mg
See leaflet CHNOS ; Batch 2 is valid until 30 November 2015
0331,1351
Yes
-20C 5C
79
Y0001615 Beta-sitosterol
25 mg
See leaflet CHO
2579
Yes
-20C 5C
79
Y0001727 Sodium alendronate trihydrate
150 mg
see leaflet CHNNaOP,3HO
1564
Yes
+5C 3C
79
Y0001678 Sodium alendronate for system suitability
5 mg
1564
Yes
+5C 3C
79
S0695000 Sodium amidotrizoate
125 mg
1150
Yes
+5C 3C
79
Y0001669 Sodium aminosalicylate dihydrate
10 mg
1993
Yes
+5C 3C
79
Y0000300 Sodium aminosalicylate dihydrate - reference spectrum
n/a
79
Y0000039 Sodium ascorbate
50 mg
1791
Yes
+5C 3C
79
S0700000 Sodium calcium edetate
100 mg
0231
Yes
+5C 3C
79
S0710000 Sodium cetostearyl sulfate
100 mg
0847
Yes
+5C 3C
79
S0750000 Sodium cromoglicate
10 mg
0562
Yes
+5C 3C
79
Y0001300 Sodium cromoglicate for system suitability
20 mg
0562
Yes
+5C 3C
79
S0760000 Sodium cyclamate
100 mg
0774
Yes
+5C 3C
79
Y0001410 Sodium fusidate
10 mg
0848
Yes
+5C 3C
79
S0780000 Sodium hyaluronate BRP
300 mg
0912
Yes
+5C 3C
79
S0781000 Sodium hyaluronate - reference spectrum
n/a
1472
79
Y0001468 Sodium iodohippurate
15 mg
2352
Yes
+5C 3C
79
Y0000620 Sodium laurilsulfate
40 mg
0802
Yes
+5C 3C
79
Y0000808 Sodium phenylbutyrate
5 mg
2183
Yes
+5C 3C
79
Y0000809 Sodium phenylbutyrate impurity C
10 mg
4-cyclohexylbutanoic acid
2183
Yes
+5C 3C
79
1031
Yes
+5C 3C
79
79
New S0785000 Sodium picosulfate
50 mg
Y0000210 Sodium polystyrene sulfonate - reference spectrum
n/a
1909
Y0000268 Sodium propionate - reference spectrum
n/a
2041
79
S0800000 Sodium salicylate
100 mg
0413
Yes
+5C 3C
79
S0808000 Sodium stearyl fumarate
50 mg
1567
Yes
+5C 3C
79
S0808060 Sodium stearyl maleate
10 mg
1567
Yes
+5C 3C
79
S0900000 Sodium taurocholate BRP
10000 mg
0350
Yes
+5C 3C
79
S0930000 Sodium valproate
50 mg
0678
Yes
+5C 3C
79
2.52 mg
2779
Yes
+5C 3C
79
New Y0001743 Solifenacin for system suitability

73

Order
Reference Standard
Code
New Y0001763 Solifenacin succinate

per vial Unit
1
5 mg
1
Information
Monograph Leaflet
2779
Yes
Storage
+5C 3C
Extra
Price
charges
79
b
S0945000 Somatostatin
2.09 mg
0949
Yes
-20C 5C
90
S0947000 Somatropin
55 mg
See leaflet
0950,
0951,0952
Yes
-20C 5C
150
Y0000711 Somatropin/desamidosomatropin resolution mixture
33 mg
See leaflet
0950,0951,0
952
Yes
-20C 5C
150
S0950000 Sorbic acid
10 mg
0592
Yes
+5C 3C
79
Y0000385 1,4-Sorbitan
50 mg
See leaflet CHO
S1000000 Sorbitol
1250 mg
See leaflet
Y0000114 Sotalol hydrochloride
25 mg
Y0000115 Sotalol impurity B
20 mg
Y0001011 Spanish sage oil for peak identification
250 mg
Y0000597 Spectinomycin hydrochloride
100 mg
Y0000549 Spectinomycin for system suitability
20 mg
Y0000655 Spectinomycin sulfate tetrahydrate
10 mg
Y0001126 Spike lavender oil
400 l
S1100000 Spiramycin
200 mg
See leaflet
Y0000381 Spirapril hydrochloride monohydrate
60 mg
See leaflet CHClNOS
Y0000332 Spirapril for system suitability
15 mg
S1200000 Spironolactone
160 mg
Y0001295 Spironolactone for system suitability
2.057 mg
Y0000185 Squalane
250 l
Y0001050 St. John's wort dry extract
500 mg
S1250000 Stanozolol
50 mg
S1250010 Stanozolol impurity A
10 mg
Y0001420 Stanozolol impurity B
10 mg
S1300000 Starch BRP
50000 mg
Y0000408 Stavudine
100 mg
Y0001683 Stavudine impurity I
5 mg
Y0000421 Stavudine for system suitability
10 mg
N-[4-[[(1-methylethyl)amino]acetyl]phenyl]methanesulphonamide ; Batch 1 is
valid until 31 March 2015
2048
Yes
+5C 3C
79
0435,0436,0
437,
1235,1236,1
337,
1381,1531,2
048
Yes
+5C 3C
79
2004
Yes
+5C 3C
79
2004
Yes
+5C 3C
79
1849
Yes
+5C 3C
79
1152, 1658
Yes
-20C 5C
79
1152, 1658
Yes
-20C 5C
79
1658
Yes
-20C 5C
79
See leaflet
2419
Yes
+5C 3C
79
0179,0293,1
982,20702
Yes
-20C 5C
79
1766
Yes
+5C 3C
79
1766
Yes
+5C 3C
79
0688
Yes
+5C 3C
79
0688
Yes
+5C 3C
79
See leaflet CH
1630
Yes
+5C 3C
79
see leaflet
1874
Yes
-20C 5C
79
1568
Yes
+5C 3C
79
1568
Yes
+5C 3C
79
1568
Yes
+5C 3C
79
0350
Yes
+5C 3C
79
2130
Yes
+5C 3C
79
2130
Yes
+5C 3C
79
2130
Yes
+5C 3C
79
See leaflet; Spironolactone CRS 2 is suitable for monograph 01/2008:0688

only.
17-hydroxy-17-methyl-5-androstan-3-one (mestanolone)
see leaflet
74

Order
Code
S1340000 Stearic acid
Reference Standard
S1350000 Stearyl alcohol

per vial Unit
3
100 mg
1 Plastic additive 19
250 mg
Information
Monograph Leaflet
See leaflet CHO
Storage
0229,0882,1
474, 1663,
2058,
30103,
30105,
30106,3010
0702,0753,0
7
801,
Yes
+5C 3C
Yes
+5C 3C
Extra
Price
charges
79
a
79
0802,0847,0
969,
1123,1340,1
411
Y0000868 Streptokinase for system suitability
30 l
0356
Yes
-20C 5C
79
S1400000 Streptomycin sulfate
100 mg
See leaflet
0032,0033,0
053,
0485,20702
Yes
-20C 5C
79
Y0001195 Strychnine
40 mg
see leaflet
2513,2514
Yes
+5C 3C
79
Y0001324 Sucralfate
10 mg
1796
Yes
+5C 3C
79
Y0001344 Sucralose
550 mg
See leaflet CHClO
2368
Yes
+5C 3C
79
Y0001342 Sucralose impurity B
0.5 mg
1,6-dichloro-1,6-dideoxy-?-D-fructofuranosyl 6-chloro-6-deoxy-?-Dglucopyranoside (1',6,6'-trichloro-1',6,6'-trideoxysucrose) ; Batch 1 is valid

until 31 May 2015
2368
Yes
+5C 3C
79
S1600000 Sucrose
100 mg
0177,0178,0
187,0188,02
04,0209,106
1,1570,2318
, 2319
Yes
+5C 3C
79
S1608100 Sufentanil - reference spectrum
n/a
1569
79
S1609000 Sufentanil citrate - reference spectrum
n/a
150 mg
Y0000529 Sulbactam sodium
10 mg
See leaflet
Y0000550 Sulbactam for peak identification
20 mg
S1700000 Sulfacetamide sodium
50 mg
S1800000 Sulfadiazine
Y0001480 Sulfadiazine for identification of impurity F
Y0001469 Sulfadiazine impurity A

Y0001677 Sulfadimethoxine
Y0001679 Sulfadimethoxine for peak identification
S1900000 Sulfadimidine
79
2209, 2211,
2212
Yes
-20C 5C
79
2209
Yes
+5C 3C
79
2209
Yes
+5C 3C
79
0107,0295
Yes
+5C 3C
79
100 mg
0294
Yes
+5C 3C
79
15 mg
0294
Yes
+5C 3C
79
20 mg
pyrimidin-2-amine
0294
Yes
+5C 3C
79
60 mg
see leaflet
2741
Yes
+5C 3C
79
10 mg
2741, 2745
Yes
+5C 3C
79
100 mg
0295
Yes
+5C 3C
79
Y0001495 Sulfadimidine for peak identification
50 mg
0295
Yes
+5C 3C
79
S1950000 Sulfadoxine
50 mg
0740
Yes
+5C 3C
79
New Y0000528 Sulbactam
1269
75

Order
Code
S1975000 Sulfafurazole
Reference Standard

per vial Unit
1
100 mg
1
Information
Monograph Leaflet
Storage
0741
Yes
+5C 3C
Extra
Price
charges
79
a
S1975600 Sulfaguanidine
60 mg
0295,1476
Yes
+5C 3C
79
S2000000 Sulfamerazine
100 mg
0358,1571
Yes
+5C 3C
79
S2050000 Sulfamethizole
100 mg
0637
Yes
+5C 3C
79
S2100000 Sulfamethoxazole
50 mg
0108
Yes
+5C 3C
79
Y0000412 Sulfamethoxazole impurity A
5 mg
N-(4-(5-methyl)-isoxazol-3-ylsulphamoyl)phenylacetamide
0108
Yes
+5C 3C
79
Y0000413 Sulfamethoxazole impurity F
5 mg
4-amino-N-(3-methylisoxazol-5-yl)benznesulphonamide
0108
Yes
+5C 3C
79
S2150000 Sulfamethoxypyridazine
50 mg
0638
Yes
+5C 3C
79
S2151000 Sulfanilamide
100 mg
1571
Yes
+5C 3C
79
S2159100 Sulfapyridine
20 mg
S2155000 Sulfasalazine
250 mg
See leaflet CHNOS
S2155010 Sulfasalazine derivative for resolution
20 mg
2-hydroxy-5-[[4-[[(6-methylpyridin-2-yl)amino]-sulfonyl]phenyl]azo]benzoic
acid
S2158000 Sulfathiazole
100 mg
S2159000 Sulfinpyrazone
30 mg
S2159010 Sulfinpyrazone impurity A
20 mg
S2159015 Sulfinpyrazone impurity B
20 mg
Y0001238 Sulfinpyrazone for system suitability
0.5 mg
S2180000 Sulindac
50 mg
S2190000 Sulpiride
100 mg
S2191000 Sulpiride impurity A
20 mg
[(2RS)-1-ethylpyrrolidin-2-yl]methanamine
New S2192000 Sulpiride impurity B
20 mg
methyl 2-methoxy-5-sulphamoylbenzoate
Y0000530 Sultamicillin
10 mg
Y0000532 Sultamicillin for peak identification
10 mg
Y0000531 Sultamicillin tosilate
200 mg
See leaflet
Y0000022 Sumatriptan succinate
50 mg
Y0000026 Sumatriptan impurity mixture
3 mg
Y0000027 Sumatriptan for system suitability
2.02 mg
S2200000 Suxamethonium chloride
1000 mg
S2400000 Suxibuzone
50 mg
S2400004 Suxibuzone impurity B
10 mg
(4-butyl-3,5-dioxo-1,2-diphenylpyrazolidin-4-yl)methyl ethyl butanedioate
S2400006 Suxibuzone impurity C
10 mg
4-butyl-4-(hydroxymethyl)-1,2-diphenyl-1,2-dihydro-4H-pyrazole-3,5-dione
S5000001 Swine erysipelas bacteria, serotyp 1 (for vaccines - vet.

use) BRP
1 mg
See leaflet
S5000002 Swine erysipelas bacteria, serotyp 2 (for vaccines - vet.

use) BRP
1 mg
See leaflet
Y0001417 Tadalafil
200 mg
0863
Yes
+5C 3C
79
0863,1457
Yes
+5C 3C
79
0863
Yes
+5C 3C
79
0742
Yes
+5C 3C
79
0790
Yes
+5C 3C
79
1,2-diphenyl-4-[2-(phenylsulphonyl)ethyl]pyrazolidine-3,5-dione
0790
Yes
+5C 3C
79
1,2-diphenyl-4-(2-phenylthioethyl)pyrazolidine-3,5-dione
0790
Yes
+5C 3C
79
0790
Yes
+5C 3C
79
0864
Yes
+5C 3C
79
1045,1348
Yes
+5C 3C
79
1045,1490
Yes
+5C 3C
79
1045
Yes
+5C 3C
79
2211
Yes
+5C 3C
79
See leaflet CHFOS; Contains 0.3% m/m of E-isomer
2211
Yes
+5C 3C
79
2211,2212
Yes
+5C 3C
79
See leaflet CHNOS
1573
Yes
-20C 5C
79
1573
Yes
-20C 5C
79
1573
Yes
-20C 5C
79
0248
Yes
+5C 3C
79
1574
Yes
+5C 3C
79
1574
Yes
+5C 3C
79
1574
Yes
+5C 3C
79
See leaflet,
0064
Yes
+5C 3C
e(b)
90
See leaflet,
0064
Yes
+5C 3C
e(b)
90
2606
Yes
+5C 3C
79
76

Order
Reference Standard
Code
T0010000 Talampicillin hydrochloride

per vial Unit
1
50 mg
1
Information
Monograph Leaflet
Storage
0808,0852
Yes
+5C 3C
Extra
Price
charges
79
a
T0014000 Tamoxifen citrate
80 mg
1046
Yes
+5C 3C
79
T0015000 Tamoxifen citrate for performance test
10 mg
1046
Yes
+5C 3C
79
Y0000650 Tamsulosin hydrochloride
10 mg
2131
Yes
+5C 3C
79
Y0000651 Tamsulosin impurity D
10 mg
2-methoxy-5-[(2R)-2-[[2-(2-methoxyphenoxy)ethyl]amino]propyl]
benzenesulfonamide
2131
Yes
+5C 3C
79
Y0000652 Tamsulosin impurity H
10 mg
(2R)-N-[2-(2-ethoxyphenoxy)ethyl]-1-(4-methoxyphenyl)propan-2-amine
2131
Yes
+5C 3C
79
Y0000653 Tamsulosin racemate
15 mg
2131
Yes
+5C 3C
79
Y0001560 Tanshinone IIa
15 mg
See leaflet CHO
2663
Yes
+5C 3C
79
Y0001102 Teicoplanin
50 mg
2358
Yes
-20C 5C
79
Y0001047 Teicoplanin for identification
40 mg
2358
Yes
-20C 5C
79
Y0000648 Telmisartan
30 mg
2154
Yes
+5C 3C
79
Y0000649 Telmisartan for peak identification
10 mg
2154
Yes
+5C 3C
79
Y0001003 Telmisartan for system suitability
0.26 mg
2154
Yes
+5C 3C
79
T0040000 Temazepam - * psy
50 mg
0954
Yes
+5C 3C
79
Y0000344 Temazepam impurity C
5 mg
(3RS)-7-chloro-1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-1,4benzodiazepin-3-yl acetate
0954
Yes
+5C 3C
79
Y0000345 Temazepam impurity D
5 mg
(3RS)-7-chloro-3-methoxy-1-methyl-5-phenyl-1,3-dihydro-2H-1,4benzodiazepin-2-one
0954
Yes
+5C 3C
79
Y0000346 Temazepam impurity F
10 mg
(5RS)-7-chloro-1-methyl-5-phenyl-4,5-dihydro-1H-1,4-benzodiazepine-2,3dione ; Batch 1 is valid until 28 February 2015
0954
Yes
+5C 3C
79
Y0000347 Temazepam impurity G
5 mg
(5RS)-7-chloro-1,4-dimethyl-5-phenyl-4,5-dihydro-1H-1,4benzodiazepine-2,3-dione
0954
Yes
+5C 3C
79
T0040800 Tenoxicam
100 mg
1156
Yes
+5C 3C
79
Y0001114 Tenoxicam impurity mixture
0.0042 mg
1156
Yes
+5C 3C
79
Y0000621 Terazosin hydrochloride dihydrate
40 mg
2021
Yes
+5C 3C
79
Y0000622 Terazosin impurity A
10 mg
2-chloro-6,7-dimethoxyquinazolin-4-amine
2021
Yes
+5C 3C
79
Y0000665 Terazosin impurity E
10 mg
2,2'-(piperazine-1,4-diyl)bis(6,7-dimethoxyquinazolin-4-amine)
2021
Yes
+5C 3C
79
Y0000623 Terazosin impurity L
10 mg
1-(furan-2-ylcarbonyl)piperazine
2021
Yes
+5C 3C
79
Y0000624 Terazosin impurity N
10 mg
See leaflet CHNO; 1-[[(2RS)-tetrahydrofuran-2-yl]carbonyl]piperazine
2021
Yes
+5C 3C
79
Y0000666 Terazosin for system suitability
0.5 mg
2021
Yes
+5C 3C
79
Y0000535 Terbinafine hydrochloride
10 mg
1734
Yes
+5C 3C
79
New Y0001143 Terbinafine for system suitability
10 mg
1734
Yes
+5C 3C
79
T0050000 Terbutaline sulfate
100 mg
0690, 2451
Yes
+5C 3C
79
T0050015 Terbutaline impurity C
15 mg
0690
Yes
+5C 3C
79
T0060000 Terconazole
250 mg
1270
Yes
+5C 3C
79
T0071000 Terfenadine
100 mg
0955
Yes
+5C 3C
79

1-(3,5-dihydroxyphenyl)-2-[(1,1-dimethylethyl)amino]ethanone
77

Order
Reference Standard
Code
T0080000 Terfenadine impurity A

Information
Monograph Leaflet
per vial Unit
2
20 mg
1 1-[4-(1,1-dimethylethyl)phenyl]-4-[4-(hydroxydiphenylmethyl) piperidin-1-yl]
0955
Yes
butan-1-one
Storage
+5C 3C
Extra
Price
charges
79
a
T0100000 Testosterone
30 mg
1373, 1048
Yes
+5C 3C
79
Y0000342 Testosterone for impurity D identification
20 mg
1373
Yes
+5C 3C
79
Y0000343 Testosterone for system suitability
20 mg
1373
Yes
+5C 3C
79
T0210000 Testosterone caproate
50 mg
T0240000 Testosterone decanoate
50 mg
Y0000696 Testosterone decanoate for system suitability
0.4 mg
T0250000 Testosterone enantate
100 mg
Y0001313 Testosterone enantate impurity H
10 mg
Y0001312 Testosterone enantate for peak identification
10 mg
Y0001317 Testosterone enantate for system suitability
2 mg
T0260000 Testosterone isocaproate
50 mg
Y0000716 Testosterone isocaproate for system suitability
5 mg
T0300000 Testosterone propionate
60 mg
Y0001409 Testosterone propionate for system suitability
5 mg
T0400000 Tetanus vaccine (adsorbed)
30 mg
T0500000 Tetracaine hydrochloride
100 mg
Y0001002 Tetracaine for system suitability
2 mg
T0550000 Tetracosactide
20.4 mg
See leaflet CHNOS
T0600000 Tetracycline hydrochloride
100 mg
See leaflet CHClNO
Y0001165 Tetrandrine
20 mg
Y0001087 Tetra-O-acetyl-mannose triflate
60 mg
Y0000015 Tetrazepam - reference spectrum
n/a
Y0000008 Tetrazepam impurity C
20 mg
Y0000460 Tetryzoline hydrochloride
10 mg
Y0000723 Thebaine - * narc
15 mg
T0700000 Theobromine
25 mg
1048
Yes
+5C 3C
79
1048, 1736
Yes
-20C 5C
79
1736
Yes
-20C 5C
79
1048
Yes
-20C 5C
79
1048
Yes
-20C 5C
79
1048
Yes
-20C 5C
79
See leaflet CHO
delta-5-testosterone-3,17-dienantate
See leaflet CHO

See leaflet CHO
1048
Yes
-20C 5C
79
1048,1737
Yes
+5C 3C
79
1737
Yes
+5C 3C
79
0297
Yes
+5C 3C
79
0297
Yes
+5C 3C
79
See leaflet,
20708
Yes
-20C 5C
90
0057
Yes
+5C 3C
79
0057
Yes
+5C 3C
79
0644
Yes
-20C 5C
79
0173,0198,0
199,
0210,0211,1
654
Yes
+5C 3C
79
See leaflet CHNO
2478
Yes
+5C 3C
79
See leaflet CHFOS
2294
Yes
-20C 5C
79
79
1738
Yes
+5C 3C
79
See leaflet
1738
7-chloro-5-cyclohexyl-1-methyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one
2101
Yes
+5C 3C
79
0777,1839,1
840,1841
Yes
+5C 3C
79
0298
Yes
+5C 3C
79
Yes
+5C 3C
79
79
see leaflet
T0800000 Theophylline
100 mg
0300,0301
Y0000294 Theophylline - reference spectrum
n/a
0299,0302
Y0000336 Thiamazole
125 mg
0884,1706
Yes
+5C 3C
79
Y0000372 Thiamazole impurity A
15 mg
2,2-dimethoxy-N-methylethanamine
1706
Yes
+5C 3C
79
Y0000373 Thiamazole impurity C
20 mg
See leaflet; 1-methyl-2-(methylsulphanyl)-1H-imidazole
1706
Yes
+5C 3C
79
78

Order
Reference Standard
Code
Y0000467 Thiamine hydrochloride
New Y0001749 Thiamine for system suitability

per vial Unit
2
10 mg
1
Information
Monograph Leaflet
Yes
0303
Yes
+5C 3C
79
0303,0531
Yes
+5C 3C
79
79
0.5 mg
10 mg
Y0000060 Thiamine nitrate - reference spectrum
n/a
0531
New Y0001758 Thiamine nitrate
+5C 3C
Extra
Price
charges
79
a
0303
Y0000059 Thiamine impurity E
3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-5-(2-hydroxyethyl)-4methylthiazol-2(3H)-thione
Storage
15 mg
0534
Yes
+5C 3C
79
T1100000 Thiamphenicol
125 mg
0109
Yes
+5C 3C
79
Y0000546 Thioctic acid
110 mg
1648
Yes
+5C 3C
79
Y0000545 Thioctic acid containing impurity B
25 mg
1648
Yes
+5C 3C
79
Y0000592 Thioctic acid for system suitability
10 mg
1648
Yes
+5C 3C
79
Y0000109 Thiomersal
30 mg
1625
Yes
+5C 3C
79
T1200000 Thiopental
500 mg
0212
Yes
+5C 3C
79
Y0001478 Thiopental for system suitability
10 mg
0212
Yes
+5C 3C
79
Y0000704 Thioridazine
10 mg
2005
Yes
+5C 3C
79
T1300000 Thioridazine hydrochloride
100 mg
0586
Yes
+5C 3C
79
Y0000541 Thioridazine for system suitability
0.21 mg
0586, 2005
Yes
+5C 3C
79
T1305100 Thioxanthene
20 mg
1347
Yes
+5C 3C
79
T1305000 Thioxanthone
10 mg
1347
Yes
+5C 3C
79
T1340000 Threonine
50 mg
1049
Yes
+5C 3C
79
T1350000 Thymol
50 mg
0791
Yes
+5C 3C
79
T1410000 Tiabendazole
50 mg
0866
Yes
+5C 3C
79
Y0000379 Tiamulin - reference spectrum
n/a
79
Y0000333 Tiamulin hydrogen fumarate
500 mg
1659,1660
Yes
+5C 3C
79
Y0000414 Tiamulin for peak identification
10 mg
1659
Yes
+5C 3C
79
Y0000151 Tianeptine sodium - reference spectrum
n/a
2022
79
Y0000153 Tianeptine impurity A
30 mg
2022
Yes
+5C 3C
79
Y0000152 Tianeptine for system suitability
30 mg
2022
Yes
+5C 3C
79
T1405000 Tiapride hydrochloride
60 mg
1575
Yes
+5C 3C
79
T1405050 Tiapride N-oxide
20 mg
1575
Yes
+5C 3C
79
T1410900 Tiaprofenic acid
50 mg
1157
Yes
+5C 3C
79
T1410910 Tiaprofenic acid impurity C
20 mg
1157
Yes
+5C 3C
79
Y0000748 Tibolone - reference spectrum
n/a
1739
79
Y0000668 Tibolone for system suitability
10 mg
1739
Yes
+5C 3C
79
Y0000465 Ticarcillin monosodium
250 mg
see leaflet ; Batch 1 is valid until 10 December 2014
0956
Yes
-20C 5C
79
T1420010 Ticarcillin impurity A
50 mg
See leaflet; (2S,5R,6R)-3,3-dimethyl-7-oxo-6-[[(thiophen-3-yl)acetyl]amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid

(decarboxyticarcillin)
0956
Yes
+5C 3C
79
1660
See leaflet CHNOS
ethyl 7-bromoheptanoate
(2RS)-2-(5-benzoylthiophen-3-yl)propanoic acid
79

Order
Reference Standard
Code
T1423000 Ticlopidine hydrochloride

per vial Unit
3
50 mg
1
Information
Monograph Leaflet
1050
Yes
+5C 3C
1050
Yes
+5C 3C
T1423025 Ticlopidine impurity F
10 mg
Y0000325 Tilidine hydrochloride hemihydrate - reference spectrum
n/a
1767
Y0000644 (R)-timolol
20 mg
0572
Yes
T1450000 Timolol maleate
100 mg
0572
Yes
Y0001270 Timolol for system suitability
5.045 mg
0572
Yes
T1470000 Tinidazole
100 mg
Y0000899 Tinidazole impurity A
15 mg
2-methyl-5-nitro-1H-imidazole
1051
T1471000 Tinidazole impurity B
20 mg
1-[2-(ethylsulphonyl)ethyl]-2-methyl-4-nitro-1H-imidazole
1051
6-(2-chlorobenzyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine
Storage
Extra
Price
charges
79
a
a
79
79
+5C 3C
79
+5C 3C
79
+5C 3C
79
+5C 3C
79
Yes
+5C 3C
79
Yes
+5C 3C
79
Yes
+5C 3C
79
79
1051
T1490000 Tinzaparin sodium
250 mg
1271
Y0000292 Tioconazole - reference spectrum
n/a
2074
Y0000282 Tioconazole for system suitability
50 mg
2074
Yes
+5C 3C
79
Y0001188 Tiotropium bromide monohydrate
10 mg
2420
Yes
+5C 3C
79
Y0001216 Tiotropium impurity F
15 mg
dithiophen-2-ylmethanone
2420
Yes
+5C 3C
79
10 mg
2420
Yes
+5C 3C
79
Y0001179 Tiotropium impurity mixture
0.08 mg
2420
Yes
+5C 3C
79
Y0001700 Tizanidine hydrochloride
100 mg
See leaflet CHClNS
2578
Yes
+5C 3C
79
Y0001698 Tizanidine impurity B
10 mg
N-(5-chloro-2,1,3-benzothiadiazol-4-yl)thiouree
2578
Yes
+5C 3C
79
T1500000 Tobramycin
49 mg
See leaflet CHNO; Suitable for LC assay only
0645
Yes
+5C 3C
79
Y0001210 Tobramycin for identification
250 mg
Suitable for identification tests only
0645
Yes
+5C 3C
79
T1550000 alpha-Tocopherol
500 mg
See leaflet CHO ; Vitamin E
0692,1256,2
0432
Yes
+5C 3C
79
T1600000 alpha-Tocopheryl acetate
500 mg
See leaflet CHO
0439,0691,1
257
Yes
+5C 3C
79
50 mg
0692
Yes
+5C 3C
79
New Y0001189 Tiotropium for system suitability
New Y0000383 All-rac-alpha-tocopherol for peak identification

Y0000384 All-rac-alpha-tocopheryl acetate for peak identification
30 mg
T1610000 RRR-alpha-Tocopheryl hydrogen succinate
150 mg
See leaflet CHO
0439
Yes
+5C 3C
79
1258,1259
Yes
+5C 3C
79
T1700000 Tolbutamide
100 mg
0304
Yes
+5C 3C
79
Y0000154 Tolfenamic acid
100 mg
2039
Yes
+5C 3C
79
T1707000 Tolnaftate
60 mg
1158
Yes
+5C 3C
79
Y0001123 Tolnaftate for system suitability
10 mg
1158
Yes
+5C 3C
79
Y0001696 Tolterodine tartrate
5 mg
2781
Yes
+5C 3C
79
Y0001699 Tolterodine impurity E
5 mg
2781
Yes
+5C 3C
79
Y0001697 Tolterodine for system suitability
5 mg
2781
Yes
+5C 3C
79
Y0000461 Torasemide anhydrous
10 mg
2132
Yes
+5C 3C
79
Y0001366 Torasemide impurity E
0.0006 mg
2132
Yes
+5C 3C
79
Y0000462 Torasemide for system suitability
5 mg
2132
Yes
+5C 3C
79
ethyl [[4-[(3-methylphenyl)amino]pyridin-3-yl]sulfonyl]carbamate
80

Order
Reference Standard
Code
Y0000155 Tramadol hydrochloride

per vial Unit
3
75 mg
1
Information
Monograph Leaflet
Storage
1681
Yes
+5C 3C
Extra
Price
charges
79
a
Y0000156 Tramadol impurity A
25 mg
(1RS,2SR)-2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)-cyclohexanol
1681
Yes
+5C 3C
79
Y0000157 Tramadol impurity E
15 mg
(2RS)-2-[(dimethylamino)methyl]cyclohexanone
1681
Yes
+5C 3C
79
Y0000072 Tramazoline hydrochloride monohydrate
20 mg
1597
Yes
+5C 3C
79
Y0000065 Tramazoline impurity A
15 mg
N-(naphthalen-1-yl)-4,5-dihydro-1H-imidazol-2-amine
1597
Yes
+5C 3C
79
Y0000066 Tramazoline impurity B
10 mg
See leaflet; Mixture of 1-acetyl-N-(5,6,7,8-tetrahydronaphthalen-1-yl)-4,5dihydro-1H-imidazol-2-amine and 1-[(EZ)-1-[(5,6,7,8tetrahydronaphthalen-1-yl)imino]ethyl]imidazolidin-2-one
1597
Yes
+5C 3C
79
Y0000501 Trandolapril
10 mg
2245
Yes
+5C 3C
79
Y0000495 Trandolapril impurity C
10 mg
(2S,3aR,7aS)-1-[(2S)-2-[[(1S)-3-cyclohexyl-1-(ethoxycarbonyl)propyl]amino]
propanoyl]octahydro-1H-indole-2-carboxylic acid (hexahydrotrandolapril)
2245
Yes
+5C 3C
79
Y0000496 Trandolapril impurity D
10 mg
ethyl (2S)-2-[(3S,5aS,9aR,10aS)-3-methyl-1,4-dioxodecahydro
pyrazino[1,2-a]indol-2(1H)-yl]-4-phenylbutanoate (trandolapril
diketopiperazine)
2245
Yes
+5C 3C
79
T1810000 Tranexamic acid
50 mg
0875
Yes
+5C 3C
79
T1820000 Trapidil
50 mg
1576
Yes
+5C 3C
79
T1820002 Trapidil impurity A
20 mg
5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-ol
1576
Yes
+5C 3C
79
T1820004 Trapidil impurity B
20 mg
1,2,4-triazol-3-amine
1576
Yes
+5C 3C
79
Y0001172 Trehalose dihydrate
250 mg
See leaflet CHO,2HO
2297
Yes
+5C 3C
79
T1850000 Tretinoin
50 mg
0693,1019,1
385
Yes
+5C 3C
79
G0400010 Triacetin - reference spectrum
n/a
1106
79
T1899990 Triamcinolone
150 mg
1376
Yes
+5C 3C
79
Y0000050 Triamcinolone impurity C
10 mg
9-fluoro-11,16alpha,17,21-tetrahydroxypregn-4-ene-3,20-dione
T1900000 Triamcinolone acetonide
150 mg
See leaflet CHFO
Y0001459 Triamcinolone acetonide for system suitability
10 mg
1376
Yes
+5C 3C
79
0533,0867,1
075
Yes
+5C 3C
79
0533
Yes
+5C 3C
79
T1950000 Triamcinolone hexacetonide
100 mg
0533,0867
Yes
+5C 3C
79
Y0000837 Triamterene
10 mg
0058
Yes
+5C 3C
79
Y0000870 Triamterene impurity B
0.5 mg
0058
Yes
+5C 3C
79
T1975000 Triazolam - * psy
10 mg
1065
Yes
+5C 3C
79
Y0000165 Tribenoside
150 mg
See leaflet
1740
Yes
-20C 5C
79
Y0000166 Tribenoside impurity A
70 mg
See leaflet CHO; 3,5,6-tri-O-benzyl-1,2-O-(1-methylethylidene)-alpha-Dglucofuranose
1740
Yes
-20C 5C
79
Y0001628 Tribenoside impurity D
35 mg
Benzyl ether
1740
+5C 3C
79
Y0001055 Tributyl acetylcitrate
1 mL
1770
Yes
+5C 3C
79
Y0000799 Tributyl acetylcitrate for peak identification
25 mg
1770
Yes
+5C 3C
79
T1977990 Tricaprin
150 mg
1410
Yes
-20C 5C
79
2,7-diamino-6-phenylpteridin-4-ol
81

Order
Code
T1977995 Tricaproin
Reference Standard

per vial Unit
1
40 mg
1
Information
Monograph Leaflet
Storage
1410
Yes
-20C 5C
Yes
-20C 5C
T1978000 Tricaprylin
225 mg
1410
Y0000111 Trichloroacetic acid - reference spectrum
n/a
1967
Extra
Price
charges
79
c
c
79
79
T1985000 Trichlorotrifluoroethane
2.5 ml
0393
Yes
+5C 3C
79
Y0001737 Triclabendazole
10 mg
2609
Yes
+5C 3C
79
Y0001723 Triclabendazole for system suitability
0.012 mg
2609
Yes
+5C 3C
79
T1986000 Triethyl citrate - reference spectrum
n/a
1479
79
T2000000 Trifluoperazine hydrochloride
100 mg
0059
Yes
+5C 3C
79
T2005000 Triflusal
50 mg
1377
Yes
+5C 3C
79
1377
Yes
+5C 3C
79
2032
Yes
+5C 3C
79
1626
Yes
+5C 3C
79
1626
Yes
+5C 3C
79
T2005010 Triflusal impurity B
15 mg
Y0000720 Triglycerol diisostearate
200 mg
Y0000108 Trihexyphenidyl hydrochloride
100 mg
Y0000068 Trihexyphenidyl impurity A
20 mg
2-hydroxy-4-(trifluoromethyl)benzoic acid
1-phenyl-3-(piperidin-1-yl)propan-1-one
T2009000 Trilaurin
1250 mg
1410
Yes
-20C 5C
79
Y0001319 Trimebutine maleate
10 mg
2182
Yes
+5C 3C
79
Y0001260 Trimebutine for system suitability
1.017 mg
2182
Yes
+5C 3C
79
Y0000092 Trimetazidine dihydrochloride - reference spectrum
n/a
1741
79
Y0000093 Trimetazidine for system suitability
50 mg
T2100000 Trimethadione
250 mg
T2200000 Trimethoprim
50 mg
T2200010 Trimethoprim impurity B
15 mg
Y0000684 Trimethoprim for system suitability
Y0001497 3-Trimethylsilyl-1-propanesulfonic acid sodium salt
120 mg
T2450000 Trimethyltetradecylammonium bromide
200 mg
T2500000 Trimipramine maleate
100 mg
Y0000759 Trimipramine for peak identification
0.51 mg
500 mg
Y0000279 Tri-n-butyl phosphate
300 l
Y0001113 Triolein
30 mg
T2501200 Tristearin
100 mg
T2545000 Trolamine
2250 mg
Y0001184 Trolamine impurity A
250 mg
Y0001183 Trolamine impurity B
1 ml
T2550000 Trometamol
100 mg
T2580000 Tropicamide
50 mg
Y0001247 Tropicamide impurity C
10 mg
New T2500100 Trimyristin
See leaflet CHNO

(2,4-diaminopyrimidin-5-yl)(3,4,5-trimethoxyphenyl)methanone
0.00075 mg 1
1741
Yes
+5C 3C
79
0440
Yes
+5C 3C
79
0060
Yes
+5C 3C
79
0060
Yes
+5C 3C
79
0060
Yes
+5C 3C
79
2645, 2165
Yes
+5C 3C
79
0378
Yes
+5C 3C
79
0534
Yes
+5C 3C
79
0534
Yes
+5C 3C
79
1410
Yes
-20C 5C
79
1682
Yes
+5C 3C
79
2454
Yes
-20C 5C
79
1410
Yes
-20C 5C
79
1577
Yes
+5C 3C
79
Ethanolamine
1577
Yes
+5C 3C
79
Diethanolamine
1577
Yes
+5C 3C
79
1053
Yes
+5C 3C
79
1159,1197
Yes
+5C 3C
79
1159
Yes
+5C 3C
79
See leaflet CHOSSi,Na

See leaflet CHO
(2RS)-3-hydroxy-2-phenylpropanoic acid (tropic acid)

82

Order
Reference Standard
Code
Y0001248 Tropicamide impurity D (Phenylacetic acid -*Drug
Precursor)

per vial Unit
1
10 mg
1 Phenylacetic acid
Information
Monograph Leaflet
Storage
1159
Yes
+5C 3C
Extra
Price
charges
79
i
Y0001316 Tropicamide for peak identification
10 mg
1159
Yes
+5C 3C
79
T2580300 Tropine
50 mg
1308, 2102
Yes
+5C 3C
79
Y0000616 Tropisetron hydrochloride
40 mg
2102
Yes
+5C 3C
79
Y0000618 Tropisetron impurity B
10 mg
2102
Yes
+5C 3C
79
Y0000429 Trospium chloride
10 mg
1798
Yes
+5C 3C
79
Y0000432 Trospium impurity A
20 mg
hydroxydiphenylacetic acid (benzilic acid)
1798
Yes
+5C 3C
79
Y0000431 Trospium impurity B
20 mg
(1R,3r,5S)-8-azabicyclo[3.2.1]oct-3-yl hydroxydiphenylacetate
1798
Yes
+5C 3C
79
Y0000430 Trospium impurity C
5 mg
(1R,3R,5S)-3-hydroxyspiro[8-azoniabicyclo[3.2.1]octane-8,1'-pyrrolidinium] ;
1798
Yes
+5C 3C
79
Y0000497 Troxerutin
30 mg
2133
Yes
+5C 3C
79
T2600000 Trypsin BRP
100 mg
See leaflet
0476,0579,0
580, 0694
Yes
+5C 3C
79
T2610000 Tryptophan
100 mg
see leaflet
1272, 2290
Yes
+5C 3C
79
T2880000 Tylosin
150 mg
see leaflet
1273,1274,1
661, 20702
Yes
+5C 3C
79
T2880100 Tylosin D
5 mg
1273,1274,1
661
Yes
+5C 3C
79
1H-indole-3-carboxylic acid
T2880200 Tylosin tartrate - reference spectrum
n/a
1274
79
Y0000498 Tylosin phosphate for peak identification
10 mg
1273,1274,1
661
Yes
+5C 3C
79
T2900000 Tyrosine
50 mg
1161, 1384
Yes
+5C 3C
79
T3000000 Tyrothricin
20 mg
0907,1662
Yes
+5C 3C
79
U0020000 Ubidecarenone
50 mg
1578
Yes
+5C 3C
79
U0020008 Ubidecarenone impurity D
5 mg
1578
Yes
+5C 3C
79
U0020001 Ubidecarenone for system suitability
1 mg
1578
Yes
+5C 3C
79
U0100000 Uracil arabinoside
60 mg
0760
Yes
+5C 3C
79
U0600000 Urea
100 mg
0743
Yes
+5C 3C
79
U0800000 Ursodeoxycholic acid
100 mg
1189,1275
Yes
+5C 3C
79
Y0001163 Ursodeoxycholic acid for system suitability
1.26 mg
1275
Yes
+5C 3C
79
Y0001523 Ursolic acid
25 mg
See leaflet CHO
Y0000834 Valaciclovir hydrochloride (anhydrous)
100 mg
See leaflet CHNOCl
Y0001096 Valaciclovir impurity D
10 mg
Y0001097 Valaciclovir impurity E
10 mg
Y0001098 Valaciclovir impurity F para-toluenesulfonate
12 mg
5,6-dimethoxy-3-methyl-2-[(all-E)-3,7,11,15,19,23,27,31,35nonamethylhexatriaconta-2,6,10,14,18,22,26,30,34-nonaenyl]benzene-1,4dione
2439
Yes
+5C 3C
79
1768,2751
Yes
+5C 3C
79
2-[(2-amino-6-oxo-1,6dihydro-9H-purin-9-yl)methoxy]ethyl N-ethyl-L-valinate
1768
Yes
+5C 3C
79
2-[(2-amino-6-oxo-1,6dihydro-9H-purin-9-yl)methoxy]ethyl N-[(benzyloxy)
carbonyl]-L-valinate
1768
Yes
+5C 3C
79
2-hydroxyethyl L-valinate
1768
Yes
+5C 3C
79
83

Order
Reference Standard
Code
Y0001099 Valaciclovir impurity G

per vial Unit
1
10 mg
1 N,N-dimethylpyridin-4-amine
Information
Monograph Leaflet
Storage
1768,2751
Yes
+5C 3C
Extra
Price
charges
79
a
Y0001662 Valaciclovir impurity P
5 mg
1768
Yes
+5C 3C
79
Y0001655 Valaciclovir impurity S
15 mg
2751
Yes
+5C 3C
79
Y0001225 Valaciclovir for system suitability
10 mg
Y0000583 Valerian dry extract
400 mg
V0030000 Valine
50 mg
Y0000584 Valnemulin hydrochloride
10 mg
Y0000586 Valnemulin impurity E
10 mg
Y0000585 Valnemulin for peak identification
10.25 mg
Y0000533 Valnemulin hydrogen tartrate
120 mg
V0033000 Valproic acid
100 mg
Y0001422 Valproic acid for system suitability
10 mg
Y0001132 Valsartan
10 mg
Y0001131 Valsartan for peak identification
10 mg
Y0001145 Valsartan for system suitability
0.202 mg
V0045000 Vancomycin hydrochloride
100 mg
V0050000 Vanillin
100 mg
Y0001648 Vardenafil for system suitability
10 mg
Y0001647 Vardenafil hydrochloride

TRIHYDRATE
120 mg
Y0001198 Varicella vaccine ( live)
420 mg
Y0000561 Vecuronium bromide
10 mg
Y0000625 Vecuronium for peak identification
10 mg
Y0001093 Vedaprofen
5 mg
Y0001118 Vedaprofen impurity mixture
Y0000587 Venlafaxine hydrochloride
Y0000588 Venlafaxine for system suitability

V0100000 Verapamil hydrochloride
See leaflet
(3aS,4R,5S,6S,8R,9R,9aR,10R)-6-ethenyl-5-hydroxy-4,6,9,10-tetramethyl-1oxodecahydro-3a,9-propano-3aH-cyclopenta[8]annulen-8-yl 2-hydroxyacetate
(pleuromulin)
See leaflet CHNOS
1768,2751
Yes
+5C 3C
79
0453,1898,1
899,2400,25
26
0796
Yes
-20C 5C
79
Yes
+5C 3C
79
2137
Yes
+5C 3C
79
2137
Yes
+5C 3C
79
2137
Yes
+5C 3C
79
2137
Yes
+5C 3C
79
1378
Yes
+5C 3C
79
0678,1378
Yes
+5C 3C
79
2423
Yes
+5C 3C
79
2423
Yes
+5C 3C
79
2423
Yes
+5C 3C
79
1058,20702
Yes
-20C 5C
79
0747
Yes
+5C 3C
79
2782
Yes
+5C 3C
79
See leaflet
2782
Yes
+5C 3C
79
See leaflet
0648, 2442
Yes
-80C 10C
90
1769
Yes
+5C 3C
79
1769
Yes
+5C 3C
79
2248
Yes
+5C 3C
79
0.006 mg
2248
Yes
+5C 3C
79
50 mg
2119
Yes
+5C 3C
79
1.002 mg
2119
Yes
+5C 3C
79
100 mg
0573
Yes
+5C 3C
79
V0100018 Verapamil impurity I
5 mg
(2RS)-2-(3,4-dimethoxyphenyl)-2-[2-[[2-(3,4-dimethoxy-phenyl)ethyl]
(methyl)amino]ethyl]-3-methylbutanenitrile hydrochloride
0573
Yes
+5C 3C
79
V0100026 Verapamil impurity M
10 mg
5,5'-[[2-(3,4-dimethoxyphenyl)ethyl]imino]bis[2-(3,4-dimethoxyphenyl)-2-(1methylethyl)pentanenitrile]
0573
Yes
+5C 3C
79
Y0000661 Verbenalin
11 mg
See leaflet CHO
1854
Yes
+5C 3C
79
V0180000 VERO cells
1 ml
Cell lines (kidney, african green monkey, Cercopithecus aethiops) titration of

live measles, mumps and rubella vaccines
0213,0538,1
057
Yes
Liquid nitrogen
100
See leaflet
84

Order
Code
Y0001400 Vigabatrin
Reference Standard

per vial Unit
1
10 mg
1
Information
Monograph Leaflet
Storage
2305
Yes
+5C 3C
Extra
Price
charges
79
a
Y0001401 Vigabatrin impurity A
25 mg
See leaflet CHNO; (5RS)-5-ethenylpyrrolidin-2-one
2305
Yes
-20C 5C
79
Y0001402 Vigabatrin impurity B
20 mg
(2E)-2-(2-aminoethyl)but-2-enoic acid
2305
Yes
+5C 3C
79
Y0001404 Vigabatrin impurity D
50 mg
4-aminobutanoic acid
2305
Yes
+5C 3C
79
Y0001403 Vigabatrin impurity E
10 mg
2-[(2RS)-2-aminobut-3-enyl]propanedioic acid
2305
Yes
+5C 3C
79
V0300000 Vinblastine sulfate
5.01 mg
See leaflet CHNOS
0748,0749
Yes
-80C 10C
79
V0305000 Vinblastine sulfate - reference spectrum
n/a
79
V0400000 Vincristine sulfate
4.96 mg
79
V0405000 Vincristine sulfate - reference spectrum
n/a
79
V0500000 Vindesine sulfate
5 mg
79
V0500010 Vindesine sulfate - reference spectrum
n/a
79
Y0000463 Vinorelbine tartrate
50 mg
2107
Yes
-80C 10C
79
Y0000464 Vinorelbine impurity B
7 mg
4-O-deacetylvinorelbine ; Batch 3 is valid until 30 September 2015
2107
Yes
-80C 10C
79
Y0000589 Vinpocetine
10 mg
2139
Yes
+5C 3C
79
Y0000590 Vinpocetine impurity A
10 mg
(12RS,13aSR,13bSR)-13a-ethyl-12-hydroxy-2,3,5,6, 12,13,13a,13boctahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12carboxylate (ethyl vincaminate)
2139
Yes
+5C 3C
79
Y0000591 Vinpocetine impurity B
10 mg
(13aS,13bS)-13a-ethyl-2,3,5,6,13a,13b-hexahydro-1H-indolo[3,2,1-de]pyrido
[3,2,1-ij][1,5]naphthyridine-12-carboxylate (apovincamine)
2139
Yes
+5C 3C
79
Y0000790 Vinpocetine impurity C
15 mg
ethyl (13aS,13bS)-13a-ethyl-9-methoxy-2,3,5,6,13a,13b-hexahydro-1Hindolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate
(methoxyvinpocetine) ; Batch 1 is valid until 31 August 2015
2139
Yes
+5C 3C
79
Y0000760 Vinpocetine impurity D
10 mg
(12RS,13aRS,13bRS)-13a-ethyl-2,3,5,6,12,13,13a,13b-octahydro-1H-indolo
[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate
(dihydrovinpocetine)
2139
Yes
+5C 3C
79
Y0000793 Vinyl acetate
200 mg
2152,2523
Yes
+5C 3C
79
New Y0001395 Voriconazole
120 mg
See leaflet CHFNO ; Batch 2 is valid until 30 November 2015
2576
Yes
+5C 3C
79
Y0001396 Voriconazole impurity B
10 mg
(2RS,3SR)-2-(2,4-difluorophenyl)-3-pyrimidin-4-yl-1-(1H-1,2,4-triazol-1-yl)
butan-2-ol
2576
Yes
+5C 3C
79
Y0001398 Voriconazole impurity D
10 mg
(2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4triazol-1-yl)butan-2-ol (epi-voriconazole)
2576
Yes
+5C 3C
79
Y0001397 Voriconazole impurity E
50 mg
[(1R,4S)-7,7-dimethyl-2-oxobicyclo[2.2.1]hept-1-yl]methanesulfonic acid
((+-)-camphorsulfonic acid)
2576
Yes
+5C 3C
79
0748
0748,0749
see leaflet
Yes
-80C 10C
0749
1276
See leaflet CHNOS
Yes
-80C 10C
1276
W0100000 Warfarin sodium
10 mg
0698
Yes
+5C 3C
79
Y0000778 Warfarin sodium clathrate
10 mg
0699
Yes
+5C 3C
79
Y0001599 Wedelolactone
15 mg
2564
Yes
-20C 5C
79
X0075000 Xylazine hydrochloride
125 mg
1481
Yes
+5C 3C
79
Y0000158 Xylazine impurity C
50 mg
1481
Yes
+5C 3C
79
Y0001224 Xylazine impurity mixture
0.02 mg
1481
Yes
+5C 3C
79
See leaflet
2,6-dimethylphenyl isothiocyanate
85

Order
Code
X0080000 Xylitol
Reference Standard
X0100000 Xylometazoline hydrochloride

Information
per vial Unit
2
500 mg
1 See leaflet
3
100 mg
1 Batch 2 is valid until 31 December 2014
Monograph Leaflet
Storage
+5C 3C
Extra
Price
charges
79
a
1381
Yes
0972,1162
Yes
+5C 3C
79
1162
Yes
+5C 3C
79
1278
Yes
+5C 3C
79
2172
Yes
+5C 3C
79
2611
Yes
+5C 3C
79
X0101000 Xylometazoline impurity A
15 mg
X0200000 Xylose
100 mg
Y0000656 Yohimbine hydrochloride
20 mg
Y0001715 Zanamivir hydrate
5 mg
Y0001703 Zanamivir impurity F
10 mg
see leaflet CHClN
2611
Yes
+5C 3C
79
Y0001702 Zanamivir for assay
50 mg
see leaflet CHNO
2611
Yes
+5C 3C
79
Y0001708 Zanamivir for system suitability
10 mg
2611
Yes
+5C 3C
79
60 mg
see leaflet ; Batch 2 is valid until 30 November 2015
1059
Yes
+5C 3C
79
Z1904000 Zidovudine impurity B
5 mg
1-(3-chloro-2,3-dideoxy--D-ribofuranosyl)-5-methylpyrimidine-2,4(1,3)dione ; Batch 2 is valid until 30 June 2015
1059
Yes
+5C 3C
79
Y0001654 Zidovudine impurity D
15 mg
Triphenylmethanol / Trityl alcohol / Triphenylcarbinol
1059
Yes
+5C 3C
79
Y0001641 Zidovudine for system suitability
10 mg
1059
Yes
+5C 3C
79
Z2000000 Zinc acexamate
50 mg
1279
Yes
+5C 3C
79
Z2000010 Zinc acexamate impurity A
50 mg
6-[[6-(acetylamino)hexanoyl]amino]hexanoic acid
1279
Yes
+5C 3C
79
Y0001286 Ziprasidone hydrochloride monohydrate
100 mg
see leaflet CHClNOS
2421,2649
Yes
+5C 3C
79
Y0001626 Ziprasidone mesilate trihydrate
30 mg
2649
Yes
+5C 3C
79
Y0001272 Ziprasidone for system suitability 1
10 mg
2421, 2649
Yes
+5C 3C
79
Y0001241 Ziprasidone for system suitability 2
0.465 mg
2421, 2649
Yes
+5C 3C
79
Z2500000 Zolpidem tartrate - * psy
200 mg
1280
Yes
+5C 3C
79
Z2500010 Zolpidem impurity A
10 mg
1280
Yes
+5C 3C
79
Z3000000 Zopiclone -* psy
40 mg
1060
Yes
+5C 3C
79
Z3001000 Zopiclone oxide
20 mg
1060
Yes
+5C 3C
79
Y0000062 Zuclopenthixol decanoate - reference spectrum
n/a
1707
79
Y0000083 Zuclopenthixol impurity B
10 mg
Y0000534 Zuclopenthixol for system suitability
0.26 mg
New Z1900000 Zidovudine
N-(2-aminoethyl)-2-(4-1,1-dimethylethyl-2,6-dimethylphenyl) acetamide ;
See leaflet CHClNO
N,N'-dimethyl-2-[7-methyl-2-(4-methylphenyl)imidazol[1,2-a] pyridin-3-yl]
acetamide ; Batch 3 is valid until 30 October 2014
2-chloro-9H-thioxanthen-9-one
86
1707
Yes
+5C 3C
79
1707
Yes
+5C 3C
79

Web Catalog CRS

Uploaded by

Document Information

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Web Catalog CRS

Uploaded by

Copyright:

Available Formats

List of European Pharmacopoeia Reference Standards

Effective from 2015/7/1

Y0001552 Abacavir for peak identification

Y0001551 Abacavir for system suitability

Y0000055 Acamprosate calcium - reference spectrum

Y0000116 Acamprosate impurity A

See leaflet ; Batch 2 is valid until 31 August 2015

Y0000354 Acarbose for identification

Y0000427 Acarbose for peak identification

A0040000 Acebutolol hydrochloride

Y0000359 Acebutolol impurity B

Y0000127 Acebutolol impurity C

Y0000128 Acebutolol impurity I

Y0000056 Aceclofenac - reference spectrum

Y0000085 Aceclofenac impurity F

Y0000086 Aceclofenac impurity H

Y0001094 Aceclofenac for peak identification

Y0000811 Acemetacin impurity A

Y0000842 Acemetacin impurity mixture

A0070000 Acesulfame potassium

A0070020 Acesulfame potassium impurity B

Y0001084 Acetazolamide for system suitability

Y0000002 Acetylcholine chloride

A0152000 Acetylcysteine impurity C

See leaflet; N,N'-diacetyl-L-cystine ; Batch 8 is valid until 31 October 2014

A0153000 Acetylcysteine impurity D

Y0000642 -Acetyldigoxin for peak identification

A0200000 Acetylsalicylic acid

Y0001460 Acetylsalicylic acid for peak identification

Council of Europe, all rights reserved 2015

Batch 2 is valid until 31 January 2015

see leaflet; 5-chloro-6-methyl-1,2,3-oxathiazin-4(3)-one 2,2-dioxide

N,-diacetyl-L-cysteine ; Batch 5 is valid until 28 May 2015

See leaflet CHO

Batch 1 is valid until 31 May 2015

Batch 1 is valid until 30 November 2014

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards

Effective from 2015/7/1

Y0001271 Aciclovir for peak identification 1

Batch 2 is valid until 30 November 2014

Y0001269 Aciclovir for peak identification 2

Batch 2 is valid until 31 December 2014

Y0001264 Aciclovir for system suitability

Y0001463 Actaea racemosa HRS

Y0001543 Actaea racemosa for assay CRS

Y0001464 Actaea racemosa dry extract for system suitability HRS

See leaflet CHO

Y0001120 Adapalene impurity C

1-[2-(methyloxy)phenyl]tricyclo[3.3.1.1]decane ; Batch 2 is valid until 30

Y0001119 Adapalene for peak identification

Y0000110 Adipic acid

Y0000740 Adrenaline impurity mixture

Y0000883 Adrenaline with impurity F

A0300000 Adrenaline tartrate

Y0000707 Adrenaline tartrate with impurity A

Y0001724 Agnus castus fruit dry extract

New A0325100 Albendazole

Batch 1 is valid until 31 December 2015

A0325200 Alcuronium chloride

See leaflet CHO

Batch 2 is valid until 30 November 2014

Y0001601 Alfacalcidol for system suitability

A0325451 Alfacalcidol - reference spectrum